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DNA methylation plays a central role in the epigenetic system of mammalian cells and in 
controlling gene expression. DNA methyltransferase 1 (Dnmt1) maintains the DNA 
methylation patterns after DNA replication. Removal of methylation can occur passively 
due to replication in the absence of DNA methyltransferases, with consequent dilution of 
this methylation modification. In addition, there is evidence supporting the occurrence of 
active demethylation in mammals. Ten-eleven translocation (Tet) dioxygenases, promote 
DNA demethylation by converting 5-methylcytosine (5mC) to 5-hydroxymethylcytosine 
(5hmC). However, it remains elusive how Tet proteins and their enzymatic activity are 
regulated. 
The aim of this study is to elucidate the multifaceted regulation mechanisms of Tet 
proteins. It was known that Tet1 has an ancestral intramolecular CXXC domain, and 
another gene encodes a standalone CXXC domain protein near tet2 in the same 
chromosome. Our research provided the first experimental evidence that Tet3 also 
harbors a CXXC. The goal was to achieve a better understanding of the complex 
functions of CXXC modules on Tet proteins. For this purpose, a variety of in vivo and in 
vitro assays were applied. CXXC motifs were reported to mediate chromatin binding in 
many proteins, and in our research, interaction between CXXC and Tet proteins were 
detected. Given that, it is assumed that the CXXC interactions have an impact on the 
gene targeting and chromatin binding dynamics of Tet proteins. To address this question, 
in vitro DNA competition affinity assays were performed. Among the unmodified, 
methylated or hydroxymethylated DNA substrates, CXXC domains share a similar binding 
preference of cytosine modification states. More specifically, 5mC and unmodified 
cytosine bind to CXXC motifs, but 5hmC shows a significant inhibition effect on DNA 
binding. Furthermore, live cell photobleaching analysis implied a slightly lower mobility 
and a weak increase in the immobile fraction of the CXXC-encoding Tet3 isoform. 
Although genomic 5hmC abundance was similar between cells expressing Tet3 isoforms 
with or without CXXC domain, significant transcriptional difference between the two Tet3 
isoforms was detected in various mouse tissues. Our data suggest that variable 
association with CXXC modules may contribute to the regulation of Tet proteins. 
To shed light on the regulation pathways in the endogenous context, we developed tools 
and techniques to monitor the Tet proteins in their natural, cellular environment. A set of 
monoclonal antibodies against Tet proteins were generated, to study Tet proteins with 
different cell biological and biochemical assays. Tet antibodies were utilized to perform 
co-immunoprecipitation assays followed by mass spectrometry analyses. Interactome 
identification of Tet proteins revealed that O-linked N-GlcNAc transferase (Ogt) is a major 
partner of all three Tet proteins. GlcNAcylation is a highly abundant post-translational 
modification in cells. Ogt and O-GlcNAcase (Oga) are the main enzymes catalyzing 
addition and removal of O-linked N-GlcNAcylation. Furthermore, antibody staining 
suggested a direct correlation between endogenous Tet, Ogt and histone marks 
associated with active transcription. We could confirm a regulatory function of Ogt/Oga on 
the glycosylation status of Tet proteins. To resolve further details of the interaction, a fine 
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mapping of Tet interaction domains was performed. I generated a library of single 
domains and deletion mutants of Tet proteins. The in vivo fluorescence three-hybrid 
assay demonstrated that the catalytic domain is the major interaction platform. 
In conclusion, this work contributes to the elucidation of mechanisms regulating Tet 





1.1 DNA methylation mediated epigenetic regulation 
1.1.1 Overview of epigenetics 
The terminology “epigenetics” describes heritable functionally relevant modifications of 
the genome that do not involve a change in the DNA sequence. Historically, the term 
“epigenetics” has been under discussion for a long time (Bird, 2007). At a Cold Spring 
Harbor meeting in 2008, epigenetics was defined as: “stably heritable phenotype resulting 
from changes in a chromosome without alterations in the DNA sequence" (Berger et al., 
2009). 
For cell division and differentiation undergoing in multicellular organisms, epigenetic 
modifications play a crucial role in defining cell fate as well as restricting the cell 
developmental potential. Specific epigenetic processes result in gene activation and 
silencing, gene imprinting, X chromosome inactivation, reprogramming, and are involved 
in the progress of carcinogenesis. Thus, cells could maintain a long-term cellular status or 
differentiate into new cell types without changing their genetic identity. 
Chromatin is a complex of DNA and histone proteins, and localized in the cell nucleus. 
The repeating unit of chromatin is the nucleosome, which is a 146 bp-long DNA 
sequence assembled with a histone octamer, including H2A, H2B, H3 and H4 (Luger et 
al., 1997). The eukaryotic genome is broadly organized into higher structural chromatin 
domains, called euchromatin and heterochromatin (Tremethick, 2007; Woodcock and 
Dimitrov, 2001). DNA staining dyes, like DAPI, normally stain heterochromatin more 
intensely. This indicates that heterochromatin is tighter packed with less gene activation, 
while euchromatin is less condensed and actively transcribed. Histone and DNA 
modifications differ between heterochromatin and euchromatin (Huisinga et al., 2006; 
Noma et al., 2001). 
Several epigenetic phenotypes play roles in controlling the formation and condensation of 
chromatin structures. And the best-studied epigenetic mechanisms are DNA methylation 
and post-translational histone modifications. Those epigenetic marks can be inherited 
through many cell generations, and thus stabilize the status of cells, which is also known 
as cell memory (Bryan et al., 2002; Bird, 2002). The epigenetic system is under regulation 
of different pathways, which allows adaptation to molecular stimuli, and thus response to 
the environmental or developmental signaling.
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1.1.2 5-Methylcytosine in DNA 
Modifications of nucleic acid bases are observed in both prokaryotic and eukaryotic cells. 
The best-studied modification is the methylation of cytosine residues in mammalian cells, 
describing a stably addition of a methyl group to 5-carbon atom. This process occurs 
post-replicative and is catalyzed by a family of DNA methyltransferases.  
In 1950, Wyatt was the first that clearly confirmed 5-methylcytosine (5mC) from DNA by 
chromatographic and spectral analyses (Wyatt, 1950; Wyatt, 1951). Today we know that 
DNA methylation is present in all kingdoms of life, and the level of DNA methylation is 
biologically and functionally relevant. DNA methylation precisely controls the gene 
expression pattern in different cell types and is strongly associated with transcriptional 
repression (Busslinger et al., 1983; Jaenisch and Bird, 2003). Promoters of housekeeping 
genes are unmethylated in most cell types, whereas tissue-specific genes are found to be 
unmethylated in corresponding tissues while highly methylated in others (Naveh-Many 
and Cedar, 1981). This indicates that DNA methylation undergoes dynamic changes 
during the whole development, and finally leads to distinct cell types that make up 
organisms. CpG di-nucleotide is the most well-studied and frequent DNA context that 
methylation modification occurs. CpG-enriched regions, which are also called CpG 
islands, are often found in the 5' regulatory region and gene body of many genes 
(Maunakea et al., 2010). The methylation status of promoter regions is important for 
controlling gene transcription (Gardiner-Garden and Frommer, 1987; Saxonov et al., 
2006). In addition, gene body methylation of high-level expression genes was also 
reported recently (Ball et al., 2009), as well as non-CpG methylation (cytosines that do 
not precede guanines) in embryonic stem cells (Dodge et al., 2002; Lister et al., 2009).  
Cell biology and molecular biology studies provide an understanding of how DNA 
methylation regulates gene transcription. An important mechanism is that DNA 
methylation changes the accessibility of transcription complexes to their responsive DNA 
binding sites at gene promoters. More specifically, methylated DNA can be bound by 
proteins known as methyl-CpG-binding domain proteins (Mbds). These proteins could 
recruit additional proteins, such as histone deacetylases (Hdacs), lysine-residues 
methyltransferases (HMTs) and other chromatin associated proteins (Nan et al., 1998; 
Fuks et al., 2003), to the locus and thereby control chromatin compaction. DNA 
methylation can also prevent transcription activation proteins from binding to CpG sites. 
This mechanism is supported by many locus-specific examples (Bell and Felsenfeld, 
2000). Evidence is that the CXXC finger protein 1 (Cfp1), a protein recruiting transcription 
activation mark H3K4me3, only specifically localizes to unmethylated cytosine (Thomson 
et al., 2012). Moreover, there is also a hypothesis that the methylation of DNA itself may 
physically impede the binding of transcription complexes to the gene promoters (Choy et 
al., 2010). 
Correct DNA methylation is of great importance for normal cellular functions, and aberrant 
patterns are sometimes associated with diseases as well as cancer pathology. Genome-
wide hypomethylation of DNA during progression of malignancy has been found in many 
tumor cell lines (Esteller, 2008; Feinberg et al., 2004; Hansen et al., 2011). Global 
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hypomethylation might have several effects, including chromatin instability (Eden et al., 
2003; Karpf and Matsui, 2005), reactivation of transposon (Bestor, 2005), and loss of 
imprinting genes (Cui et al., 2003; Holm et al., 2005). Hypermethylation of tumor-
suppressor genes is another mechanism of carcinogenesis (Esteller, 2008; Baylin et al., 
1986). The understanding of epigenetic oncogenesis pathways provides basis for drug 
development. 5-azacytidine is an inhibitor of C5 DNA methyltransferase and it is used in 
the treatment of myelodysplastic syndrome, a disease with the potential to progress into 
acute myelogenous leukemia (Voso et al., 2009; Christman, 2002). 
Both DNA methylation and histone modification are involved in establishing patterns of 
gene repression during development. Different amino acid residues of histones are 
substrates for several types of modification, including acetylation, methylation, 
phosphorylation and ubiquitination. There is a functional relationship between DNA 
methylation and chemical modifications of histone tails. Recent studies suggest that the 
establishment of histone modification pattern mediates DNA methylation (Ooi et al., 
2007). At the post-implantation stage, histone modification plays a role in controlling the 
establishment of de novo DNA methylation patterns and thus together silence pluripotent 
genes, such as octamer-binding transcription factor 4 (Oct4), in early development. The 
lysine residue H3K9 of histone 3 is firstly deacetylated, and subsequently H3K9 can be 
methylated by a complex containing the G9a protein, which is a histone 
methyltransferase (Tachibana et al., 2002; Freitag and Selker 2005). This modification 
further mediates heterochromatinization, and these combined processes finally stabilize 
the gene silencing by recruiting DNA methyltransferase 3a and 3b (Dnmt3a and 3b) to 
establish the DNA methylation pattern (Feldman et al., 2006; Epsztejn-Litman et al., 
2008). Conversely, DNA methylation is also important in maintaining histone modification 
patterns. Researches demonstrated that DNA methylation mediates histone H3 lysine 9 
(H3K9) methylation and inhibits histone H3 lysine 4 (H3K4) methylation, both of which are 
evidence for chromatin compaction (Hashimshony et al., 2003; Lande-Diner et al., 2007). 
Although DNA methylation is chemically stable, there are two waves of global 
demethylation during development. When fertilization, DNA methylation marks can be 
removed by an epigenetic “reprogramming”. The erasure of gametic marks during embryo 
formation is very important for establishing totipotency (Reik et al., 2010). Widespread 
reprogramming also takes place in primordial germ cells (PGCs). At this stage, chromatin 
undergoes global alterations and parental imprints are erased (Surani, 2001). The 
reprogramming processes will be discussed further in later chapter (chapter 1.2).
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1.1.3 DNA methyltransferases 
As illustrated above, DNA methylation plays a crucial role in many cellular processes. The 
mechanisms of the initial establishment (de novo methylation) and maintenance of DNA 
methylation during replication are of great research interest. DNA methyltransferases are 
the key enzymes to catalyze these reactions, and contain several members: Dnmt1, 
Dnmt2, Dnmt3a, Dnmt3b and Dnmt3L.  
1.1.3.1 Dnmt1 
Dnmt1 is a DNA methyltransferase that is most abundant and ubiquitously expressed in 
mammalian cells. It was first identified and cloned from mouse cells (Bestor et al., 1988). 
On one hand, it plays a central role in maintenance of DNA methylation patterns during 
DNA replication (Li et al., 1992) and DNA repair (Mortusewicz et al., 2005). During 
replication, the synthesis of a new DNA strand generates hemi-methylated DNA strands. 
Using the template strand with an established methylation pattern, Dnmt1 modifies the 
newly synthesized strand to generate symmetric methylation patterns (Razin and Riggs, 
1980). Biochemical research indicates that Dnmt1 has a 5- to 30-fold preferentially 
binding of hemi-methylated DNA substrates over unmethylated substrates, which is 
consistent with its maintenance function (Yoder et al., 1997; Frauer and Leonhardt, 
2009). On the other hand, Dnmt1 is also reported to contribute to de novo methylation in 
cancer cells (Jair et al., 2006; Ting et al., 2006). 
 
Figure 1: Structure of the mammalian DNA methyltransferase family. The Dnmts differ in their N-terminal domains, which 
are their regulatory regions. Abbreviations indicate: PBD: PCNA binding domain; TS: pericentric heterochromatin targeting 
sequence; ZnF: CXXC-type zinc finger motif; BAH: bromo adjacent homology domains; PWWP: domain with a conserved 
Pro-Trp-Trp-Pro motif; PHD: plant homeodomain. The C-terminal parts of all Dnmts share a similar catalytic domain with 
conserved motifs (I–X) (Rottach et al., 2009). 
Overall, Dnmt1 is composed of two parts, the C-terminal catalytic domain and the 
remaining N-terminal regulatory domain, which are connected by a flexible Lys-Gly (KG)-
repeat linker (Figure 1). The N-terminal domain of Dnmt1 harbors a proliferating cell 
nuclear antigen (PCNA) binding domain (PBD), targeting sequence (TS domain), a 
CXXC-type zinc finger domain (ZnF), and two bromo adjacent homology domains 
(BAH1/2) (Figure 1). It was reported that in absence of the regulatory domain, the 
isolated C-terminal domain of Dnmt1 is catalytically inactive, suggesting that the 
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regulatory domain may play a role in enzymatic activity of Dnmt1 (Fatemi et al., 2001; 
Pradhan et al., 2008; Margot et al., 2000).  
In the N-terminus of Dnmt1, the targeting sequence (TS) domain presents very important 
regulatory function. Protein interaction assay demonstrated that the N-terminal domain of 
Dnmt1 can form stable dimers by hydrophobic interaction between two TS-domains 
(Fellinger et al., 2009). Furthermore, in late S to G2 phase of cell cycle, the TS domain 
and PBD domain have been found to mediate association of Dnmt1 to heterochromatin 
(Leonhardt et al., 1992; Easwaran et al., 2004). The TS domain of Dnmt1 shows 
necessity in interacting with the Uhrf1 protein (ubiquitin-like, containing PHD and RING 
finger domains, 1), which is an important regulator of Dnmt1 (Achour et al., 2008; Frauer 
and Leonhardt, 2011; Sharif et al., 2007). Another important domain is embedded 
between TS and BAH regions: the cysteine-rich CXXC (C is cysteine; X is any amino 
acid) domain that is also found in many other CpG dinucleotides binding proteins. 
The carboxyl-terminal part of Dnmt1 shows sequence similarity with prokaryotic DNA 
methyltransferases. These C-terminal parts of Dnmt1/2/3 are highly conserved with 10 
motifs, which have specific structural roles and are involved in catalysis (Cheng et al., 
1993; Kumar et al., 1994). More specifically, the motifs I and X together create the 
binding site for reaction cofactor S-adenosyl-L-methionine (SAM). Motif VI transiently 
protonates the N3 position of target cytosine by a glutamyl residue and will stabilize the 
DNA-protein complex. Between motif VIII and IX, there is a sequence-specific contact 
region, named as target recognition domain (Bestor, 2000; Hermann et al., 2004; Jeltsch, 
2002). In motif IV, there is a conserved prolylcysteinyl (PC) dipeptide center. The cysteine 
thiolate in PC center could form a covalent bond with the C6 of cytosine, and this 
formation activates the C5 atom for electrophilic attack (Bestor and Verdine, 1994; Kumar 
et al., 1994). The PC center is necessary for the enzymatic function of Dnmts, and 
mutation of the cysteine in PC center will cause the loss of methyltransferase activity 
(Hsieh, 1999).  
In 2011 and 2012, crystal structures of multi-domain Dnmt1 fragments were resolved 
(Takeshita et al., 2011; Song et al., 2012b). Takeshita et al. reported the crystal structure 
of mouse Dnmt1 AA291–1620, under the condition that cofactor SAM and its product S-
adenosyl-L-homocysteine (SAH) presenting. It was shown that the TS domain inserts 
deeply into the DNA binding pocket formed by catalytic domain of Dnmt1. Thus position 
changing of TS domain and the CXXC motif is required in order to allow DNA binding and 
succeeding reactions. The binding of SAM flips the position of a cysteine residue in the 
PC dipeptide center towards the target cytosine (Takeshita et al., 2011). Taking together, 
maintenance DNA methylation is a multi-step process and structural changes of Dnmt1 
domains occur during the process. 
The biological function of Dnmt1 is not only controlled by its sequence and structure, but 
also by its interacting proteins. Many interaction partners of Dnmt1 assist during DNA 
methylation process (Figure 2, Qin et al., 2011a). For example when DNA is replicated, 
Dnmt1 is recruited to replication forks by interaction with proliferating cell nuclear antigen 
(PCNA) via PBD domain of Dnmt1 (Chuang et al., 1997; Leonhardt et al., 1992; 
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Easwaran et al., 2004). This interaction between Dnmt1 and PCNA is highly dynamic 
during cell cycle, and increases the methylation activity of approximately 2-fold 
(Schermelleh et al., 2007; Spada et al., 2007). 
 
Figure 2: Overview of Dnmt1 interacting proteins. Interaction proteins of Dnmt1 include many different classes, such as 
DNA methyltransferases, DNA binding proteins, chromatin binding proteins, tumor suppressors and transcriptional 
regulators. (Modified from Qin et al., 2011a; Ruzov et al., 2009). 
Another important interaction partner is the multi-domain protein Uhrf1 (also known as 
Np95), which is involved in directing Dnmt1 to modification sites (Bostick et al., 2007; 
Sharif et al., 2007). Uhrf1 protein recognizes hemi-methylated, rather than fully-
methylated DNA, via its SET and RING-associated (SRA) domain (Kim et al., 2009; Arita 
et al., 2008; Sharif et al., 2007; Rottach et al., 2010). Uhrf1 also interacts with many 
transcription-repressive marks and then mediates gene silencing via Dnmt1 (Kim et al., 
2009; Nady et al., 2011).  
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Dnmt1 undergoes several post-translational modifications, including phosphorylation, 
methylation, ubiquitination and SUMOylation, which regulate the stability and functions of 
Dnmt1 (Sugiyama et al., 2010; Wang et al., 2009; Agoston et al., 2005; Lee and Muller 
2009). It has been proposed that phosphorylation increases stability of Dnmt1 and 
regulates its DNA binding activity (Sun et al., 2007). The methylation of several lysine 
residues of Dnmt1 was reported to destabilize Dnmt1 via proteasomal degradation, which 
is controlled by histone methyltransferase Set7 and demethylase Lsd1 (also known as 
Kdm1) (Esteve et al., 2009; Wang et al., 2009). 
Ubiquitination-mediated proteasomal degradation is also involved in controlling the 
stability of Dnmt1 (Agoston et al., 2005). Dnmt1 and Uhrf1 were shown to interact with 
ubiquitin specific peptidase 7 (Usp7), which protein belongs to the ubiquitin specific 
peptidase class of deubiquitinating enzymes. Usp7, together with Uhrf1 as E3-ligase, 
regulates the ubiquitination of Dnmt1, and thus controls stability of Dnmt1 via ubiquitin-
mediated proteasomal degradation (Qin et al., 2011b; Bronner, 2011). Research 
demonstrated that human DNMT1 is a substrate for acetylation by a protein lysine 
acetyltransferase 5 (KAT5, also known as Tip60) and this reaction triggers ubiquitination 
of DNMT1 by the E3-ligase activity of UHRF1 (Du et al., 2011). In contrast, DNMT1 is 
deacetylated by histone deacetylase 1 (HDAC1) and deubiquitinated by USP7. 
Proteasomal degradation of DNMT1 is promoted by acetylation via KAT5 and UHRF1; 
while DNMT1 is protected and stabilized by HDAC1 and USP7. These antagonistic 
reactions regulate the stability of DNMT1 (Du et al., 2011). 
 
1.1.3.2 The Dnmt3 family 
In 1998, the group from Okano cloned and characterized the enzymatic function of two 
members of the Dnmt family, Dnmt3a and 3b (Okano et al., 1998). Dnmt3a and Dnmt3b 
are known to catalyze de novo methylation reactions in early developmental stages (Goll 
and Bestor, 2005; Hermann et al., 2004). These enzymes mainly participate in 
establishing methylation patterns during embryogenesis (Hermann et al., 2004) and in 
site-specific methylation of cancer-associated genes during tumorigenesis (Roll et al., 
2008; Rhee et al., 2003). Both enzymes are comprised of a regulatory N-terminal domain 
and a catalytic C-terminal domain that bears all MTase motifs (Figure 1). Dnmt3a and 3b 
show 84% identity in their C-terminal regions.  
Later, researchers identified a DNA methylation regulator, Dnmt3-like (Dnmt3L) protein, 
which contains an N-terminal part similar to Dnmt3a and 3b but lacks the catalytic motifs. 
Knock-out mice of Dnmt3L show an abnormal sex-specific de novo methylation in germ 
cells, indicating the necessity of Dnmt3L in establishing methylation patterns during 
development, even though Dnmt3L lacks methyltransferase activity (Webster et al., 
2005). It was also shown that H3K4-methylation affects the binding of Dnmt3L to H3 
histone. This evidence suggests that Dnmt3L is a necessary modulator in de novo DNA 
methylation, and functionally links DNA methylation with histone modifications (Hu et al., 




Dnmt2 was discovered by molecular informational manipulation (Okano et al., 1998). It 
widely distributes among different species and is much conserved from yeast to 
mammals (Yoder and Bestor, 1998). In contrast to Dnmt1 and 3, Dnmt2 only contains a 
C-terminal catalytic domain and is located in the cytoplasm. It has been shown that 
Dnmt2 has methylation activity on tRNAASP, specifically on cytosine 38 in the anticodon 
loop of tRNAASP, indicating that Dnmt2 is actually a RNA methyltransferase rather than a 
DNA modifier (Goll et al., 2006; Jurkowski et al., 2008). 
 
1.1.3.4 Catalytic mechanism of Dnmts 
A ‘base-flipping’ is a conserved mechanism (Cheng and Roberts, 2001) that has been 
studied best in the bacterial 5mC methyltransferase (MTase) M.HhaI (Klimasauskas et 
al., 1994). Base-flipping is recognized as a necessary strategy for nucleotide access for 
many enzyme classes, such as Dnmts (Cheng and Blumenthal, 2008), non-catalytic 
transcription factors, Uhrf1 (Arita et al., 2008) and endonucleases (Horton et al., 2006). 
Briefly, this mechanism describes a process that the Mtases extract the base from a DNA 
molecule and insert it into a typically concave catalytic pocket, covalently attack to C6 of 
cytosine, transfer a methyl group to activate C5, and followed by many consecutive 
releasing steps. 
The reaction cofactor SAM is a really effective donor for methyl moieties (Figure 3). With 
prokaryotic cytosine methyltransferase M.HhaI as model, research indicated that DNA 
Mtases have high binding affinity to SAM and buries SAM into a hydrophobic pocket 
formed by C-terminal motifs of Dnmts (Kumar et al., 1994; Jeltsch, 2002). Some 
hydrophobic interactions exist between certain amino acids in Dnmts and corresponding 
atoms in SAM (Roth et al., 1998). 
 
Figure 3: Cytosine is methylated at C5 position, catalyzed by Dnmt proteins. The donor of methyl moiety is a cofactor S-
adenosyl-methionine (SAM). The reaction produces S-adenosyl-L-homocysteine (SAH). DNA methylation is a central 
epigenetic mark in controlling gene expression. 
In conclusion, epigenetics is very important research field in cell biology. The epigenetic 
marks, including DNA methylation and histone modifications, play central roles in 
regulating many cellular processes. DNA methylation is catalyzed by a family of Dnmt 
proteins. Dnmt1, which has most abundance and ubiquitously expresses in mammalian 
cells, is responsible for maintenance and propagation of DNA methylation pattern to the 
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next generation. Our functional study and characterization on the structure of Dnmt1 
showed that a motif in N-terminal part, the CXXC zinc finger, selectively binds DNA 
substrates containing unmethylated CpG sites. Anyhow, the CXXC-lacking mutation of 
Dnmt1 can still efficiently rescue DNA methylation patterns in dnmt1-/- embryonic stem 
cells and form covalent complex with cytosines, indicating the CXXC motif of Dnmt1 
might participate, but not be indispensible in regulating Dnmt1 function (Frauer et al., 
2011, see chapter 2.1).  
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1.2 Reprogramming and DNA demethylation 
During mammalian development, two waves of large-scale reprogramming occur, 
including a series of chromatin remodeling. DNA demethylation is a landmark event 
during reprogramming. There are various hypotheses raised to explain the mechanism of 
active demethylation. Until now, the oxidative removal of methyl moiety catalyzed by Tet 
family is the most well-studied and credible model. Tet family is a class of 2-oxoglutarate 
and Fe (II)-dependent dioxygenase, and contains Tet1, 2 and 3. Tet1 and Tet2 participate 
in epigenetic regulation at the blastocyst pluripotent stage, and Tet2 is also closely 
associated in hematopoietic cell differentiation and mutagenesis. Tet3 is a key factor in 
totipotent zygotes and widely exists in many somatic cell lineages. 
1.2.1 Cellular reprogramming 
1.2.1.1 Reprogramming in early development 
The formation of the zygote symbolizes the starting point of development. Fusion of two 
highly differentiated gametes becomes a zygote and it reacquires totipotency after the 
fertilization process. The two parental genomes in the zygote are asymmetrically 
organized (Van der Heijden et al., 2005; Shi and Wu, 2009). Dramatic change of the 
epigenome takes place and the characteristic epigenetic profile is very crucial for further 
development. For example, the paternal genome is wrapped by protamines at final 
stages of spermatogenesis to condensate chromatin (Kimmins and Sassone-Corsi, 
2005). After fertilization, histone H3.3 shortly incorporates into the male pronucleus to 
replace protamines (Torres-Padilla et al., 2006). Also many post-translational 
modifications of histones of both pronuclei take place during the few cell cycles (Feil, 
2009; Figure 4). 
Dynamic changes of DNA methylation patterns are significant events occurring after 
fertilization, particularly an active DNA demethylation wave of paternal pronucleus in a 
few hours after fusion. Active demethylation describes the process that the paternal 
genome undergoes a replication-independent, large-scale demethylation in some kinds of 
mammal. This event is detected by both indirect immunofluorescence (Santos et al., 
2002; Mayer et al., 2000) and bisulfite genomic sequencing technology (Oswald et al., 
2000). In contrary, the maternal pronucleus is resistant to nuclear reprogramming and 
preserves DNA methylation, until the passive demethylation begins after the formation of 
the syngamy (Aoki et al., 1997).  
While the first cycle of DNA replication starts, fused diploid genome is passively 
demethylated (Rougier et al., 1998; Barton et al., 2001). The maintenance DNA 
methyltransferase Dnmt1 is absent during this time. This mechanism is termed as 
passive demethylation because its dependence on mitotic cycles, whereas followed by 




Figure 4: Dynamic changing of genome methylation in mammalian preimplantation embryonic development. Dramatic 
epigenetic changes occur during the early developmental stages. After fusion of two gametes, paternal genome 
experiences replacement of protamines, active DNA demethylation and many modifications of histones. After fusion of two 
haploid genomes, the syngamy takes place passive demethylation and later re-establishes DNA methylation pattern via de 
novo mechanism. 
Another large-scale chromatin reprogramming in vivo occurs in primordial germ cells 
(PGCs), the precursors setting up the male and female germ lines. During gastrulation 
stage, the germ line specification is inducted by signaling system in embryo, and thus 
actively decides cell fate to form either oocyte or sperm in later development. The 
commitment of PGCs involves repression of somatic differentiation genes and activation 
of germ cell lineage genes (Saitou and Yamaji, 2012). 
Early PGCs show similar epigenetic profiles compared to epiblast cells, including X 
chromosome inactivation, DNA methylation and imprinted genes. However, at embryonic 
(E) day 10.5, PGCs arrive at the genital ridge and begin to mature; from E12.5 onwards, 
PGCs undergo sex-specific development in gonads. Extensive chromatin remolding and 
a bulk of DNA demethylation occur during E11.5 to E12.5, including on both normal 
genes (Hajkova et al., 2002) and imprinted genes (Lee et al., 2002). It is still unclear how 
the migrating PGCs maintain their methylation pattern, given that an essential component 
of DNA methylation maintenance machinery, Uhrf1, is specifically down-regulated 
(Kurimoto et al., 2008).  Nevertheless, numerous evidences support the idea that this 
global DNA demethylation is an active process (Wu and Zhang, 2010). One important 
supporting point is that the maintenance DNA methyltransferase Dnmt1 is still expressed 
and localizes in the nucleus at this stage (Sakai et al., 2001). Another cooperative model 
is also raised where both active and passive demethylation exist as parallel systems in 
PGCs reprogramming process (Hackett et al., 2012). 
There are many questions in the early developmental reprogramming that remain elusive. 
For example: how maternal genome escapes from active demethylation in zygotic 
reprogramming?  What is the function of the large-scale remodeling of chromatin? And 
most importantly, what is the mechanism and catalytic enzyme for removal of methyl 
moiety from 5mC? Some hypotheses have been raised in recent years and will be 





1.2.1.2 Experimental Reprogramming 
In 1981, the first embryonic stem cells (ES cells) were isolated from the inner cell mass in 
blastocyst by Martin (Martin, 1981) and Kaufman (Evans and Kaufman, 1981). These 
cells can be grown in cell culture condition while still keeping pluripotency, meaning that 
they can form chimera when transferred into mouse blastocyst and differentiate into all 
tissues including the germ line (Kuehn et al., 1987). Therefore, ES cells serve as an 
excellent in vitro model for studying molecular and cellular biology at implantation stage. 
Experimentally, reprogramming has been achieved by somatic cell nuclear transfer in 
early decades. In 2006, Yamanaka’s group described that a combination of transcription 
factors (Oct4, Sox2, Klf4 and c-Myc) can dedifferentiate somatic cells back into 
pluripotent ES-like cells, which then have been named induced pluripotent cells (iPS) 
(Takahashi and Yamanaka, 2006). It was the first investigation of iPS and this is a 
landmark report in cell biology. Human iPS cells provide a possibility to generate 
specialized cell types for individual patients, so it brings a new era for cell therapy and is 
of great medical interest. Thence Shinya Yamanaka, sharing with John B. Gurdon, was 
awarded the Nobel Prize in physiology or medicine 2012, for phrasing their finding that 
mature cells can be reprogrammed to become immature cells capable of developing into 
all tissues (Rossant and Mummery, 2012). In recent years, many further studies followed 
after this initial study from Yamanaka for a better understanding of this process and to 
improve the reprogramming event (Takahashi et al., 2007; Yu et al., 2009; Chang et al., 
2009). 
Some proteins have been frequently applied in different combinations of ectopic 
expression factor when generating iPS, e.g. Klf4, Sox2, Oct4, Nanog and c-Myc. Oct4 is 
a bipartite homeodomain transcription factor that belongs to the Pit-Oct-Unc (POU) 
family, therefore also named as POU domain, class 5, transcription factor (Pou5f1) 
(Scholer et al., 1990). Oct4 has long been recognized to be a master factor for inner cell 
mass formation (Nichols et al., 1998) and maintenance of undifferentiation state in mouse 
and human ES cells (Niwa et al., 2000; Brandenberger et al., 2004). Researches 
elegantly showed that the precise relevant level of Oct4 abundance produces different 
phenotypic effects in ES cells, meaning that obvious decrease in Oct4 expression triggers 
cell differentiation toward the trophectoderm lineage, proper Oct4 dosage maintains the 
ES cells pluripotency, and sustained up-regulation in Oct4 expression level promotes 
cells into mesoderm or endoderm (Niwa et al., 2000; Shimozaki et al., 2003). The 
expression and silencing of Oct4 is precisely programmed by the epigenetic system and 
the cell differentiation status. For example, H3K9 methylation and heterochromatinization 
are involved in Oct4 inactivation, and this progress is mediated by G9a protein, a 
dominant H3K9 methyltransferase for euchromatic fraction of the genome (Feldman et 
al., 2006; Tachibana et al., 2002). Nanog, a homeodomain-containing transcription 
regulator, is another protein undoubtedly linked to mammalian pluripotency (Chambers et 
al., 2003; Mitsui et al., 2003). Nanog is named after Tir Na Nog, the mythological Celtic 
land of the ever young, because Nanog confers ability for cell self-renewal and 
pluripotency in mouse ES cells independently from LIF/Stat3 signaling pathway. Nanog-
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deficient mouse ES cells differentiate slowly into extra-embryonic endoderm lineages 
(Mitsui et al., 2003). The other involved ectopic factor c-Myc is a famous oncogene, as 
well as a regulator of cell cycle and metabolism (Kim et al., 2010). During generation of 
iPS cells, c-Myc functions mainly as enhancer of reprogramming efficiency rather than 
directly inducing pluripotency (Wernig et al., 2008).  
These aforesaid transcription factors have been reported to co-occupy and regulate 
promoter regions of many ES cell-specific genes, and there is also complicated 
interaction network between these factors. For example, Nanog could be a strong 
activator of Oct4 expression (Pan et al., 2006). Human and mouse Sox2 often acts as a 
partner of Oct4 to regulate gene expression (Kuroda et al., 2005; Nakatake et al., 2006). 
These transcription factor synergy systems govern the self-renewal and undifferentiation 
of ES cells (Pei, 2009). 
Chemical components were also applied to assist cell reprogramming. For example, 
HDAC inhibitor valproic acid (VPA) improves reprogramming efficiency of fibroblast cells 
with only Oct4 and Sox2, without Klf4 or c-Myc (Huangfu et al., 2008). With only Oct3/4 
and Klf4, G9a inhibitor BIX-01294 enables reprogramming neural progenitor cells, and 
stem cell pluripotency, global expression profile and epigenetic status are all well re-
established in this process (Shi et al., 2008). 
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1.2.2 Active DNA demethylation 
1.2.2.1 Active DNA demethylation is a landmark event of reprogramming 
Epigenetics is the key system for reacquiring pluripotency, because the specific gene 
expression profile in a particular cell type is determined by the epigenetic status. 
Therefore insight into DNA demethylation is crucial for understanding reprogramming and 
thus suggests direction for regenerative medicine. 
As mentioned above, active demethylation occurs during developmental stages. The 
global removal of 5mC in the paternal genome during zygotic reprogramming is observed 
in human, mouse, rat, pig and bovine (Dean et al., 2001; Fulka et al., 2004), but not in 
sheep (Beaujean et al., 2004). More specifically, some genomic elements escape from 
this large-scale demethylation, including imprinted genes (Olek and Walter, 1997) and 
transposable elements (Lane et al., 2003). Experimental dedifferentiated cells show 
similar DNA methylation level with ES cells, indicating genomic demethylation occurs 
during reprogramming (Dean et al., 2003; Maherali et al., 2007). PGCs undergo another 
large-scale wave of active erasure of methyl marks in most genes (Hajkova et al., 2002), 
which routine to re-establish totipotent epigenetic patterns in the next generation of 
mammals. 
In addition, loci-specific demethylation in somatic cells was also detected (Wu and Zhang, 
2010). It was reported that in the presence of VPA, a human estrogen responsive gene 
trefoil factor 1 (TFF1, also named pS2) becomes quiescent and its proximal promoter is 
methylated (Reid et al., 2005). In response to the stimuli of estrogens, the promoter of 
pS2/TFF1 gene undergoes local cyclical methylation/demethylation during transcriptional 
cycle (Metivier et al., 2008; Kangaspeska et al., 2008). Another example of loci-specific 
demethylation is found in T-cells, where the proximal enhancer of interleukin 2 gene (il2) 
gets rapidly and specifically demethylated after activation signal, which is correlated with 
enhancement of the il2 gene expression. This dynamic demethylation is a pathway to 
control rapid immune response for T-cell (Bruniquel and Schwartz, 2003; Kersh et al., 
2006). 
 
1.2.2.2 Hypotheses of active DNA demethylation mechanism 
Considering the importance of DNA demethylation in embryogenesis and somatic 
development, the mechanism is of great interest for researchers. In the last decades, 
many different hypotheses and catalytic candidates have been raised (Wu and Zhang, 
2010; Ooi and Bestor, 2008; Gjerset and Martin, 1982). Among them, some hypotheses 
describe a direct removal of methyl moiety from cytidine ring (by one or many steps), and 
some others depict a complete replacement of cytidine (or nucleoside or nucleotide) 




Figure 5: Summary for hypotheses of active DNA demethylation. Direct removal of the methyl group of 5-methylcytosine 
(5mC) involves breaking a carbon-carbon bond, which requires an enzyme with high catalytic energy. (a) Mbd4 and (b) 
Elp3 protein were reported to enzymatically remove the methyl moiety from 5mC. (c) Tet proteins were reported to oxidize 
the 5mC to 5hmC, followed by further oxidation to 5fC and 5caC, and the deformylation of 5fC or decarboxylation of 5caC 
is proposed to be required for completed demethylation. (e) The 5mC or (d) its oxidative intermediate 5hmC are also 
reported to undergo deamination, which are catalyzed by deaminase Aid or Apobec proteins, and produce T or 5hmU, 
respectively. The deamination products could be further processed by BER pathway. (f) BER mechanism is an important 
pathway that involved in DNA damage repair. After recognizing incorrect nucleotide, a key factor belonging to glycosylase 
family can catalyze hydrolysis reaction of the N-glycosidic bond. Tdg is found to execute the nucleotide excision step for a 
broad range of substrates, including thymine, uracil, 5hmU, 5fC and 5caC. (g) NER is also a mechanism of DNA repair, 
which is involved in large fragment removal of DNA strands. Gadd45 is reported to be a factor in NER pathway, and 
recently found to be recruited at active demethylation sites. Therefore it is also possible that nucleotide excision occurs 
during active DNA demethylation. 
Direct enzymatic removal of methyl group 
Demethylation at C5 of cytosine is not a trivial reaction, because cytosine is an electron-
poor heterocyclic aromatic ring system and therefore high energy is required to break the 
strong carbon-carbon bond of 5mC. Therefore, a potential enzyme carrying out a direct 
methyl-removal process must overcome a high energy barrier. Methyl-CpG-binding 
domain protein 2 (Mbd2) has been claimed to directly erase a methyl group from DNA, 
releasing methanol as product (Bhattacharya et al., 1999). But this research did not 
substantiate; people found that paternal pronucleus fused with an Mbd2-lacking mouse 
oocyte still present normal methylation pattern (Santos et al., 2002). Additionally, 
although Mbd2 shows necessity for transcriptional repression, mbd2-/- mice show normal 
physiological phenotypes, such as viability, offspring production and normal DNA 
methylation patterns in different tissues (Hendrich et al., 2001), and these researches 
raise the doubt to the role of Mbd2 in DNA demethylation. 
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The group from Yi Zhang found that elongator acetyltransferase complex subunit 3 
(Elp3), plays a role in zygotic demethylation (Okada et al., 2012). In addition to the 
previously assumed candidates, Mbd2 and Gadd45, many potential factors were selected 
according to their catalytic motifs in that study. Effects of those factors were examined by 
knocking-down in pronuclear stages and screened by a live cell imaging system in mouse 
zygotes. It was found that Elp3 knock-down impairs demethylation in the paternal 
genome. The functional entity of elongation complex is shown to be consisted with 6 
subunits (Elp1-Elp6), termed as DNA polymerase II (Pol II) holo-elongator complex 
(Krogan and Greenblatt, 2001). Deficiency of other two components in elongation 
complex, Elp1 and Elp4, also results in similar DNA methylation abnormalities (Okada et 
al., 2012). Elp3 belongs to a radical S-adenosyl-L-methionine (SAM) family, which class 
contains a wide range of enzymes that are involved in DNA repair and biosynthesis of 
vitamins and coenzymes. They share a common CxxxCxxC motif, which can form a [4Fe-
4S] 1+ iron-sulfur cluster. An iron-sulfur center serves as a strong reducing agent, and 
could generate a powerful oxidizing 5’-deoxyadenosyl radical together with the cofactor 
SAM. With a series of radical products, this mechanism can catalyze the cleavage of 
inactive hydrocarbon bond in alkyl group (Wang and Frey, 2007). The energetic similarity 
between C-H and C-C bonds makes this mechanism attractive to study active DNA 
demethylation. In addition to the SAM domain, Elp3 also contains a C-terminal histone 
acetylation (HAT) motif, which might indicate the linkage between histone and DNA 
modifications (Winkler et al., 2002). 
Up until now, the best characterized pathway of DNA demethylation is an oxidative 
mechanism catalyzed by ten-eleven translocation (Tet) enzymes. Tet proteins belong to a 
2-oxoglutarate (2OG) and iron (II) -dependent dioxygenase superfamily (Aravind and 
Koonin, 2001). This superfamily is widespread from prokaryotic to eukaryotic organisms, 
and modifies a range of substrates.  Alpha-ketoglutarate-dependent dioxygenase (AlkB), 
kinetoplastid base J binding protein (Jbp) and Tet family perform hydroxylation of nucleic 
acid bases (Lyer et al., 2009). This model describes a stepwise oxidation of 5mC, first 
into 5-hydroxymethylcytosine (5hmC) (Tahiliani et al., 2009; Ito et al., 2010), which is 
further oxidized into 5-formylcytosine (5fC) and later into 5-carboxylcytosine (5caC) (Ito et 
al., 2011; Nable and Kohli, 2011; He et al., 2011). Thereupon, one possibility is that the 
deformylation of 5fC or decarboxylation of 5caC achieves the final erasure of cytosine 
modifications, and another possibility is that the oxidative intermediates associate with 
other pathways to achieve complete demethylation, for instance with base excision repair 
(BER) pathway. To support the importance of Tet proteins and 5hmC in zygotic 
demethylation, two reports have shown that the rapid loss of 5mC in mouse paternal 
haploid is accompanied by an accumulation of 5hmC (Iqbal et al. 2011; Wossidlo et al., 
2011). Further details about Tet family are described in chapter 1.3. 
Indirect demethylation 
In plant, many genetic and biochemical studies indicate that active demethylation can be 
achieved by base excision repair (BER) pathways (Zhu, 2009; Gehring et al., 2006; 
Penterman et al., 2007). BER is one of the most important pathways involved in DNA 
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repair from mutagenic or cytotoxic damage. The BER pathway contains the following 
steps: recognition of an incorrect nucleotide, followed by an excision of the inappropriate 
base to leave a single nucleotide gap, then insertion of a new nucleotide (Sancar et al., 
2004; Wilson and Bohr, 2007). The key factors that execute the nucleotide excision step 
belong to a glycosylase family, which catalyze hydrolysis reaction of the N-glycosidic 
bond (Dizdaroglu, 2005; Stivers and Jiang, 2003) and generate an abasic (AP) site 
(Sancar et al., 2004). 
Arabidopsis is a very good model to display this active demethylation process (Zhu, 2009; 
Gehring et al., 2006; Penterman et al., 2007). Repressor of silencing 1 (ROS1, also 
known as DML1), Demeter (DME), DME-like 2 (DML2) and DML3 belong to Demeter 
(DME) DNA glycosylase family. This family was first identified when DME mutation was 
found to cause an imprinted gene MEDEA silenced (Choi et al., 2002). Researches 
demonstrated that DME members can target methylated DNA substrates, process 
glycosylation function, and are essential for gametogenesis and parental methylation 
pattern (Schoft et al., 2011; Gehring et al., 2006). 
The model in plants raises the question whether similar mechanism exists also in 
mammalian cells. One possible candidate might be the thymine DNA glycosylase (Tdg), 
which belongs to the uracil DNA glycosylase family. In addition to biological functions in 
DNA repair and gene expression regulation (Cortaza et al., 2007), Tdg presents putative 
involvement in DNA demethylation (Cortaza et al., 2011; Metivier et al., 2008).  Tdg 
knock-out leads to embryonic lethality and DNA hypermethylation in mice (Cortellino et 
al., 2011). Tdg is proposed to be involved in demethylation by either a direct glycosylation 
excision of 5mC (Zhu et al., 2000b) or by combinative pathways with other enzymes, 
which will be discussed later. The methyl-CpG binding domain 4 (Mbd4) protein is 
another candidate enzyme for glycosylating 5mC during DNA demethylation (Zhu et al., 
2000a). Mbd4 is a nuclear protein and localizes at heterochromatin (Hendrich and Bird, 
1998), consisted of an N-terminal MBD domain and a C-terminal glycosylase domain 
(Hendrich et al., 1999). 
Nucleotide excision repair (NER) is another mechanism for DNA repair. UV light, 
chemotherapy drugs and toxic could cause large lesions on DNA, and NER pathway 
repairs such damages (Nouspikel, 2009; Dinant et al., 2012). NER includes following 
steps: lesion recognizing, opening of a denaturation bubble, incision of the damaged 
strand, displacement of the lesion-containing oligonucleotide, and gap sealing (Nouspikel, 
2009). The deficiency of NER results in many inherited diseases: such as xeroderma 
pigmentosum, cockayne syndrome, trichothiodystrophy and UV-sensitive syndrome 
(Nouspikel, 2009; Mu et al., 1995). 
The growth arrest and DNA-damage-inducible 45 alpha (Gadd45a) protein was firstly 
reported to be involved in NER pathway (Smith et al., 1996). In 2007, Gadd45a was 
found to be recruited to methylated reporter and activate silenced promoters by loci-
specific and global demethylation (Barreto et al., 2007). Using zebrafish embryos as 
model, Gadd45 is shown to be involved in widespread demethylation, in cooperation with 
the activation-induced cytidine deaminase (Aid, also named Aicda) and a glycosylase 
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Mbd4 (Rai et al., 2008). It was found that active demethylation takes place at lineage-
specific genes when adult stem cells differentiate into terminal cells. Gadd45a up-
regulates this process, and knock-down of Gadd45a causes hypomethylation of those 
genes, leading to suppression of differentiation (Zhang et al., 2011). Mouse Gadd45a 
expression strongly increases at E7.5-E8.5 during embryonic stage (Kaufmann et al., 
2011), which is consistent with the occurrence of the DNA demethylation in early 
development. Anyhow, conflicting evidence also exists; a normal DNA methylation 
pattern exhibits in gadd45a-/- cells (Engel et al., 2009). 
Cooperated pathways for DNA demethylation 
Some studies support that combinations of aforementioned enzymes may provide answer 
for how active DNA demethylation happens. One speculation is that a deaminase first 
converts 5mC into an intermediate nucleotide, such as thymine, followed by mismatch 
excision by BER pathway (Wu and Zhang, 2010; Figure 5). Deaminases, such as Aid or 
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 (Apobec1), were reported 
to be involved in the demethylation (Metivier et al., 2008; Rai et al., 2008; Morgan et al., 
2004). 
Aid/Apobec protein family is well-known for participation in antigen-driven antibody 
diversification and maturation (Conticello, 2008). Aid and Apobec share structural and 
functional similarities, and both belong to a widespread superfamily of zinc-dependent 
deaminase (Conticello et al., 2007). Apobec was first described to catalyze deamination 
of cytidine to uridine in apolipoprotein B pre-mRNA (Scott, 1995), and Aid was reported to 
convert C to U in DNA of immunoglobulin loci (Neuberger et al., 2003). Later, Morgan et 
al. demonstrated that Aid and Apobec1 convert 5-methylcytosine to thymine, which leads 
to a T:G mismatch in DNA (Morgan et al., 2004). Aid and Apobec1 are detected to be 
expressed in oocytes and PGCs (Morgan et al., 2004), while Aid-deficient PGCs exhibit 
hypermethylation throughout genome (Popp et al., 2010). Knock-down and rescue 
experiments demonstrated that Aid is required for the onset of cellular reprogramming in 
iPS cell generation (Bhutani et al., 2013). These evidences suggest the involvement of 
deamination in DNA demethylation process. 
A study in zebrafish embryos showed that Aid, together with a glycosylase Mbd4 and a 
promoting Gadd45, participate in widespread demethylation (Rai et al., 2008). In vitro 
studies showed that among the derivatives of 5mC, Mbd4 binds preferentially to 
deamination products rather than other types (Hendrich et al., 1999; Morera et al., 2012). 
In addition to an N-terminal region that recognizes 5mC, Mbd4 contains a C-terminal 
catalytic domain that shares sequence identity with many known DNA glycosylases. The 
catalytic domain of this enzyme excises thymine or uracil at T:G or U:G mismatch, 
regardless of the methylation status (Sjolund et al., 2012; Hendrich et al., 1999). 
Crystallization of the catalytic domain of human MBD4 together with mismatched DNA 
substrates shows the MBD4 can flip out and capture the target thymine or 5hmC base 
into binding pocket (Morera et al., 2012; Hashimoto et al., 2012b). 
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Participation of Tdg as glycosylase in demethylation process is also widely accepted. 
Biochemical methods indicated that Tdg interacts with Aid and Gadd45a (Cortellino et al., 
2011). It is proposed that deamination of 5mC, thymine, is the substrate for Tdg (Cortaza 
et al., 2007). Besides thymine and uracil, systematic studies showed that Tdg has 
glycosylation activity on a broad range of oxidation-linked substrates, including 
5‐hydroxymethyluracil (5hmU), 5fC and 5caC, but not 5mC or 5hmC (Cortellino et al., 
2011; He et al., 2011; Maiti and Drohat, 2011). Tdg-deficiency in mouse ES cells causes 
accumulation of 5fC and 5caC, and further mapping with modification-specific antibodies 
demonstrated that the 5fC and 5caC accumulate mostly in proximal and distal gene 
regulatory regions (He et al., 2011; Shen et al., 2013). Guo et al., proposed a stepwise 
processing of 5mC, including oxidation to 5hmC, deamination to 5hmU by Aid/Apobec in 
adult mouse brain (Guo et al., 2011; Figure 5). Although the concentration of 5hmU is 
relatively low in tissues (Globisch et al., 2010), co-crystallization of the catalytic domain of 
human TDG with G:T or G:5hmU mismatch DNA substrates demonstrated the binding 
between DNA and TDG, and also exhibits a flipping-out of the target nucleotide from the 
double-strand DNA, which supports the hypothesis (Hashimoto et al., 2012a).  
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1.3 Dioxygenase Tet family 
As a well-known candidate for catalyzing active DNA demethylation, Tet proteins are 
found in several tissues of mouse and human, particularly at the developmental stages of 
zygote, blastocyst inner cell mass and PGCs formation, in which stages global 
demethylation and de novo methylation take place, indicating their functions in early 
embryonic development. The biological functions, expression profile and catalytic activity 
of Tet family bring great interest of research.  
1.3.1 2-Oxoglutarate (2OG) and iron (II)-dependent dioxygenase superfamily 
As described in chapter 1.2.2, Tet proteins belong to a 2-oxoglutarate (2OG) and iron (II) 
-dependent dioxygenase superfamily, which contains many enzymes with diverse 
biological functions. Two other members of this class, AlkB and Jbp, also have been 
reported to catalyze in situ hydroxylation of bases in nucleic acids (Lyer et al., 2009). 
The E. coli enzyme AlkB catalyzes the oxidative demethylation of 1-methyladenine and 
N3-methylcytosine (3meC) in the bacterial response to DNA alkylated base lesion, 
together with 2OG and Fe (II) as cofactors. Decarboxylation converts 2OG to succinate 
and carbon dioxide (Figure 6) (Falnes et al., 2002; Trewick et al., 2002; Mishina and He, 
2006). The crystal structure of AlkB has been solved, which might be very helpful for 
understanding its homologues, such as the Tet proteins who also share the conserved 
2OG-Fe2+ binding domain (Sedgwick et al., 2007; Yang et al., 2008). The 90 amino acids 
in the N-terminus of AlkB form a special structure, which consists of a β-strand and α-
helix, and covers the surface of dioxygenase part. This N-terminal part is inferred to be 
the “nucleotide-recognition lid” of AlkB (Yu et al., 2006; Figure 6). A substrate-bound 
AlkB-DNA complex reveals conformational changes of amino acid residues within the 
active site, which is recognized to be important for binding damaged bases (Holland and 
Hollis, 2010). 
The Jbp family is defined according to its involvement in synthesis of Beta-d-
glucopyranosyloxymethyluracil (base J), a DNA modification that exists in kinetoplastid. 
The generation of base J begins with a hydroxylation of thymidine, followed by 
glycosylation (Borst and Sabatini, 2008). There are two proteins, Jbp1 and Jbp2, which 
catalyze the thymidine hydroxylation. Jbp1 and 2 have different C-terminus for specific 
protein interactions, but share a conserved N-terminal 2OG-Fe (II) dioxygenase domain 




Figure 6: (a) Diagram of AlkB-catalyzing oxidative demethylation. AlkB belongs to the 2-oxoglutarate (2OG) and iron (II) -
dependent dioxygenase superfamily. One atom of oxygen is transferred from 2OG into hydroxylation intermediate, 
releasing CO2 and succinate. (b) Cartoon representation of AlkB protein (PDB: 2FD8; Yu et al., 2006). AlkB was shown 
under the presence of DNA substrate, Fe (II) ion and its cofactor 2-oxoglutarate (2OG). In the 2OG structure, carbon atoms 
are shown red and the rest of the structure carbons are shown in grey. Fe (II) is shown in orange. The α-helix of AlkB is 
present in pink and β-sheet in yellow. The figure was generated using the PyMol software (DeLano, 2002). 
The Tet family contains three members: Tet1, 2 and 3, which are paralogues with Jbp 
proteins (Tahiliani et al., 2009). Tet family displays the typical double-strand β helix 
(DSBH) fold of 2OG-Fe (II) dioxygenase, including the conserved motif to chelate iron 
and 2OG (Lyer et al., 2009). Tet1 was the first described member of Tet family and 
initially discovered as a fusion partner with H3K4 methyltransferase MLL (mixed lineage 
leukemia protein), and therefore Tet family is named after the ten-eleven translocation (t 
(10; 11) (q22; q23)) (Lorsback et al., 2003; Ono et al., 2002) in acute myeloid leukemia 
(AML). Recently, it was shown that Tet proteins hydroxylate 5mC into 5-
hydroxymethylcytosine (5hmC) (Tahiliani et al., 2009; Ito et al., 2010), and further oxidize 
5hmC stepwise into 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (Ito et al., 
2011; Nable and Kohli, 2011; He et al., 2011). One hypothesis proposes that the 





1.3.2 Tet proteins and 5hmC 
1.3.2.1 Cellular functions of Tet1 
Tet1 was discovered in human MLL1-TET1 fusion protein from acute myeloid leukemia 
(AML) cells and was initially encoded as leukemia-associated protein with a CXXC 
domain (LCX) (Lorsback et al., 2003; Ono et al., 2002). MLL1, which is located on 11q23 
in the human chromosome, belongs to a H3K4 methyltransferase family. MLL1 is 
frequently found to be a target of recurrent specific chromosomal translocation in human 
hematological malignancies. These cytogenetic abnormalities implicate many different 
genes and over 30 different fusion partners have been described, such as RNA 
polymerase II elongation factor, transcriptional co-activator and histone acetyltransferase 
(Daser and Rabbitts, 2005). Those fusion proteins, including MLL-TET1, consistently 
retain the amino-terminal fragment of MLL1 and carboxyl-terminal domains from the 
fusion partners (Ayton and Cleary, 2001; Ayton et al., 2004). 
Tet1 is of great importance in different developmental stages, particularly in blastocyst 
and PGCs formation. Tet1 is highly expressed in pluripotent mouse ES cells, in which an 
elevated level of 5hmC is also observed. Tet1 is drastically down-regulated when ES 
cells differentiate, indicating that Tet1 has a specific function for ES cells maintenance or 
for lineage specification at this stage (Szwagierczak et al., 2010). ES cells with either 
Tet1 knock-out or knock-down show reduction of 5hmC level and formation of large 
haemorrhagic teratomas, which is likely due to excessive number of trophoblast-derived 
cells. Therefore, deficiency of Tet1 leads to skew of extraembryonic lineages (Dawlaty et 
al., 2011; Koh et al., 2011). Tet1 depletion hyperactivates some key trophoblast 
regulators, like E74-like factor 5 (Elf5) and caudal-type homeobox 2 (Cdx2) (Ito et al., 
2010; Koh et al., 2011; Ficz et al., 2011). At the same time, Tet1-depletion negatively 
regulates neurogenic differentiation factor 1 (Neurod1) and neural development gene 
paired box 6 (Pax6) (Dawlaty et al., 2011; Xu et al., 2011; Williams et al., 2011). These 
evidences suggest essential regulatory functions of Tet1 in the first lineage commitment 
stages. 
In ES cells, a large amount of developmentally regulated factors and lineage-specific 
genes are under control of a “bivalent marker”, which describes a co-occupation of the 
marker for transcription active genes, H3K4me3, and the repressive marker H3K27me3. 
This dual-marker system keeps genes silenced, but is proposed to prepare genes for 
future initial transcription. This poised state is likely to be necessary for the development 
potential of ES cells (Pan et al., 2007; Bernstein et al., 2006). Comparing the list of Tet1 
binding protein with identified genes in mouse ES cells, the enrichment of Tet1 shows a 
positive correlation with genes that either are transcriptional active or contain bivalent 
chromatin signature (Wu et al., 2011b; Wu and Zhang, 2011). 5hmC also shows a 
similarity of genomic occupation with Tet1 in ES cells. High-throughput sequencing 
revealed an enrichment of 5hmC within exons and near transcription start sites (TSSs), 
especially at the start sites of genes whose promoters bear the bivalent marks (Pastor et 
al., 2011), suggesting that Tet1 and 5hmC may play a key role in orchestrating the 
balance between pluripotent and lineage committed states. However, conflicting evidence 
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exists representing that Tet1 binds throughout the genome of ES cells, with the majority 
of binding sites located at TSSs of CpG-rich promoters and within genes (Williams et al. 
2011). 
Although Tet1 is important for lineage regulation in ES cells and inner cell mass, tet1-/- 
and tet1-/- tet2-/- mice form all three germ layers and are viable (Dawlaty et al., 2011; 
Dawlaty et al., 2013), indicating that Tet1 and Tet2 may have important but not crucial 
functions during mouse development. 
As introduced in a previous chapter (chapter 1.2.2), PGCs undergo a rapid drop in DNA 
methylation levels. Simultaneously with the wave of demethylation, generation of 5hmC 
and transcriptional activity of Tet1/2 was detected (Vincent et al., 2013; Hackett et al., 
2013). At embryonic day E9.5 to E10.5, a significant conversion of 5mC to 5hmC is 
observed en masse and at individual loci, consistent with the fact that numerous 
promoters and gene bodies are hypermethylated in Tet1 knock-down PGCs (Hackett et 
al., 2013). Investigation based on immunofluorescence measurements showed that the 
levels of 5fC and 5caC remained relatively stable during PGCs reprogramming, indicating 
that the oxidative excision might not occur during this stage (Yamaguchi et al., 2013).  
Compared to normal germ cells, Tet1-deficient germ cells show developmental 
abnormality and dysregulation of a large set of genes. During E16.5-E18.5, nearly half of 
the tet1-/- female gamete samples suffer a defect in meiotic synapsis formation and show 
developmental arrest. Many meiosis-related genes seem to be activated by Tet1, 
including malate dehydrogenase (Mae1) and synaptonemal complex protein 1 (Sycp1) 
(Yamaguchi et al., 2012). 
Conclusively, Tet1 plays an important role in determining lineage commitment at inner 
cell mass stage. It participates in the conversion of 5mC to 5hmC at the demethylation 
wave in PGCs, positively regulating many meiosis-related genes in germ cells. The 
functional perturbation of Tet1 significantly reduces female germ-cell numbers and 
fertility. 
 
1.3.2.2 Cellular functions of Tet2 
Compared to Tet1, Tet2 has been found to be highly expressed in many somatic tissues, 
as well as in ES cells and PGCs (Szwagierczak et al., 2010; Vincent et al., 2013). Apart 
from the collaborative functions together with Tet1 in embryogenesis and PGC formation, 
Tet2 is also linked to myeloid leukemia. 
Deletions and mutations of TET2 were found in a wide range of human myeloid 
malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome 
(MDS), myeloproliferative neoplasms (MPN) and secondary AML (sAML) (Langemeijer et 
al., 2009; Delhommeau et al., 2009; Konstandin et al., 2011). Tet2 mRNA is found in high 
levels in hematopoietic multipotent progenitors from bone marrow, maintains high levels 
in myeloid progenitors, and gets low in mature granulocytes (Ko et al., 2010), which 
suggests the tightly relationship between Tet2 and hematopoietic lineage. 
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1.3.2.3 Cellular functions of Tet3 
Tet3 is proposed to be the answer for the mysterious rapid DNA demethylation wave in 
zygotic pronuclear stage. Recent researches proved that a massive DNA methylation 
oxidation exists in zygote, along with 5hmC accumulation in paternal pronucleus and 
reduction of 5mC (Wossidlo et al., 2011). Moreover, Tet3 is found to be enriched 
specifically in the male DNA. In Tet3 knock-out zygotes, conversion of 5mC into 5hmC 
fails to occur in paternal DNA, and the level of 5mC remains. Tet3-deficient oocytes also 
get reduced in their capability of reprogramming the injected somatic nuclei, and the 
Tet3-depleted germ cells show severely developmental failure at around E11.5 for 
unknown reason (Wossidlo et al., 2011; Gu et al., 2011). 
In comparison to other tissues, the nervous system shows highest 5hmC level and 
prominent transcriptional activity of Tet3 (Szwagierczak et al., 2010). Xenopus laevis Tet3 
participates in early eye and neural development by regulating some developmental 
related genes (Xu et al., 2012). Loss of Tet2 and Tet3 leads to a defect in neuronal 
differentiation from neural progenitor cells (Hahn et al., 2013), which indicates the 
functional role of Tet proteins in neural development. 
 
1.3.2.4 5-Hydroxymethylcytosine (5hmC) - the sixth base in the genome 
5-Hydroxymethylcytosine (5hmC) was discovered as a new composition of mammalian 
DNA (Penn et al., 1972). The discovery is of tremendous importance because it was the 
only other modified base in genome of higher organisms besides 5mC for a long time. 
Therefore, it is also called the sixth base in mammalian genome, namely after the four 
nucleotides and 5mC. 
Evidence is increasing that DNA hydroxymethylation is strongly associated with actively 
transcribed genes, but the mechanism of this regulation function is still unknown (Ito et 
al., 2010; Ficz et al., 2011). The distribution of 5hmC varies in different tissues. Various 
methods were established to quantify the level of 5hmC, and 5hmC is found to be 
enriched in neuron system and ES cells (Szwagierczak et al., 2010; Kriaucionis and 
Heintz, 2009; Globisch et al., 2010). 5hmC constitutes around 0.6% of guanine in 
genome of Purkinje neurons and 0.2% in genome of granule cells (Kriaucionis and 
Heintz, 2009). In ES cells, 5hmC takes around 4% of all cytosine modification species 
(Tahiliani et al., 2009) and the 5hmC abundance in genome decreases very rapidly 
during differentiation of ES cells (Szwagierczak et al., 2010). Taken together, 5hmC is of 
a detectable portion in genome and is physiologically regulated by cell developmental 
stage. Mass spectrometry analysis also revealed that human induced pluripotent stem 
(iPS) cells show a high increase of 5hmC levels when compared to parental fibroblast 
cells, which indicates that the 5hmC is an important epigenetic change during cell 
reprogramming (Le et al., 2011). It was observed that 5hmC is enriched in gene bodies of 
active genes in mouse cerebellum and ES cells, in contrast to 5mC that is mainly 
enriched at CpG-rich transcription start sites (TSSs) (Song et al. 2011a; Williams et al. 
2011). 5hmC can be further oxidized to 5fC and 5caC. 5fC in genome is quantified by 
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biochemical methods (Pfaffeneder et al., 2011; Song et al., 2013); around 0.02% (against 




1.3.3 Post-translational modification of Tet proteins 
Post-translational modification (PTM) is an important step of protein biosynthesis. During 
translation step, amino acids are incorporated into polypeptide chains by ribosome. PTMs 
describe the chemical modifications of proteins after their translation, which largely 
increases the complexity and diversity of the proteome. Research showed that the PTMs 
are widely present in proteome (Khoury et al., 2011). Statistics of relative abundance for 
different post-translational modifications have been experimentally and putatively 
detected using proteome-wide information analysis. The importance of PTM on protein 
function and stability raises the question: whether Tet proteins are also under regulation 
of PTM systems. 
PTMs widely extend the range of protein functions. For example, phosphorylation, a very 
widespread PTM, which describes the addition of a phosphate group to a protein, plays 
an important role in almost every aspect of eukaryotic cell regulation. Usually, the 
reversible phosphorylation reaction is involved in a transfer of a phosphoryl group from a 
high-energy organic compound, such as adenosine triphosphate or guanosine 
triphosphate, to the side chain of serine, threonine or tyrosine amino acid residues. 
Protein phosphorylation affects every basic cellular process, including metabolism, 
division, differentiation, motility, growth, signaling transduction and muscle contraction 
(Manning et al., 2002; Dephoure et al., 2008; Engholm-Keller and Larsen, 2013). 
Aberrant phosphorylation patterns are found to be implicated in many developmental 
abnormalities and human diseases, such as breast cancer, diabetes, cardiovascular and 
neuropsychiatric disorders (Hendriks and Pulido, 2013; Nunes-Xavier et al., 2013; 
Hendriks et al., 2013). Therefore, for many decades, phosphorylation is of central 
research interest for academic and therapeutic aspects. 
Another abundant and essential post-translational modification event is O-linked N-
acetylglucosamine (O-GlcNAc), which occurs both in cytoplasm and nucleus. In the 
1980s, a PTM of serine or threonine residues by a monosaccharide, β-D-N-
acetylglucosamine, was discovered (Torres and Hart, 1984), and later it became clear 
that this modification is intracellular (Holt and Hart, 1986). The O-GlcNAc modification is 
dynamic, with cycling addition and removal of the special monosaccharide β-D-N-
acetylglucosamine to target proteins. The cycling of O-GlcNAc is a nutrient-responsive 
PTM that can influence the activity of a target protein, and thus effects cellular signaling 
transduction, protein turnover and mRNA transcription (Love et al., 2010; Love and 
Hanover, 2005).  
Until recently, O-GlcNAc cycling was found to be a novel regulator that affects also the 
epigenome and high-order chromatin structure. A combination of techniques showed that 
acetylated histones are modified by O-GlcNAc. Over expression of O-GlcNAc transferase 
modestly increases chromatin condensation (Sakabe et al., 2010). A later research 
reported that histone H2B could be O-GlcNAcylated at a serine residue S112 in vitro and 
in vivo, which subsequently facilitates the mono-ubiquitination of a lysine residue K120 
(Fujiki et al., 2011). 
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Crosstalk between different types of PTMs encodes numerous amount of information. 
Identification of key protein targets of O-GlcNAcylation demonstrated that O-
GlcNAcylation may be as widespread as phosphorylation. Furthermore, there is a 
possibility of reciprocal regulation of O-GlcNAc and O-phosphate, because these two 
modifications always modify the same or adjacent sites on proteins (Kamemura and Hart, 
2003). The mechanism and function of this extensive interplay between O-GlcNAc and O-
phosphate are still elusive, and it is only known that they can either occupy different sites 
on same peptide, or competitively occupy a single site or proximal sites (Zeidan and Hart, 
2010; Hart et al., 2011). Deficient O-GlcNAcylation could lead to neurodegenerative 
diseases and cancers. Abnormal crosstalk between O-GlcNAcylation and 
phosphorylation is involved in diabetes (Butkinaree et al., 2010).  
Protein glycosylation is one of the most abundant PTMs in eukaryotic cells. Data showed 
that 1-3% of the human genome is dedicated to encoding glycoside hydrolase or 
glycosyltransferase enzymes (Davies et al., 2005). To date, two enzymes are known to 
regulate O-GlcNAc cycling in higher metazoans: O-GlcNAc transferase (Ogt), which 
catalyzes the addition of O-GlcNAc, and O-GlcNAcase (Oga), a single enzyme that 
catalyzes the selectively removal of O-GlcNAc from target substrates (Hanover et al., 
2012; Butkinaree et al., 2010).  
Ogt is a highly evolutionary conserved protein found in most organisms (Lubas et al., 
1997; Love and Hanover, 2005). A conditional knock-out experiment of mouse Ogt 
demonstrated the essential role of Ogt in early development. Deficiency of Ogt leads to 
embryonic lethality at around E5.5 (Shafi et al., 2000). In mammals, the alternatively 
splicing produces three isoforms of Ogt, which differ in the length of their N-terminal 
tetratricopeptide repeats (TPR) and the cellular localization (Lubas et al., 1997; Kreppel 
and Hart, 1999; Hanover et al., 2012). The C-terminal domain of this protein represents 
the catalytic portion. The longest isoform, termed nucleocytoplasmic Ogt (ncOgt), 
contains 12 TPR motifs and is found to localize in both nucleus and cytoplasm. ncOgt 
protein binds to many transcriptional regulators through the TPR domain, and thus 
regulates the activity of these transcriptional regulators by O-GlcNAcylation (Hanover et 
al., 2012). It was found that Ogt binds with a switch-independent 3a (Sin3a), and thus 
interacts with a histone deacetylase complex, which normally represses gene 
transcription (Yang et al., 2002). The intermediate isoform, mitochondrial Ogt (mOgt), 
contains 9 TPRs, and the shortest Ogt isoform (sOgt) contains only 2 TPRs and is found 
to localize in both nucleus and cytoplasm (Hanover et al., 2012). 
Oga, together with Ogt, regulates the O-GlcNAcylation cycling in higher eukaryotic cells 
(Braidman et al., 1974). Oga is found in both the nucleus and the cytoplasm, and 
catalyzes the removal of O-GlcNAc from target substrates. The structure of Oga bacterial 
homologues has been resolved, and thus provides the basis for understanding the 
mechanism of O-GlcNAc removal (Gloster and Vocadlo, 2010; Rao et al., 2006). 
Until recently, Tet proteins were found to be a target of O-GlcNAcylation modification. Ogt 
was found to interact with Tet1, and the Tet1 expression level is regulated by its 
interaction with Ogt (Shi et al., 2013). In our research, we provide novel evidence for Ogt 
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interaction with the triplication Tet1/2/3, and demonstrate that the Tet proteins undergo O-
GlcNAcylation modification in vivo (chapter 2.3).
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1.3.4 CXXC-type zinc finger and Tet proteins 
CXXC-type zinc finger domains widely exist in divergent chromatin-binding proteins, 
including Dnmt1, Mll proteins, Mbd1 and Tet1 (Lee et al., 2001; Ono et al., 2002; 
Thomson et al., 2010; Lorsbach et al., 2003; Birke et al., 2002). Because the CXXC 
domain requires zinc ions for efficient DNA binding activity, it is also named zinc finger 
(Lee et al., 2001). Data showed that CXXC domains of some these proteins specifically 
mediate binding to DNA templates containing unmethylated CpG sites (Thomson et al., 
2010; Birke et al., 2002). However, there are also CXXC motifs being reported to have no 
DNA binding activity. For instance, Mbd1 protein contains three CXXC zinc fingers, but 
only one of them shows affinity with DNA substrate (Jorgensen et al., 2004). 
CXXC of human DNMT1 is found to bind specifically to unmethylated CpG (Pradhan et 
al., 2008). Anyway, there is also conflicting data that fragment including AA 613-748 of 
mouse Dnmt1, which shows DNA affinity with a slight preference for hemi-methylated 
CpG sites (Fatemi et al., 2001). Deficiency of CXXC displays significant reduction in DNA 
methyltransferase enzymatic activity, indicating that Dnmt1 CXXC affects DNA 
methyltransferase activity (Pradhan et al., 2008). However, our independent research 
demonstrated conflicting results and this will be discussed in later chapters (Frauer et al., 
2011, see chapter 2.1 and 3.1). Structural study of a DNA-Dnmt1 complex clearly reveals 
a contact between DNA and CXXC domain (Song et al., 2011b). It was shown that CXXC 
domain forms two short helical segments, with eight reserved cysteine residues in two 
clusters. A loop from one cluster penetrates into the major groove of DNA. 
In addition to a CXXC motif in Dnmt1, members of dioxygenase Tet family are also find to 
be closely accompanied with CXXC domains. In human and mouse, Tet1 contains a 
CXXC motif in N-terminal part, which is referred to CXXC6 as well. And the tet2 and tet3 
genes are adjacent to cxxc4 and cxxc10-1, respectively. According to the sequence 
homology, all these CXXC motifs together identify a distinct subgroup within the whole 
CXXC domain family (Frauer et al., 2011, see chapter 2.1).  
CXXC4, which is also termed as inhibitor of the Dvl and Axin complex (Idax), was 
reported as an inhibitor of Wnt signaling pathway by directly binding to the PDZ domain of 
Dishevelled (Dvl), a positive regulator of Wnt signaling (Hino et al., 2001; Michiue et al., 
2004). Human CXXC4 gets increasingly expressed in colonic villous adenoma, which 
means CXXC4 might be involved in tumorigenesis (Nguyen et al., 2010). Further 
evidence showed that in renal cell carcinoma, expression of CXXC4 decreases and thus 
activates malignancy through WNT pathway (Kojima et al., 2009). On genomic level, both 
human and mouse cxxc4 localizes near tet2 in the chromosome, and a recent 
evolutionary study indicates that cxxc4 was originally encoded within an ancestral tet2 
gene. A study hypothesized that chromosomal gene inversion occurs during evolution, 
thus separating the Tet2 CXXC domain from the catalytic domain (Ko et al., 2013). 
Rat CXXC5 is found to be another modulator of Wnt signaling pathway in neural stem 
cells and positively regulated by Bmp4 (bone morphogenetic protein 4). CXXC5 shows 
partial sequence homology and functional similarity with CXXC4. CXXC5 is shown to bind 
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with Wnt mediator Dvl and antagonize Wnt signaling by competing with Axin (Andersson 
et al., 2009). Human CXXC5 is identified in normal and tumoral myelopoiesis, and is 
functionally required in the differentiation progress of normal blood progenitors and 
promyelocytic leukemia cells (Pendino et al., 2009). 
In conclusion, the CXXC-type zinc finger motif is a widely existing domain found in many 
chromatin modifiers with diverse functions, and is usually found to be associated with 
DNA binding activity. CXXC motifs are accompanied with Tet family members. In this 
study, we provide experimental evidence for the claim that Tet3 harbors a CXXC domain, 
CXXC10-1. Additionally, interaction between Tet3 and CXXC4 were shown in vivo. Many 
properties, including DNA affinity, expression pattern, cellular localization and mobility of 
these zinc fingers, will also be discussed in this study (Frauer et al., 2011, see chapter 
2.1; Liu et al., 2013, see chapter 2.2).
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1.4 Aims of this work 
The main objective of this work was the study of active DNA demethylation and the CXXC 
domain, cell cycle dependent localization, protein interaction and post-translational 
modifications of Tet proteins. The goal was, to get further insight into the complex 
regulatory mechanisms of Tet proteins and to identify the biological functions of different 
domains. 
The first part of this study focused on elucidating the regulatory function and role of the 
zinc finger CXXC motifs of Tet proteins. CXXC domain is found in many chromatin-
binding proteins. Tet1 protein has an ancestral intramolecular CXXC domain, and a cxxc4 
gene is encoded in the genome as a neighboring gene with tet2. This might suggest that 
the CXXC interacts or plays important role for Tet proteins. To address this hypothesis, 
tools and techniques to monitor Tet1/2/3 and 5hmC in vitro and in vivo had to be 
developed. GFP-trap was applied to study the DNA binding activity and preference of 
GFP-fused CXXC domains (chapter 2.1). Our research provided the experimental 
evidence that Tet3 co-transcribes with a CXXC domain (chapter 2.2). Photobleaching 
technology was used to detect the effect of mobility for CXXC. Isotope-labeling assay for 
detecting 5hmC abundance, which was established in our group, was applied for finding 
the influence on the hydroxylation activity of Tet proteins and their mutants. 
It is also interesting to investigate how the Tet proteins get regulated during cell cycle 
(chapter 2.4). Specific monoclonal antibodies were generated as a tool for studying Tet1 
and Tet2 in cellular context. Endogenous Tet1 and Tet2 were presented together with cell 
cycle marker. Furthermore, we performed direct DNA competition binding assay on 
isolated domains, and thus demonstrated the DNA binding platform of Tet proteins. 
Moreover, our group found Tet proteins interact with some post-translational modifier 
proteins (chapter 2.3). The interaction between Tets and modifiers (Ogt, Oga) was 
studied by F3H and biochemical assays, including western blot, immunofluorescence and 


















2.1 Different Binding Properties and Function of CXXC Zinc 






Different Binding Properties and Function of CXXC Zinc
Finger Domains in Dnmt1 and Tet1
Carina Frauer1., Andrea Rottach1., Daniela Meilinger1, Sebastian Bultmann1, Karin Fellinger1¤a, Stefan
Haseno¨der1¤b, Mengxi Wang1, Weihua Qin1, Johannes So¨ding2, Fabio Spada1*, Heinrich Leonhardt1*
1Department of Biology II and Center for Integrated Protein Science Munich (CIPSM), Ludwig Maximilians University Munich, Planegg, Germany, 2Gene Center Munich,
Ludwig Maximilians University Munich, Munich, Germany.
Abstract
Several mammalian proteins involved in chromatin and DNA modification contain CXXC zinc finger domains. We compared
the structure and function of the CXXC domains in the DNA methyltransferase Dnmt1 and the methylcytosine dioxygenase
Tet1. Sequence alignment showed that both CXXC domains have a very similar framework but differ in the central tip region.
Based on the known structure of a similar MLL1 domain we developed homology models and designed expression constructs
for the isolated CXXC domains of Dnmt1 and Tet1 accordingly. We show that the CXXC domain of Tet1 has no DNA binding
activity and is dispensable for catalytic activity in vivo. In contrast, the CXXC domain of Dnmt1 selectively binds DNA substrates
containing unmethylated CpG sites. Surprisingly, a Dnmt1 mutant construct lacking the CXXC domain formed covalent
complexes with cytosine bases both in vitro and in vivo and rescued DNA methylation patterns in dnmt12/2 embryonic stem
cells (ESCs) just as efficiently as wild type Dnmt1. Interestingly, neither wild type nor DCXXC Dnmt1 re-methylated imprinted
CpG sites of the H19a promoter in dnmt12/2 ESCs, arguing against a role of the CXXC domain in restraining Dnmt1
methyltransferase activity on unmethylated CpG sites.
Citation: Frauer C, Rottach A, Meilinger D, Bultmann S, Fellinger K, et al. (2011) Different Binding Properties and Function of CXXC Zinc Finger Domains in Dnmt1
and Tet1. PLoS ONE 6(2): e16627. doi:10.1371/journal.pone.0016627
Editor: Anton Wutz, Wellcome Trust Centre for Stem Cell Research, United Kingdom
Received September 14, 2010; Accepted January 5, 2011; Published February 2, 2011
Copyright:  2011 Frauer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB646 and TR5; http://www.dfg.de/en/index.jsp), the
Nanosystem Initiative Munich (NIM; http://www.nano-initiative-munich.de/) and the Center for NanoScience (CeNS; http://www.cens.de/) to HL. The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: f.spada@lmu.de (FS); h.leonhardt@lmu.de (HL)
. These authors contributed equally to this work.
¤a Current address: Intervet International GmbH, Unterschleissheim, Germany
¤b Current address: Institute of Stem Cell Research, Helmholtz Zentrum Mu¨nchen, Neuherberg, Germany
Introduction
In mammals DNA methylation is restricted to cytosine residues
and mainly involves CpG dinucleotides. CpG methylation is
widespread across mammalian genomes, including gene bodies
regardless of their transcriptional activity [1–4]. However, highly
CpG-rich regions (CpG islands) are refractory to methylation and
mostly coincide with promoters of constitutively active genes. The
methylation state of other regulatory sequences with moderate to
low CpG density, including promoters and enhancers, shows
developmental and/or tissue-specific variations and positively
correlates with a transcriptionally silent state [1,3–8]. Dense
methylation of repetitive sequences is also thought to maintain
these elements in a silent state and thus contribute to genome
stability [9–11]. In mammals cytosine methylation is catalyzed by
a family of DNA methyltransferases (Dnmts) [12]. Dnmt3a and
Dnmt3b establish methylation patterns during embryonic devel-
opment of somatic as well as germ cell lineages and, consistently,
show developmental stage and tissue specific expression patterns.
In contrast, Dnmt1 is ubiquitous and generally the most abundant
DNA methyltransferase in mammalian tissues, where it associates
with the replication machinery and restores symmetrical methyl-
ation at hemimethylated CpG sites generated by the semi-
conservative DNA replication process [13]. Thus, Dnmt1
maintains methylation patterns with high fidelity and is essential
for embryonic development and genome integrity [9,14,15].
Dnmt1 is a large enzyme with a complex domain structure that
likely evolved by fusion of at least three genes [16]. It comprises a
regulatory N-terminal region and a C-terminal catalytic domain
connected by a linker of seven glycine-lysine repeats (Figure 1A)[17].
The N-terminal part contains a PCNA binding domain (PBD), a
heterochromatin targeting sequence (TS), a CXXC-type zinc finger
domain and two Bromo-Adjacent Homology domains (BAH1 and
BAH2). The C-terminal domains of mammalian Dnmts contain all ten
catalytic motifs identified in bacterial DNA (cytosine-5) methyltrans-
ferases [12]. Thus, prokaryotic and mammalian cytosine methyltrans-
ferases are thought to adopt the same catalytic mechanism. However,
the C-terminal domain of Dnmt1 is the only DNA methyltransferase
domain in Dnmts that is not catalytically active when expressed
separately. Indeed, interaction with the N-terminal part is required for
allosteric activation of the enzyme [18]. Remarkably, the first 580
amino acids (aa) of human DNMT1 are dispensable for both
enzymatic activity and substrate recognition, whereas deletion of the
first 672 aa results in an inactive enzyme [19]. Interestingly, this
truncation eliminates part of the CXXC domain, suggesting an
involvement of this domain in allosteric activation. However, addition
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of an N-terminal fragment containing the isolated CXXC domain to
the catalytic domain was not sufficient for catalytic activation [20].
CXXC-type zinc finger domains are found in several other
proteins with functions related to DNA or chromatin modification,
including the histone H3 lysine 4 (H3K4) methyltransferases mixed-
lineage leukaemia (MLL) proteins 1 and 4, the CpG-binding protein
(CGBP, also known as Cfp1 or CXXC1), the methyl-CpG binding
domain protein 1 (MBD1), the H3 lysine 36 (H3K36) demethylases
KDM2A and B (also known as JHD1A/FBXL11 and JHD1B/
FBXL10) and the MLL1 fusion partner TET1 (Figure 1A) [21–28].
The CXXC domains of some of these proteins were shown to
mediate specific binding to double stranded DNA templates
containing unmethylated CpG sites [21,22,29,30]. A region of
Dnmt1 which mainly includes the CXXC domain (aa 628–753) was
also shown to bind Zn ions and DNA [20,31,32]. However, available
data on the selectivity of this DNA binding activity are conflicting.
Whereas a fragment including aa 613–748 of mouse Dnmt1 was
shown to bind DNA with a slight preference for hemimethylated
CpG sites [20], aa 645–737 of human DNMT1 were shown to
selectively bind unmethylated DNA [32]. As these studies used
different constructs and species, the selectivity of DNA binding by
the CXXC domain of Dnmt1 with regard to CpG methylation state
and the role of the CXXC domain in allosteric activation and
substrate discrimination remain to be firmly established.
Notably, not all CXXC domains show DNA binding activity, as
exemplified by the fact that only one out of three CXXC domains
in MBD1 binds DNA [29]. Interestingly, TET1 was recently
shown to be a 2 oxoglutarate- and Fe(II)-dependent dioxygenase
responsible for converting genomic 5-methylcytosine (mC) to 5-
hydroxymethylcytosine (hmC) [33,34]. However, it is not known
whether the CXXC domain of TET1 is involved in recognition of
methylated DNA substrates.
Here we report a functional study and characterization of the
DNA binding activity for the CXXC domains of mouse Dnmt1
and Tet1 proteins. We generated isolated CXXC domain and
deletion constructs based on structural homology models to
minimize structural alterations. We show that the CXXC domain
of Dnmt1 preferentially binds DNA substrates containing
unmethylated CpG sites, but does not contribute significantly to
the DNA binding properties of the full length enzyme and is
dispensable for its catalytic activity in vitro and in vivo. In addition,
we found that the CXXC domain of Tet1 does not bind DNA in
vitro and is also dispensable for catalytic activity of Tet1 in vivo.
Results
Sequence homology and structural modeling identify
distinct CXXC domain subtypes
Dnmt1 contains a zinc finger domain of the CXXC type, which
is present in several mammalian proteins including MLL1
(Figure 1A–C) and is highly conserved among Dnmt1 sequences
from various animal species (Figure S1 in File S1). The primary
structure of CXXC domains spans two clusters of 6 and 2 cysteine
residues separated by a stretch of variable sequence and length.
Sequence alignment and homology tree construction identified
three distinct groups of CXXC domains (Figure 1B and C). The
sequence between the two cysteine clusters in the CXXC domains
of Dnmt1, CGBP/Cfp1, Fbxl19, Mll1, Mll2 and Kdm2 proteins
and CXXC domain 3 of Mbd1 is highly conserved and contains a
KFGG motif. The two other homology groups, including the
CXXC domains 1 and 2 of Mbd1 on one side and those of Tet1,
Cxxc4/Idax, Cxxc5/RINF and Cxxc10 on the other side, lack the
KFGG motif and diverge from the first group and from each other
in the sequence between the cysteine clusters. We generated
structural homology models for the CXXC domains of mouse
Dnmt1 and Tet1 using the NMR structure of the MLL1 CXXC
domain as a template (Figure 1D and E)[35]. The CXXC domains
of these proteins adopt an extended crescent-like structure that
incorporates two Zn2+ ions each coordinated by four cysteine
residues. The peptide of the MLL1 CXXC domain predicted to
insert into the major groove of the DNA double helix (cyan in
Fig. 1E) is located on one face of the structure and is contiguous to
the KFGG motif [35]. The predicted structure of the Tet1 CXXC
domain lacks the short 310 helix (g1 in Figure 1E) formed by
residues PKF and partially overlapping the KFGG motif, but is
similar to the MLL1 CXXC domain in the region of the DNA-
contacting peptide. However, each of the two predicted b-strands
in Tet1 carries three positive charges, whereas there is only one or
no charged residue in the C-terminal strands of the CXXC
domains in MLL1 and Dnmt1. Depending on the orientation of
the positively charged side chains, it cannot be excluded that the
charge density prevents strand pairing in the Tet1 CXXC domain.
The Dnmt1 CXXC domain binds unmethylated DNA
To investigate the binding properties of the Dnmt1 CXXC
domain, we generated a GFP fusion construct including aa 652–699
(GFP-CXXCDnmt1). According to our homology model the ends of
this fragment form an antiparallel b-sheet that structurally delimits
the domain as in MLL1. We first compared the localization and
mobility of GFP-CXXCDnmt1 and GFP in mouse C2C12
myoblasts. While GFP was diffusely distributed in both nucleus
and cytoplasm, GFP-CXXCDnmt1 was exclusively nuclear with a
punctuated pattern throughout the nucleoplasm and was enriched
in nucleoli, a pattern independent of cell cycle stage (Figure 2A and
Figure S2 in File S1). Enrichment in the nucleus and nucleoli is
frequently observed with constructs containing stretches with high
density of basic residues. After photobleaching half of the nuclear
volume we observed a slower fluorescence recovery rate for GFP-
CXXCDnmt1 than for GFP (Figure 2B). To rule out a contribution of
nucleolar interactions to the slower kinetics of GFP-CXXCDnmt1,
Figure 1. Sequence and predicted structural homology of CXXC domains. (A) Schematic representation of the domain structure in Dnmt1 and
Tet1. The catalytic domain and the N-terminal region of Dnmt1 are connected by seven lysine-glycine repeats [(KG)7]. PBD: PCNA binding domain; TS:
targeting sequence; CXXC: CXXC-type zinc finger domain; BAH1 and 2: bromo-adjacent homology domain; NLS: nuclear localization signal; Cys-rich:
cysteine rich region. (B) Alignment of mammalian CXXC domains. Numbers on the right side indicate the position of the last amino acid in the
corresponding protein. The Mbd1a isoform contains three CXXC motifs (Mbd1_1-3). Absolutely conserved residues, including the eight cysteines
involved in zinc ion coordination are highlighted in red and the conserved KFGG motif is in red bold face. Positions with residues in red face share 70%
similarity as calculated with the Risler algorithm [66]. At the top residues of MLL1 involved in b sheets b1 and b2 (black arrows), a helices a1 and a2 and
strict a turns (TTT) are indicated. All sequences are from M. musculus. Accession numbers (for GenBank unless otherwise stated): Dnmt1, NP_034196;
Mll1, NP_001074518; Mll4, O08550 (SwissProt); CGBP, NP_083144; Kdm2a, NP_001001984; Kdm2b, NP_001003953; Fbxl19, NP_766336; Mbd1,
NP_038622; CXXC4/Idax, NP_001004367; CXXC5, NP_598448; CXXC10 (see Materials and Methods). (C) A homology tree was generated from the
alignment in (B). The three subgroups of CXXC domains identified are in different colors. Average distances between the sequences are indicated. (D–E)
Homology models of the mouse Dnmt1 (D; red) and Tet1 (E; blue) CXXC domains superimposed to the CXXC domain of MLL1 (green; [35]). MLL1
residues that were described to contact DNA according to chemical shift measurements [35] are cyan in (E), while cysteines involved in coordination of
the two zinc ions are yellow. Arrows point to the KFGG motif in MLL1 and Dnmt1. The locations of a helices and b sheets are indicated as in (B).
doi:10.1371/journal.pone.0016627.g001
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we separately bleached nucleoplasmic and nucleolar regions and
found that GFP-CXXCDnmt1 has even faster kinetics within the
nucleolus (Figure S3 in File S1). These results are consistent with a
binding activity of GFP-CXXCDnmt1 in the nucleus and very
transient, unspecific binding in the nucleolus. To investigate
whether the CXXC domain of Dnmt1 binds DNA and its possible
selectivity with respect to CpG methylation we used a recently
developed fluorescent DNA binding assay [36,37]. GFP-
CXXCDnmt1 was transiently expressed in HEK293T cells, im-
munopurified with the GFP-trap (Figure S4 in File S1) and
incubated with fluorescent DNA substrates containing either no
CpG site or one central un-, hemi- or fully methylated CpG site in
direct competition. As shown in Figure 2C, GFP-CXXCDnmt1
displayed a significant preference for the substrate containing one
unmethylated CpG site, which increased substantially with a five-
fold higher concentration of the DNA substrates (Figure S5 in File
S1). These results are consistent with the reported binding pre-
ference of the CXXC domains in human DNMT1 and other factors
belonging to the same CXXC homology group [21,22,29,32].
Notably, the CXXC domains 1 and 2 of Mbd1 lack the KFGG
motif and do not bind DNA, while mutation of this motif prevented
DNA binding by the CXXC domain of MLL1 [29,38]. Therefore,
we generated a GFP-CXXCDnmt1 construct where the KFGG motif
was mutated to AAGG (GFP-CXXCDnmt1KF/AA, Figure S4 in File
S1) to test the requirement of the KFGG motif for binding by the
CXXC domain of Dnmt1. The mutant domain showed signifi-
cantly decreased binding to all DNA substrates and complete loss of
preferential binding to the unmethylated substrate in vitro
(Figure 2B). In addition, GFP-CXXCDnmt1KF/AA showed faster
recovery after photobleaching (FRAP) in vivo compared to the
corresponding wild type construct (Figure 2C). These results further
support the importance of the KFGG motif for DNA binding by
CXXC domains.
The CXXC domain of Tet1 shows no specific DNA binding
activity and is dispensable for enzymatic activity in vivo
It was recently shown that Tet1 oxidizes genomic mC to hmC.
However, the mechanism by which Tet1 is targeted to genomic
mC is not known. Our model for the structure of the Tet1 CXXC
domain diverged from the structure of the MLL1 CXXC domain
with respect to the KFGG motif but not to the DNA-contacting
peptide, suggesting that the Tet1 CXXC domain may still bind
DNA. To test this we generated a GFP-tagged Tet1 CXXC
Figure 2. Properties of isolated Dnmt1 and Tet1 CXXC domains. (A–B) Subcellular localization (A) and binding kinetics (B) of GFP-CXXCDnmt1,
GFP-CXXCDnmt1KF/AA, GFP-CXXCTet1 and GFP in mouse C2C12 myoblasts. Localization and binding kinetics were independent from the cell cycle stage
(Figures S2 and S5 in File S1). Arrowheads in (A) point to nucleoli. Scale bar: 5 mm. Binding kinetics were analyzed by FRAP. (C) DNA binding specificity
of the Dnmt1 and Tet1 CXXC domains. GFP, GFP-CXXCDnmt1, GFP-CXXCDnmt1KF/AA and GFP-CXXCTet1 were pulled down from extracts of transiently
transfected HEK293T cells and incubated with fluorescent DNA substrates containing no CpG site or one central un-, hemi- or fully methylated CpG
site in direct competition (noCGB, UMB, HMB, FMB, respectively). Shown are the mean DNA/protein ratios and corresponding standard errors from 5
(GFP), 4 (GFP-CXXCDnmt1 and GFP-CXXCDnmt1KF/AA) and 2 (GFP-CXXCTet1) independent experiments. * P=0.01; ** P=0.007; ***P= 0.001.
doi:10.1371/journal.pone.0016627.g002
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construct (GFP-CXXCTet1) following the same criteria as for GFP-
CXXCDnmt1 and investigated its cellular localization, in vivo
binding kinetics and in vitro DNA binding activity. GFP-CXXCTet1
was prevalently nuclear with a homogeneous distribution includ-
ing nucleoli that was independent of cell cycle stage (Figure 2A and
Figure S6 in File S1). After photobleaching GFP-CXXCTet1
showed very fast recovery kinetics similar to GFP (Figure 2B) and
its DNA binding activity in vitro was also similar to the background
levels of the GFP control (Figure 2C). We conclude that the
isolated CXXC domain of Tet1 has no specific DNA binding
activity. Together with the observation that the CXXC domains 1
and 2 of Mbd1 also lack the KFGG motif and do not bind DNA
[29] and that mutation of this motif reduced DNA binding by the
CXXC domains of both Dnmt1 (Figure 2C) and MLL1 [38], this
result indicates that the KFGG motif is a major determinant for
DNA binding by CXXC domains.
To assess whether the CXXC domain is required for catalytic
activity of Tet1 we generated a GFP-Tet1 fusion construct and a
corresponding mutant lacking the CXXC domain (GFP-
Tet1DCXXC). In C2C12 myoblasts GFP-Tet1 and GFP-
Tet1DCXXC showed punctuated nuclear patterns that did not
depend on the cell cycle stage (Figure 3A and data not shown).
The same constructs were transfected in HEK293T cells and
global levels of genomic hmC were measured using a recently
described hmC glucosylation assay [39]. Overexpression of GFP-
Tet1 and GFP-Tet1DCXXC determined a similar 5-fold increase of
genomic hmC levels relative to control samples overexpressing
GFP (Figure 3B), indicating that the CXXC domain is not
required for enzymatic activity of Tet1 in vivo.
Deletion of the CXXC domain does not affect the activity
of Dnmt1 in vitro
To explore the role of the CXXC domain in Dnmt1 function
we generated GFP-Dnmt1 fusion constructs where the CXXC
domain, as defined by our homology model, was deleted. We
reasoned that precise deletion of the entire structure delimited by
the antiparallel b-sheet (Figure 1D) would have the highest
chances to preserve native folding of the rest of the protein. We
introduced this deletion in GFP fusion constructs encoding either
the full length Dnmt1 or the isolated N-terminal region (GFP-
Dnmt1DCXXC and GFP-NTRDCXXC, respectively; Figure 4A and
Figure S4 in File S1). We then compared DNA binding properties,
catalytic activity and interaction between N-terminal region and
C-terminal catalytic domain of DCXXC and corresponding wild
type constructs. Competitive DNA binding assays with the same
set of substrates as used for the experiments with GFP-
CXXCDnmt1 and GFP-CXXCTet1 reported above (Figure 2C)
showed that both GFP-Dnmt1 and GFP-Dnmt1DCXXC bind DNA
independently of the presence and methylation state of a CpG site
(Figure 4B). As the isolated CXXC domain preferentially bound
the substrate containing an unmethylated CpG site, the result with
GFP-Dnmt1 and GFP-Dnmt1DCXXC indicates that the CXXC
domain contributes negligibly to the DNA binding specificity of
the full-length enzyme.
Several groups reported that interaction between the N-
terminal region and the C-terminal catalytic domain of Dnmt1
leads to allosteric activation of Dnmt1 [16,18–20,40]. To test
whether the CXXC domain is involved in this intramolecular
interaction, we co-expressed either GFP-tagged N-terminal region
(GFP-NTR) or GFP-NTRDCXXC constructs with a Cherry- and
His-tagged C-terminal domain (Ch-CTD-His) in HEK293T cells
and performed co-immunoprecipitation experiments. Ch-CTD-
His co-precipitated both GFP-NTR and GFP-NTRDCXXC,
indicating that the CXXC domain is dispensable for the
interaction between the N-terminal region and the C-terminal
domain of Dnmt1 (Figure 4C).
To investigate whether the CXXC domain is needed for
enzymatic activity or substrate recognition, we tested formation of
the covalent complex with cytosine and transfer of the methyl
group for GFP-Dnmt1 and GFP-Dnmt1DCXXC. We first employed
an assay to monitor covalent complex formation that exploits the
formation of an irreversible covalent bond between the enzyme
and the mechanism-based inhibitor 5-aza-2-deoxycytosine (5-aza-
dC). This results in permanent trapping of the enzyme by DNA
substrates containing 5-aza-dC, as opposed to the reversible
complex formed with substrates containing the natural substrate 2-
deoxycytosine (dC) [36]. GFP-Dnmt1 and GFP-Dnmt1DCXXC
were incubated with fluorescent DNA substrates containing either
dC (binding) or 5-aza-dC (trapping) at a single CpG site in direct
competition. DNA-protein complexes were then isolated by GFP
pulldown and molar DNA/protein ratios were calculated from
fluorescence measurements (Figure 4D). Covalent complex
Figure 3. Cellular localization and in vivo catalytic activity of GFP-Tet1 and GFP-Tet1DCXXC. (A) Live images of C2C12 myoblasts expressing
GFP-Tet1. Scale bar: 5 mm. (B) Genomic hmC content in HEK293T cells overexpressing GFP, GFP-Tet1 and GFP-Tet1DCXXC. Shown are mean values and
standard deviation of hmC percentage over total cytosine for three measurements from one transfection.
doi:10.1371/journal.pone.0016627.g003
CXXC Domains of Dnmt1 and Tet1
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e16627
formation was then estimated by comparing trapping and binding
activities. GFP-Dnmt1 and GFP-Dnmt1DCXXC showed compara-
ble covalent complex formation rates (trapping/binding ratios),
which were about 15- and 12-fold higher for hemi- than un-
methylated substrates, respectively (Figure 4E). Together with the
data from binding experiments (Fig. 4B), this result indicates that
the preference of Dnmt1 for hemimethylated substrates is
determined at the covalent complex formation step rather than
upon DNA binding. Furthermore, the CXXC domain clearly does
not play a major role in determining either the efficiency or the
methylation state-specificity of covalent complex formation.
Next, we tested whether deletion of the CXXC domain affects
the ability of Dnmt1 to transfer [3H]methyl groups from the donor
S-adenosylmethionine (SAM) to a poly(dI?dC)-poly(dI?dC) sub-
strate, a standard DNA methyltransferase activity assay. This
showed that in vitro GFP-Dnmt1 and GFP-Dnmt1DCXXC are equally
active methyltransferases (Figure S7 in File S1). This result is in
contrast with a previous report showing that deletion of aa 647–690
in human DNMT1 encompassing the CXXC domain resulted in a
drastic loss of catalytic activity [32]. However, according to our
homology model the deletion by Pradhan et al. would eliminate the
predicted N-terminal b-strand (b1 in Figure 1) preventing the
formation of the antiparallel b-sheet and potentially distort the
folding of the rest of the protein. This is in contrast with our GFP-
Dnmt1DCXXC mutant that was designed to retain the b-sheet
structure. To test whether this may account for the observed
discrepancy, we generated GFP fusion constructs of wild type
human DNMT1 and the same deletion as reported by Pradhan et al.
and tested covalent complex formation with 5-aza-dC containing
DNA substrates as described above. While the human wild type
construct showed the same preference for hemimethylated over
unmethylated trapping substrates as the mouse constructs, this
preference was clearly reduced for the human CXXC deletion
mutant (Figure S8 in File S1). This result is consistent with the loss of
enzymatic activity shown by Pradhan et al. for this mutant and
together with the retention of trapping and catalytic activity by the
different deletion in GFP-Dnmt1DCXXC suggests that disruption of
the antiparallel b-sheet delimiting the CXXC domain results in
further distortion and loss of activity of the enzyme.
In conclusion, we showed that, in vitro, deletion of the CXXC
domain does not affect the interaction between N-terminal region
and C-terminal domain, DNA binding, the preference for
hemimethylated substrates upon covalent complex formation
and the methyltransferase activity of Dnmt1. Together, these
data strongly argue against an involvement of the CXXC domain
in allosteric activation of Dnmt1.
Figure 4. DNA binding specificity, intramolecular interaction and trapping of wild-type Dnmt1 and CXXC deletion constructs in
vitro. (A) Schematic representation of Dnmt1 expression constructs. (B) DNA binding specificity of GFP-Dnmt1 and GFP-Dnmt1DCXXC were assayed as
described in Figure 2C. (C) Co-immunoprecipitation of the C-terminal domain of Dnmt1 (Ch-CTD-His) and the N-terminal region with and without
deletion of the CXXC domain (GFP-NTR and GFP-NTRDCXXC, respectively). GFP fusions were detected using an anti-GFP antibody, while the C-terminal
domain construct was detected using an anti-His antibody. GFP was used as negative control. I = input, B = bound. (D) Comparison of binding and
trapping activities for GFP-Dnmt1 and GFP-Dnmt1DCXXC to monitor irreversible covalent complex formation with hemimethylated substrates. (E)
Relative covalent complex formation rate of GFP-Dnmt1 and GFP-Dnmt1DCXXC on substrates containing one un- (UMT) or hemi-methylated CpG site
(HMT) in direct competition. The trapping ratio for GFP-Dnmt1 on unmethylated substrate was set to 1. In (D) and (E) the means and corresponding
standard deviations of triplicate samples from three independent experiments are shown. GFP was used as negative control.
doi:10.1371/journal.pone.0016627.g004
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Deletion of the CXXC domain does not affect Dnmt1
activity in vivo
We then undertook a functional characterization of the GFP-
Dnmt1DCXXC construct in vivo. We first compared localization and
binding kinetics of GFP-Dnmt1 or GFP-Dnmt1DCXXC in mouse
C2C12 myoblasts co-transfected with RFP-PCNA, which served
as S-phase marker [41]. GFP-Dnmt1DCXXC showed the same cell-
cycle dependent nuclear localization pattern as previously shown
for GFP-Dnmt1 and endogenous Dnmt1 (Figure 5A)[42,43].
Interaction with PCNA via the PBD directs Dnmt1 to replication
foci throughout S-phase. In addition, in late S-phase and G2
Dnmt1 is enriched at chromocenters, clusters of pericentric
heterochromatin (PH) that are observed as discrete domains
densely stained by DNA dyes in mouse interphase cells.
Association of Dnmt1 with PH at these stages is mediated by
the TS domain [42]. Thus, the CXXC domain clearly does not
contribute to the subnuclear localization of Dnmt1 at this level of
resolution.
We also compared the mobility of GFP-Dnmt1 and GFP-
Dnmt1DCXXC in living C2C12 myoblasts by FRAP analysis
(Figure 5B). These experiments revealed that the kinetics of
Dnmt1 is not significantly affected by deletion of the CXXC
domain in early-mid as well as late S-phase.
To test covalent complex formation in living cells, we used a
previously established trapping assay [44]. Mouse C2C12
myoblasts were co-transfected with RFP-PCNA and either GFP-
Dnmt1 or GFP-Dnmt1DCXXC and treated with 5-aza-dC.
Immobilization of the Dnmt1 constructs at the site of action was
then measured by FRAP analysis (Figure 5C). GFP-Dnmt1 and
GFP-Dnmt1DCXXC showed very similar trapping kinetics, the
immobile enzyme fraction reaching nearly 100% after 20 and 40
minutes in early-mid and late S-phase, respectively. This result
clearly shows that the CXXC domain is dispensable for covalent
complex formation also in vivo.
Finally, we compared the ability of GFP-Dnmt1 and GFP-
Dnmt1DCXXC to restore DNA methylation patterns in mouse
dnmt12/2 ESCs. Cells transiently expressing either GFP-Dnmt1 or
GFP-Dnmt1DCXXC were FACS sorted 48 h after transfection.
Isolated genomic DNA was then bisulfite treated and fragments
corresponding to major satellite repeats, intracisternal type A
particle (IAP) interspersed repeats, skeletal a-actin and H19a
promoters were amplified and subjected to pyrosequencing
(Figure 6). As shown previously [43], under these conditions
GFP-Dnmt1 partially restored methylation of major satellite and
IAP repeats and the skeletal a-actin promoter, but not of the
imprinted H19a promoter, as establishment of the methylation
imprint requires passage through the germ line [45]. Methylation
patterns of all these sequences in cells expressing GFP-
Dnmt1DCXXC were very similar to those in GFP-Dnmt1
expressing cells, including the lack of (re-) methylation at the
H19a promoter. These results suggest that the CXXC domain is
not required for maintenance of DNA methylation patterns by
Dnmt1 and does not restrain the DNA methyltransferase activity
of Dnmt1 on unmethylated CpG sites. Thus, the CXXC domain
does not play a major role in subcellular localization, it does not
contribute to the global binding kinetics of Dnmt1 and, consistent
with the in vitro data reported above, is dispensable for maintaining
DNA methylation patterns in living cells.
Figure 5. Cell cycle dependant cellular localization, protein mobility and trapping of wild-type Dnmt1 and CXXC deletion
constructs in mouse C2C12 myoblasts. (A) Cell cycle dependent localization of GFP-Dnmt1 and GFP-Dnmt1DCXXC constructs. Scale bar: 5 mm. (B)
Analysis of binding kinetics of GFP-Dnmt1 and GFP-Dnmt1DCXXC in early and late S-phase cells by FRAP. The recovery curve for GFP is shown for
comparison. (C) In vivo trapping by FRAP analysis in cells treated with 5-aza-dC. The trapped enzyme fraction is plotted over time for early and late S-
phase cells. For each construct three to six cells in early-mid and late S phase were analysed per time point. Shown are mean values 6 SEM. In (A–C)
RFP-PCNA was cotransfected to identify cell cycle stages in living cells.
doi:10.1371/journal.pone.0016627.g005
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Discussion
We generated homology models based on the reported structure
of the MLL1 CXXC domain to design isolated CXXC domain
constructs and CXXC domain deletion mutants for Dnmt1 and
Tet1 with minimal probability of structural alteration. According
to these models CXXC domains are delimited by an antiparallel
b-sheet, a discrete structural element. Our data show that the
CXXC domain of mouse Dnmt1 preferentially binds DNA
substrates containing unmethylated CpG sites as previously shown
for CXXC domains of human DNMT1 and other mammalian
proteins. We note that sequences C-terminal to the corresponding
peptide in CGBP/Cfp1 were reported to be required for DNA
binding in vitro [22] and that only a significantly larger peptide
spanning the CXXC-3 domain of Mbd1a was tested for DNA
binding. However, sequences C-terminal to CXXC domains are
not conserved (Figure 1B) and our data show that they are not
required for DNA binding by the CXXC domain of Dnmt1.
Nevertheless, all the CXXC domains reported to selectively bind
unmethylated CpG sites cluster in a distinct homology group and
contain the KFGG motif. The latter was shown to be crucial for
DNA binding by the CXXC domain of MLL1 [38] and here we
extend this observation to the CXXC domain of Dnmt1.
Sequence alignment reveals two distinct CXXC domain homology
groups that lack the KFGG motif (Figure 1A). Consistent with a
role of this motif in DNA binding, members of these groups such
as CXXC-1/2 of Mbd1 [29] and the CXXC domain of Tet1 (this
study) show no DNA binding activity. While no specific function is
known for CXXC-1/2 of Mbd1, the CXXC domain of Tet1 is
closely related to those in CXXC4/Idax and CXXC5/RINF that
were shown to mediate protein-protein interactions [46–48]. This
suggests that the CXXC domain of Tet1, rather than mediating
DNA binding, may function as a protein-protein interaction
domain. However, our data do not rule out the possibility that the
DNA binding properties of the CXXC domain within the context
of full length Tet1 may be different from those of the isolated
domain. Nevertheless, we show that the CXXC domain is not
required for enzymatic activity of Tet1 in vivo.
Although we observed a clear DNA binding activity by the
isolated CXXC domain of Dnmt1, we found that, within the
context of the full length enzyme, this domain is dispensable for
overall DNA binding properties, preference for hemimethylated
substrates upon covalent complex formation, methyltransferase
activity and allosteric activation as well as for the ability to restore
methylation of representative sequences in dnmt1 null ESCs.
Consistent with our data, a recent report showed a preference of
the CXXC domain of human DNMT1 for substrates containing
unmethylated CpG sites [32]. However, the same report showed
that deletion of the CXXC domain from the human enzyme
results in a significant decrease in methyltransferase activity on
hemimethylated substrates in vitro and 25% lower methylation at
rDNA repeats upon overexpression in HEK293 cells, suggesting a
dominant negative effect of the deletion construct. These
discrepancies may be due to the fact that the fragment deleted
by Pradhan et al. includes the N-terminal strand of the predicted
antiparallel b-sheet, potentially leading to disruption of native
folding, to species-specific differences and/or to the analysis of
non-physiological expression levels in HEK293 cells. In our
trapping assay the same human deletion mutant showed reduced
covalent complex formation, consistent with loss of enzymatic
activity. The report from Pradhan et al. also showed that mutation
of cysteine 667 to glycine within the CXXC domain of human
Figure 6. The CXXC deletion construct of Dnmt1 restores methylation in dnmt1 null cells. Mouse dnmt12/2 ESCs transiently expressing
GFP-Dnmt1 or GFP-Dnmt1DCXXC were isolated by FACS-sorting 48 h after transfection and CpG methylation levels within the indicated sequences
were analyzed by bisulfite treatment, PCR amplification and direct pyrosequencing. Methylation levels of untransfected wild type and dnmt12/2 ESCs
are shown for comparison.
doi:10.1371/journal.pone.0016627.g006
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DNMT1 disrupts DNA binding and enzymatic activity. However,
as this point mutation involves one of the zinc coordinating
residues it is not unlikely to alter peptide folding with negative
consequences potentially extending beyond the CXXC domain
and including reduced enzymatic activity. In this respect the
dominant negative effect observed upon overexpression of this
mutant may be explained by the prevalent occurrence of Dnmt1
as a dimer [49]. These observations, together with preserved
ability for covalent complex formation and catalytic activity of our
CXXC domain deletion, support the validity of our homology
model-driven approach for functional characterization of the
CXXC domain. In addition, our genetic complementation
approach constitutes a rather physiologic functional assay.
However, due to the transient approach and the analysis of
genomic methylation at only a few representative sequences, subtle
or highly sequence specific effects of deletion of the CXXC
domain cannot be excluded.
It was recently shown that binding of Cfp1/CGBP and
KDM2A to CpG islands through their CXXC domains leads to
local enrichment and depletion of H3K4 and H3K36 methylation,
respectively [26,30]. Analogously, Dnmt1 may bind CpG islands
through its CXXC domain. However, this interaction would not
lead to a straightforward functional interpretation as CpG islands
with high CpG density are generally refractive to DNA
methylation and a function of Dnmt1 as a de novo DNA
methyltransferase is not well established. It could be envisaged
that binding to unmethylated CpG sites/islands by the CXXC
domain may have a negative effect on the enzymatic activity of
Dnmt1 and restrain its function as a de novo DNA methyltrans-
ferase. However, we show that in dnmt1 null ESCs methylation of
the imprinted H19a promoter is not restored upon expression of
either wild type or DCXXC Dnmt1 constructs, arguing against a
negative regulatory function of the CXXC domain.
Notably, binding of unmethylated CpG sites by KFGG motif-
containing CXXC domains does not exclude a role in protein-
protein interaction as the CXXC domain of MLL1 was reported
to interact with both DNA and Polycomb Repressive Complex 1
components HPC2/CBX4 and BMI-1 [21,50]. Therefore, it is
possible that the CXXC domain of Dnmt1 has regulatory
functions in specific cell types or developmental stages that may
involve DNA binding and/or interaction with other proteins. The




Alignments were performed using the ClustalW2 software [51].
The CXXC domain homology tree (Figure 1C) was generated
from the alignment in Figure 1B with Jalview 2.4 by unweighted
pair group method with arithmetic mean (UPGMA). The
neighbor-joining method gave the same result. Average distances
between the sequences were calculated using the BLOSSUM62
matrix. The human CXXC10 coding sequence [52] was
determined by assembling ESTs AI438961, BX114363,
BX492895, BU633058.1, AW207644.1 and the genomic sequence
AC073046.7. The putative translational start site is located
16308 bp upstream of the annotated transcriptional start site of
TET3. A partial coding sequence of murine Cxxc10 containing
the CXXC domain was identified by aligning the human
CXXC10 protein sequence to the ORFs present in
NT_039353.7 upstream of the tet3 gene from position 35663306
to 35808487). A very high match was found 13266 nt upstream of
tet3 at positions 35676374-35676572 of NT_039353.7. To build
homology models for the CXXC domains of Dnmt1 (aa 645–696)
and Tet1 (aa 561–614), we submitted the respective sequences to
the HHpred server [53]. The best template was the CXXC
domain of MLL1 (PDB-ID: 2J2S). The 49 residues of the CXXC
domain in Dnmt1 can be aligned to this domain with 45%
sequence identity and only a single amino acid gap after residue
661 (Figure 1B). 3D models were calculated with the homology
modeling software MODELLER [54] (version 9.5) using this
alignment. Distance restraints were given to MODELLER to
enforce a distance of 2.360.1 A˚ between the eight sulphurs in the
Zn-coordinating cysteines and the Zn2+ ions. TM-align [55] was
used to superpose the model structure with the template domain.
Images were generated using the PyMol Molecular Graphics
System (Version 1.3, Schro¨dinger, LLC). The quality of the
models and the underlying alignments were checked with DOPE
[56] and Verify3D [57] and results for both models were found to
be comparable to the MLL1 template structure (2J2S).
Expression constructs
Fusion constructs were generated using enhanced green
fluorescent protein, monomeric red fluorescent protein or
monomeric cherry and are here referred to as GFP, RFP and
Cherry fusions, respectively. Mammalian expression constructs for
GFP, mouse GFP-Dnmt1, GFP-NTR and human RFP-PCNA
were described previously [42,44,49,58]. The deletion construct
GFP-Dnmt1DCXXC was obtained by replacing the sequence
coding for aa 655–696 with three alanine codons in the GFP-
Dnmt1 construct as described [59]. The GFP-DNMT1DCXXC
construct was generated by subcloning the sequence coding for
human DNMT1DCXXC from the homonymous construct by
Pradhan et al. [32] in the pEGFP-C2 vector (Clonetech). To
generate GFP-Tet1 three partially overlapping fragments span-
ning the Tet1 coding sequence were amplified using E14 ESCs
cDNA as template. The fragments were then joined by overlap
extension PCR and inserted into the pCAG-GFP-IB vector [43].
To generate GFP-Tet1DCXXC aa 569-621 of murine Tet1 were
deleted from GFP-Tet1 using a type IIs restriction endonuclease
approach as described [60]. To generate GFP-CXXCDnmt1 and
GFP-CXXCTet1 sequences coding for the respective CXXC
domains (aa 643-700 for Dnmt1 and 561-614 for Tet1) were
amplified by PCR using the GFP-Dnmt1 expression construct and
cDNA from E14 ESCs as templates, respectively. PCR fragments
were then inserted into the pCAG-GFP-IB vector. GFP-
NTRDCXXC was obtained by replacing the BglII-XhoI fragment
of GFP-NTR with the same fragment of GFP-Dnmt1DCXXC. Ch-
CTD-His was generated by replacing the GFP coding sequence in
a GFP-CTD construct [49] with the Cherry coding sequence. All
constructs were confirmed by sequencing.
Cell culture, transfection and cell sorting
HEK293T cells [61] and mouse C2C12 myoblasts [62] were
cultured in DMEM supplemented with 50 mg/ml gentamicin and
10% and 20% fetal calf serum, respectively. For expression of
fusion proteins HEK293T cells were transfected with polyethy-
lenimine (Sigma). For live cell imaging, C2C12 cells were grown
to 40% confluence on Lab-Tek chambers (Nunc) or m-slides
(Ibidi) and transfected with TransFectin transfection reagent
(BioRad) according to the manufacturer’s instructions. Mouse
ESCs were cultured as described [63] and transfected with
FuGENE HD (Roche) according to the manufacturer’s instruc-
tions. ESCs were sorted with a FACS Aria II instrument (Becton
Dickinson). The dnmt12/2 J1 ESCs used in this study are
homozygous for the c allele [14].
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In vitro DNA binding and trapping assays
In vitro DNA binding and trapping assays were performed as
described previously [36,37] with the following modifications.
DNA substrates labeled with four different ATTO fluorophores
(Tables S1 and S2 in File S1) were used at a final concentration of
125 nM each in the pull-down assay with immobilized GFP
fusions. After removal of unbound substrate, the amounts of
protein and DNA were determined by fluorescence intensity
measurements with a Tecan Infinite M1000 plate reader using
calibration curves from purified GFP or DNA coupled ATTO
fluorophores, respectively. The following excitation/emission 6
detection bandwidth settings were used: 490/511610 nm for
GFP, 550/580615 nm for ATTO550, 600/630615 nm for
ATTO590, 650/670610 nm for ATTO647N and 700/
720610 nm for ATTO700. Cross detection of GFP and different
ATTO dyes was negligible with these settings. Binding and
trapping ratios were calculated dividing the concentration of
bound DNA substrate by the concentration of GFP fusion on
the beads.
In vivo mC hydroxylation assay
Genomic DNA was isolated from HEK293T cells 24 h after
transfection with the GFP-Tet1 and GFP-Tet1DCXXC constructs
and global hmC levels were measured using the in vitro
glucosylation assay as previously described [63], except that
100 nM b-glucosyltransferase and only UDP-[3H]glucose donor
(0.43 mM) were used.
Co-immunoprecipitation
Co-immunoprecipitation was performed as described previously
[49,64]. Shortly, HEK293T cells were transiently co-transfected
with expression plasmids for GFP fusions and the Ch-CTD-His
construct, harvested and lysed. GFP fusions were pulled down
using the GFP-Trap [65] (Chromotek) and subjected to western
blotting using anti-GFP (Roche or Chromotek) and anti-His
(Invitrogen) monoclonal antibodies.
Live cell microscopy, FRAP analysis and live cell trapping
assay
Live cell imaging and FRAP experiments were performed as
described previously [43]. For each construct 6-15 nuclei were
averaged and the mean values as well as the standard errors were
calculated. For presentation, we used linear contrast enhancement
on entire images. The DNA methyltransferase trapping assay was
described previously [44]. Briefly, transfected cells were incubated
with 30 mM 5-aza-dC (Sigma) for the indicated periods of time
before photobleaching experiments. FRAP analysis was performed
with a confocal laser scanning microscope (TCS SP5, Leica)
equipped with a 636/1.4 NA Plan-Apochromat oil immersion
objective. Microscope settings were as described except that a
smaller region of interest (3 mm63 mm) was selected for photo-
bleaching. Mean fluorescence intensities of the bleached region
were corrected for background and for total loss of nuclear
fluorescence over the time course, and normalized by the mean of
the last 10 prebleach values.
DNA Methylation Analysis
Genomic DNA was isolated with the QIAmp DNA Mini Kit
(Qiagen) and 1.5 mg were bisulfite converted using the EZ DNA
Methylation-Gold Kit (Zymo research) according to the manu-
facturer’s instructions. Primer sets and PCR conditions for IAP-
LTR, skeletal a-actin and H19 promoters were as described [43].
Primer sequences for major satellites were AAAATGAGAAA-
CATCCACTTG (forward primer) and CCATGATTTT-
CAGTTTTCTT (reverse primer). For amplification we used
Qiagen Hot Start Polymerase in 1x Qiagen Hot Start Polymerase
buffer supplemented with 0.2 mM dNTPs, 0.2 mM forward
primer, 0.2 mM reverse primer, 1.3 mM betaine (Sigma) and
60 mM tetramethylammonium-chloride (TMAC, Sigma). Pro-
moter regions and IAP-LTR were amplified with two subsequent
(nested) PCR reactions and major satellite repeats were amplified
with a single amplification reaction. Pyrosequencing reactions
were carried out by Varionostic GmbH (Ulm, Germany).
Pyrosequencing primers are listed in Table S3 in File S1.
Supporting Information




The authors thank Sabine Brunner and Lucia Puchbauer for technical
assistance in the generation of the homology models. We also thank
Taiping Chen and En Li (Novartis Institutes for Biomedical Research,
Boston, MA) for providing dnmt1 null ESCs and Shriharsa Pradhan (New
England BioLabs, Ipswich, MA) for the human DNMT1DCXXC construct
and constructive discussion.
Author Contributions
Conceived and designed the experiments: FS HL. Performed the
experiments: CF AR SB DM KF SH MW WQ. Analyzed the data: CF
AR SB DM KF SH JS. Contributed reagents/materials/analysis tools: JS.
Wrote the paper: FS HL. Generated homology models: JS.
References
1. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, et al. (2009) Targeted and
genome-scale strategies reveal gene-body methylation signatures in human cells.
Nat Biotechnol 27: 361–368.
2. Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights
from epigenomics. Nat Rev Genet 9: 465–476.
3. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, et al. (2010) Dynamic changes
in the human methylome during differentiation. Genome Res 320: 320–331.
4. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, et al. (2009) Human
DNA methylomes at base resolution show widespread epigenomic differences.
Nature 462: 315–322.
5. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, et al. (2008) Lineage-
specific polycomb targets and de novo DNA methylation define restriction and
potential of neuronal progenitors. Mol Cell 30: 755–766.
6. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, et al. (2009) Targeted
bisulfite sequencing reveals changes in DNA methylation associated with nuclear
reprogramming. Nat Biotechnol 27: 353–360.
7. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, et al. (2009) Lineage-
specific DNA methylation in T cells correlates with histone methylation and
enhancer activity. Genome Res 19: 1165–1174.
8. Edwards JR, O’Donnell AH, Rollins RA, Peckham HE, Lee C, et al. (2010)
Chromatin and sequence features that define the fine and gross structure of
genomic methylation patterns. Genome Res 20: 972–980.
9. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, et al. (2003)
Induction of tumors in mice by genomic hypomethylation. Science 300:
489–492.
10. Walsh CP, Chaillet JR, Bestor TH (1998) Transcription of IAP endogenous
retroviruses is constrained by cytosine methylation. Nat Genet 20: 116–117.
11. Xu G-L, Bestor TH, Bourc’his D, Hsieh C-L, Tommerup N, et al. (1999)
Chromosome instability and immunodeficiency syndrome caused by mutations
in a DNA methyltransferase gene. Nature 402: 187–191.
12. Goll MG, Bestor TH (2005) Eukaryotic cytosine methyltransferases. Annu Rev
Biochem 74: 481–514.
CXXC Domains of Dnmt1 and Tet1
PLoS ONE | www.plosone.org 10 February 2011 | Volume 6 | Issue 2 | e16627
13. Leonhardt H, Page AW, Weier HU, Bestor TH (1992) A targeting sequence
directs DNA methyltransferase to sites of DNA replication in mammalian nuclei.
Cell 71: 865–873.
14. Lei H, Oh SP, Okano M, Juttermann R, Goss KA, et al. (1996) De novo DNA
cytosine methyltransferase activities in mouse embryonic stem cells. Develop-
ment 122: 3195–3205.
15. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA
methyltransferase gene results in embryonic lethality. Cell 69: 915–926.
16. Margot JB, Aguirre-Arteta AM, Di Giacco BV, Pradhan S, Roberts RJ, et al.
(2000) Structure and function of the mouse DNA methyltransferase gene:
Dnmt1 shows a tripartite structure. J Mol Biol 297: 293–300.
17. Spada F, Rothbauer U, Zolghadr K, Schermelleh L, Leonhardt H (2006)
Regulation of DNA methyltransferase 1. Adv Enzyme Regul 46: 224–234.
18. Zimmermann C, Guhl E, Graessmann A (1997) Mouse DNA methyltransferase
(MTase) deletion mutants that retain the catalytic domain display neither de
novo nor maintenance methylation activity in vivo. Biol Chem 378: 393–405.
19. Pradhan S, Esteve PO (2003) Allosteric activator domain of maintenance human
DNA (cytosine-5) methyltransferase and its role in methylation spreading.
Biochemistry 42: 5321–5332.
20. Fatemi M, Hermann A, Pradhan S, Jeltsch A (2001) The activity of the murine
DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic
domain with the N-terminal part of the enzyme leading to an allosteric
activation of the enzyme after binding to methylated DNA. J Mol Biol 309:
1189–1199.
21. Birke M, Schreiner S, Garcia-Cuellar MP, Mahr K, Titgemeyer F, et al. (2002)
The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA
and discriminates against methylation. Nucl Acids Res 30: 958–965.
22. Lee JH, Voo KS, Skalnik DG (2001) Identification and characterization of the
DNA binding domain of CpG-binding protein. J Biol Chem 276: 44669–44676.
23. Cross SH, Meehan RR, Nan X, Bird A (1997) A component of the
transcriptional repressor MeCP1 shares a motif with DNA methyltransferase
and HRX proteins. Nat Genet 16: 256–259.
24. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, et al.
(2006) Histone demethylation by a family of JmjC domain-containing proteins.
Nature 439: 811–816.
25. Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M
(2007) JHDM1B/FBXL10 is a nucleolar protein that represses transcription of
ribosomal RNA genes. Nature 450: 309–313.
26. Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, et al. (2010)
CpG Islands Recruit a Histone H3 Lysine 36 Demethylase. Mol Cell 38:
179–190.
27. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, et al. (2003)
TET1, a member of a novel protein family, is fused to MLL in acute myeloid
leukemia containing the t(10;11)(q22;q23). Leukemia 17: 637–641.
28. Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, et al. (2002) LCX,
leukemia-associated protein with a CXXC domain, is fused to MLL in acute
myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res
62: 4075–4080.
29. Jorgensen HF, Ben-Porath I, Bird AP (2004) Mbd1 is recruited to both
methylated and nonmethylated CpGs via distinct DNA binding domains. Mol
Cell Biol 24: 3387–3395.
30. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, et al. (2010) CpG islands
influence chromatin structure via the CpG-binding protein Cfp1. Nature 464:
1082–1086.
31. Bestor TH (1992) Activation of mammalian DNA methyltransferase by cleavage
of a Zn binding regulatory domain. EMBO J 11: 2611–2617.
32. Pradhan M, Esteve PO, Chin HG, Samaranayke M, Kim GD, et al. (2008)
CXXC domain of human DNMT1 is essential for enzymatic activity.
Biochemistry 47: 10000–10009.
33. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian
DNA by MLL Partner TET1. Science 324: 930–935.
34. Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, et al. (2010) Role of
Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell
mass specification. Nature 466: 1129–1133.
35. Allen MD, Grummitt CG, Hilcenko C, Min SY, Tonkin LM, et al. (2006)
Solution structure of the nonmethyl-CpG-binding CXXC domain of the
leukaemia-associated MLL histone methyltransferase. EMBO J 25: 4503–4512.
36. Frauer C, Leonhardt H (2009) A versatile non-radioactive assay for DNA
methyltransferase activity and DNA binding. Nucl Acids Res 37: e22.
37. Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, et al. (2010) The multi-
domain protein Np95 connects DNA methylation and histone modification.
Nucl Acids Res 38: 1796–1805.
38. Ayton PM, Chen EH, Cleary ML (2004) Binding to nonmethylated CpG DNA
is essential for target recognition, transactivation, and myeloid transformation by
an MLL oncoprotein. Mol Cell Biol 24: 10470–10478.
39. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H (2010)
Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic
DNA. Nucleic Acids Research 38: e181.
40. Bacolla A, Pradhan S, Larson JE, Roberts RJ, Wells RD (2001) Recombinant
human DNA (cytosine-5) methyltransferase. III. Allosteric control, reaction
order, and influence of plasmid topology and triplet repeat length on
methylation of the fragile X CGG.CCG sequence. J Biol Chem 276:
18605–18613.
41. Easwaran HP, Leonhardt H, Cardoso MC (2005) Cell Cycle Markers for Live
Cell Analyses. Cell Cycle 4: 453–455.
42. Easwaran HP, Schermelleh L, Leonhardt H, Cardoso MC (2004) Replication-
independent chromatin loading of Dnmt1 during G2 and M phases. EMBO
Rep 5: 1181–1186.
43. Schermelleh L, Haemmer A, Spada F, Rosing N, Meilinger D, et al. (2007)
Dynamics of Dnmt1 interaction with the replication machinery and its role in
postreplicative maintenance of DNA methylation. Nucl Acids Res 35:
4301–4312.
44. Schermelleh L, Spada F, Easwaran HP, Zolghadr K, Margot JB, et al. (2005)
Trapped in action: direct visualization of DNA methyltransferase activity in
living cells. Nat Methods 2: 751–756.
45. Tucker KL, Beard C, Dausmann J, Jackson-Grusby L, Laird PW, et al. (1996)
Germ-line passage is required for establishment of methylation and expression
patterns of imprinted but not of nonimprinted genes. Genes Dev 10: 1008–1020.
46. Andersson T, So¨dersten E, Duckworth JK, Cascante A, Fritz N, et al. (2009)
CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural
Stem Cells. J Biol Chem 284: 3672–3681.
47. Hino S-i, Kishida S, Michiue T, Fukui A, Sakamoto I, et al. (2001) Inhibition of
the Wnt Signaling Pathway by Idax, a Novel Dvl-Binding Protein. Mol Cell Biol
21: 330–342.
48. London TBC, Lee H-J, Shao Y, Zheng J (2004) Interaction between the internal
motif KTXXXI of Idax and mDvl PDZ domain. Biochem Biophys Res
Commun 322: 326–332.
49. Fellinger K, Rothbauer U, Felle M, Langst G, Leonhardt H (2009) Dimerization
of DNA methyltransferase 1 is mediated by its regulatory domain. J Cell
Biochem 106: 521–528.
50. Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ (2003) MLL repression domain
interacts with histone deacetylases, the polycomb group proteins HPC2 and
BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad
Sci U S A 100: 8342–8347.
51. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucl Acids
Res 22: 4673–4680.
52. Katoh M (2004) Identification and characterization of human CXXC10 gene in
silico. Int J Oncol 25: 1193–1199.
53. So¨ding J, Biegert A, Lupas AN (2005) The HHpred interactive server for protein
homology detection and structure prediction. Nucl Acids Res 33: W244–248.
54. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M (1995) Evaluation of
comparative protein modeling by MODELLER. Proteins 23: 318–326.
55. Zhang Y, Skolnick J (2005) TM-align: a protein structure alignment algorithm
based on the TM-score. Nucl Acids Res 33: 2302–2309.
56. Shen M-y, Sali A (2006) Statistical potential for assessment and prediction of
protein structures. Protein Sci 15: 2507–2524.
57. Eisenberg D, Lu¨thy R, Bowie JU (1997) VERIFY3D: Assessment of protein
models with three-dimensional profiles. In: Carter CWJ, Sweet RM, eds.
Methods Enzymol: Academic Press. pp 396–404.
58. Sporbert A, Domaing P, Leonhardt H, Cardoso MC (2005) PCNA acts as a
stationary loading platform for transiently interacting Okazaki fragment
maturation proteins. Nucl Acids Res 33: 3521–3528.
59. Fellinger K, Leonhardt H, Spada F (2008) A mutagenesis strategy combining
systematic alanine scanning with larger mutations to study protein interactions.
Anal Biochem 373: 176–178.
60. Ko J-K, Ma J (2005) A rapid and efficient PCR-based mutagenesis method
applicable to cell physiology study. Am J Physiol Cell Physiol 288: C1273–1278.
61. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of
mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell
Biol 7: 379–387.
62. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, et al. (1985)
Plasticity of the differentiated state. Science 230: 758–766.
63. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H (2010)
Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic
DNA. Nucl Acids Res 38: e181.
64. Meilinger D, Fellinger K, Bultmann S, Rothbauer U, Bonapace IM, et al. (2009)
Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b,
and mediates epigenetic silencing of the viral CMV promoter in embryonic stem
cells. EMBO Rep 10: 1259–1264.
65. Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, et al.
(2007) A versatile nanotrap for biochemical and functional studies with
fluorescent fusion proteins. Mol Cell Proteomics 7: 282–289.
66. Mohseni-Zadeh S, Brezellec P, Risler JL (2004) Cluster-C, an algorithm for the
large-scale clustering of protein sequences based on the extraction of maximal
cliques. Comput Biol Chem 28: 211–218.
CXXC Domains of Dnmt1 and Tet1
PLoS ONE | www.plosone.org 11 February 2011 | Volume 6 | Issue 2 | e16627
1 
 
Different binding properties and function of CXXC zinc finger domains in 
Dnmt1 and Tet1 
 
Carina Frauer#, Andrea Rottach#, Daniela Meilinger, Sebastian Bultmann, Karin Fellinger, 
Stefan Hasenöder, Mengxi Wang, Weihua Qin, Johannes Söding§, Fabio Spada* and Heinrich 
Leonhardt* 
 
Department of Biology and Center for Integrated Protein Science Munich (CIPSM), Ludwig 
Maximilians University Munich, Planegg-Martinsried and §Gene Center Munich, Ludwig 




FS: f.spada@lmu.de; Fax +49 89 2180-74236; Tel. +49 89 2180-74230 
HL: h.leonhardt@lmu.de; Fax +49 89 2180-74236; Tel. +49 89 2180-74232 
 









Frauer et al.  Supplemental Information File 
2 
 
Table S1. Sequences of DNA oligonucleotides used for preparation of double stranded DNA 
substrates. M: 5-methylcytosine. 
Name Sequence 
CG-up 5’- CTCAACAACTAACTACCATCCGGACCAGAAGAGTCATCATGG -3’ 
MG-up  5’- CTCAACAACTAACTACCATCMGGACCAGAAGAGTCATCATGG -3’ 
noCG-up 5’- CTCAACAACTAACTACCATCTGGACCAGAAGAGTCATCATGG -3’ 
Fill-In-550 5’- ATTO550-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-590 5’- ATTO590-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-647N 5’- ATTO647N-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-700 5’- ATTO700-CCATGATGACTCTTCTGGTC -3’ 
 
Table S2. DNA substrates used for the in vitro DNA binding and trapping assays. 
Name CpG site Label Oligo I Oligo II dCTP reaction  Purpose 







UMB 590 590 Fill-In-590 
UMB 647N 647N Fill-In-647N 
UMB 700 700 Fill-In-700 







HMB 647N 647N Fill-In-647N 
HMT 550 550 Fill-In-550 
5-aza-dCTP Trapping
HMT 647N 647N Fill-In-647N 
FMB 647N fully methylated 647N MG-up Fill-In-647N 5methyl dCTP Binding 
 
Table S3. Primers used for pyrosequencing. Each primer is biotinylated at the 5’ end. 
Name Sequence 
skeletal α-actin-1 5’- AGTTGGGGATATTTTTTATA -3’ 
skeletal α-actin-1b  5’- TTTTGGTTAGTGTAGGAGAT -3’ 
skeletal α-actin-2 5’- TGGGAAGGGTAGTAATATTT -3’ 
H19-1 5’- ATAGTTATTGTTTATAGTTT -3’ 
H19-2 5’- AGGAATATGTTATATTTAT -3’ 
IAP LTR-1 5’- CCCTAATTAACTACAACCCA -3’ 
IAP LTR-2 5’- TGTAGTTAATTAGGGAGTGA -3’ 
Major Satellite-1 5’- AAAATGAGAAATATTTATTTG -3’ 
Major Satellite-2 5’- GAGAAATATATACTTTAGGA -3’ 








Figure S1. Dnmt1 domain structure and alignment of Dnmt1 CXXC domains from different 
species. Numbers on the right side indicate the position of the last amino acid in each 
sequence. PBD: PCNA binding domain; TS: targeting sequence; CXXC: CXXC-type zinc 
finger domain; BAH1 and 2: bromo-adjacent homology domain; (KG)7: seven lysine-glycine 
repeats. Absolutely conserved residues are highlighted in red. Positions with residues in red 
face share 70% similarity as calculated with the Risler algorithm {Mohseni-Zadeh, 2004 
#133}. The alignment was generated with ClustalW2 and displayed with ESPript 2.2. 
GenBank accession numbers are: Mus musculus: NP_034196; Homo sapiens: 
NP_001124295; Bos taurus: NP_872592; Monodelphis domestica: NP_001028141; Gallus 
gallus: NP_996835; Xenopus laevis: NP_001084021; Danio rerio: NP_571264; 
Paracentrotus lividus: Q27746 (Swiss Prot); Apis mellifera: NP_001164522 (Dnmt1a); 
Bombyx mori: NP_001036980. 






Figure S2. The cellular localization of GFP-CXXCDnmt1 is independent of cell cycle stage. 
Live images of C2C12 mouse myoblasts cotransfected with expression constructs for 
GFP-CXXCDnmt1 and RFP PCNA. The latter served for identification of the cell cycle stage. 
Scale bar: 5 µm. 








Figure S3. Differential mobility of GFP-CXXCDnmt1 in nucleoli and nucleoplasm of mouse 
C2C12 myoblasts measured by FRAP analysis. Identical regions of interest over the 
nucleoplasm or nucleoli (as exemplified in the inset) were bleached and recovery curves were 
recorded over 30 seconds. GFP-CXXCDnmt1 kinetics is faster in nucleoli than in the nucleus, 
which indicates more transient (possibly unspecific) binding in the former than in the latter. 
Scale bar: 5 µm. 








Figure S4. GFP fusion pulldowns from transiently transfected HEK293T cells using the 
GFP-trap. Shown is a SDS polyacrylamide gel stained with coomassie blue. I = input (1%); B 
= bound (10%). 








Figure S5. The CXXC domain of Dnmt1 preferentially binds unmethylated CpG sites. GFP 
and GFP-CXXCDnmt1 purified from transiently transfected HEK293T cells with the GFP trap 
were challenged with fluorescent DNA substrates containing no CpG site or one central un-, 
hemi- or fully methylated CpG site in direct competition (noCGB, UMB, HMB and FMB, 
respectively) as in Figure 2C, except that a five-fold higher concentration (625 nM) of each 
substrate was used. 







Figure S6. The cellular localization of GFP-CXXCTet1 is independent of cell cycle stage. Live 
images of C2C12 mouse myoblasts cotransfected with expression constructs for 
GFP-CXXCTet1 and RFP PCNA. The latter served for identification of the cell cycle stage. 
Scale bar: 5 µm. 








Figure S7. Radioactive methyltransferase activity assay for GFP Dnmt1 and 
GFP-Dnmt1∆CXXC. The transfer of [3H]-methyl groups to poly(dI•dC)-poly(dI•dC) substrate 
was measured for increasing volumes of GFP fusion proteins immunopurified from 
transiently transfected HEK293T cells. Counts per minute (cpm) were normalized to the 
relative protein concentration as determined by SDS-PAGE analysis. GFP was used as 
negative control. Numbers above the bars indicate the volume (µl) of protein solution added. 








Figure S8. Competitive DNA binding and trapping assays for human GFP-DNMT1 and 
GFP-DNMT1∆CXXC. GFP, GFP-DNMT1 and GFP-DNMT1∆CXXC were purified from 
transfected HEK293T cells using the GFP-trap and incubated with fluorescent DNA 
substrates containing one central unmethylated (UM) or hemimethylated (HM) CpG site in 
direct competition. Both substrates contained either dC (binding) or 5 aza dC (trapping) on the 
strand opposite to the differentially methylated one. The comparison of binding and trapping 
ratios reflects irreversible covalent complex formation. Note the reduction in trapping of 
GFP-DNMT1∆CXXC relative to GFP-DNMT1 by the hemimethylated substrate. Shown are 
mean values and standard deviation of DNA/protein ratios from two independent 
experiments. 





In vitro methyltransferase activity assay 
Eight milligrams of His-tagged GFP-binding protein (GBP; Chromotek) were coupled to 1ml 
Ni-NTA agarose beads (Qiagen) by incubating for 2 h at 4°C in PBS and unbound protein 
was washed out twice with PBS. Extracts of HEK293T cells expressing GFP or a GFP fusions 
were prepared in 200 µl lysis buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM 
imidazole, 0.5 % Tween-20, 2 mM MgCl2, 1 mg/ml DNaseI, 2 mM PMSF, 1X mammalian 
protease inhibitor mix). After centrifugation, supernatants were diluted to 500 µl with 
immunoprecipitation buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole, 
0.05 % Tween-20) and precleared by incubation with 25 µl of equilibrated Ni-NTA agarose 
beads for 30 min at 4°C followed by centrifugation. Precleared extracts were then incubated 
with 40 µg of His-tagged GFP-trap coupled to Ni-NTA beads for 2 h at 4°C with constant 
mixing. GFP or GFP fusions were pulled down by centrifugation at 540 g. After washing 
twice with wash buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.05 
% Tween-20), complexes were eluted with 60 µl of elution buffer (10 mM Tris pH 7.5, 100 
mM KCl, 1 mM EDTA, 1 mM DTT, 250 mM imidazole) for 10 min at 25°C with constant 
mixing. 10 µl aliquots of all eluates were subjected to western blot analysis using mouse or rat 
monoclonal antibodies to GFP (Roche and Chromotek, respectively) and quantified by 
densitometry. Indicated volumes of eluate were incubated with 1 µg of poly(dI·dC)- 
poly(dI·dC) substrate (Sigma), 0.5 µg/µl of BSA and 1 µCi of S-adenosyl-[3H-
methyl]-methionine in 50 µl of trapping buffer (10 mM Tris pH 7.5, 100 mM KCl, 1 mM 
EDTA, 1 mM DTT) for 60 min at 37°C. 15 µl of each sample were spotted onto blotting 
paper and the DNA was precipitated with ice cold 5 % TCA. After washing twice with 5% 
TCA and once with cold 70 % ethanol, paper filters were air dried and analyzed by 
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Introduction
In higher eukaryotes methylation of genomic cytosine to 5-
methylcytosine (mC) prominently contributes to epigenetic index-
ing of transcriptional activity. mC has long been regarded as a
stable mark mediating permanent repression, but recent compel-
ling evidence supports a highly dynamic modulation of transcrip-
tional activity by both gain and loss of mC and several pathways
for erasure of cytosine methylation have been proposed [1–3].
Recently, it has been shown that mC can be progressively
oxidized to 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC)
and 5-carboxycytosine (caC) by a three member family of Tet a-
chetoglutarate and Fe(II)-dependant dioxygenases [4–7]. The
discovery of mC derivatives generated by enzymatic oxidation
has kindled the idea that they represent intermediates in mC
demethylation pathways. Although there is now support for hmC,
fC and caC as demethylation intermediates, the relative
abundance of hmC in tissues and the stability of its genomic
patterns point to a role of this modification as an epigenetic mark
with functional relevance distinct from mC [8–13]. Direct
mutation of Tet2 or inhibition of its catalytic activity by 2-
hydroxyglutarate generated through neomorphic IDH1/2 muta-
tions lead to perturbed cytosine methylation patterns in hemato-
poietic progenitors and are associated with myeloid and lymphoid
neoplasia [14–17]. Interestingly, Tet1 has been shown to mediate
both transcriptional activation and repression and at least part of
its repressive function has been proposed to be independent of its
catalytic activity [18–20]. A role of Tet2 as transcriptional
activator has been recently proposed [21], but it is not known
whether Tet2 and Tet3 share the dual functional properties of
Tet1. Maternally inherited Tet3 has been shown to oxidize
paternal genomic mC in the zygote shortly after fertilization and is
required for demethylation and subsequent efficient acitivation of
the paternal Oct4 and Nanog alleles [22].
Very few interactions involving Tet proteins have so far been
reported [18,20,23] and even fewer known domains are identified
in these proteins despite their relatively large size. As a
consequence, little is known about how Tet proteins are targeted
to specific genomic loci in distinct cell types and developmental
stages. The only relatively well characterized modules in Tet
proteins are the double-stranded b-helix fold typical of Fe(II)-
dependent oxygenase domains and an N-terminal CXXC-type
zinc finger in Tet1, thereby the latter has also been referred to as
Cxxc6. The CXXC domains in these proteins, as well as that of
Tet1, were shown to bind DNA sequences rich in CpG sites.
Similar domains are also present in two factors, Cxxc4 and Cxxc5,
shown to antagonize the canonical Wnt pathway and an
additional CXXC domain is encoded in Cxxc10-1, a predicted
ORF adjacent to the Tet3 gene [24–27]. We have previously
shown that the CXXC domains of Tet1, Cxxc4, Cxxc5 and
Cxxc10-1 form a distinct homology group among CXXC domains
[24]. Although human and mouse Tet3 have also been reported to
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harbour a CXXC domain in recent reviews [28,29], experimental
evidence for these claims was not available. CXXC domains are
present in several other proteins with functions related to DNA
and histone modification. Here we provide evidence for cis and
trans association of mouse Tet3 isoforms with Cxxc10-1 and
Cxxc4, respectively, and characterize the DNA binding properties
of their CXXC domains with respect to the modification state of
cytosine at CpG sites. Our data suggest that association with
distinct CXXC domains may modulate Tet3 function.
Results
Identification and expression pattern of mouse Tet3
transcripts encoding a CXXC domain
The N-terminal region of Tet1 contains a CXXC-type zinc
finger domain [4]. In contrast, none of the human and mouse
annotated genomic or transcript sequences for Tet2 and Tet3
includes a sequence encoding such domain. However, in both the
human and mouse genomes the Tet2 and Tet3 genes are adjacent
to loci encoding CXXC domains, Cxxc4 and Cxxc10-1, respectively
(Fig. 1A) [24,30]. The Cxxc4 and Tet2 loci are 700 and 800 kb
apart in the human and mouse genomes, respectively. These loci
are transcribed in opposite orientations and encode distinct
proteins, suggesting that they evolved through splitting of a Tet1-
like ancestral gene and intergenic inversion. The Cxxc10-1 ORF
was identified in silico about 13 kb upstream of the annotated
transcriptional start site of Tet3 and has the same orientation as the
Tet3 ORF. Previously, we showed that the CXXC domains of
Tet1, Cxxc10-1, Cxxc4 and Cxxc5 constitute a homology group
distinct from CXXC domains present in several other factors with
functions related to DNA or chromatin modification [24]. The
proximity and co-orientation of the Cxxc10-1 and Tet3 ORFs in
the human and mouse genomes suggest that alternative Tet3
transcripts may include the Cxxc10-1 ORF. This is also suggested
by GenBank entries of Tet3 orthologues encompassing an N-
terminal CXXC domain from other vertebrate species, including a
Xenopus Tet3 transcript and a Tet3 protein homolog predicted
from the genomic sequence of the naked mole rat (Heterocephalus
glaber). Alignment of the CXXC domains from these Tet3
homologues with the CXXC domains of mouse Cxxc10-1, Tet1,
Cxxc4 and Cxxc5 shows that they all belong to the same
homology subgroup that we identified previously (Fig. 1B). In
addition, the Hydra genome encodes a single Tet homolog and its
predicted protein product contains an N-terminal CXXC domain
with key features of this subgroup (Fig. 1B). These observations
support the idea of a common ancestral Tet gene encoding a
CXXC domain and that in addition to Tet1, this arrangement is
preserved also in vertebrate Tet3.
Thus, we set out to verify whether Tet3 transcripts including the
Cxxc10-1 ORF are expressed in the mouse. To this aim we
performed conventional PCR on total cDNA template from a
neural stem cell (NSC) line derived by in vitro differentiation of E14
embryonic stem cells (ESCs; Fig. S1). We used primer pairs
spanning from the Cxxc10-1 ORF to the Tet3 ORF in exon 3
according to the annotated Tet3 sequence. Cloning and sequenc-
ing of products identified two alternative transcripts where the
exon containing the Cxxc10-1 ORF is spliced to the first position
of either exon 2 or exon 3 of the annotated Tet3 gene (Fig. 2A,B).
These splicing events set the Cxxc10-1 ORF in frame with the
annotated Tet3 coding sequence through its exon 2 and/or exon 3
sequences representing part of the 59UTR in the annotated Tet3
transcript. Rapid amplification of cDNA 59 ends (RACE)
identified a 59UTR sequence upstream of the Cxxc10-1 ORF
including an additional exon upstream of the one encoding the
Cxxc10-1 ORF (Fig. 2A). To verify the expression and size of
alternative Tet3 transcripts we first performed northern blotting of
RNA from the same NSC line and parental ESCs (Fig. 2D). In
NSCs a cDNA probe comprising exons 3–6 of the annotated Tet3
transcript detected two bands with estimated sizes of 10.9 and
11.6 kb, roughly corresponding to the sizes of the annotated Tet3
transcript and those encoding the Cxxc10-1 ORF, respectively,
assuming the same splicing events downstream of the annotated
exon 3 (Fig. 2A). A probe spanning the Cxxc10-1 ORF detected
only the 11.6 kb band. Each of these probes detected the same
respective bands in RNA from ESCs, but their intensity was much
weaker than for NSCs (not visible in Fig. 2C) despite the same
amount of RNA was loaded. We found no evidence for
independent expression of the Cxxc10-1 sequence in these
samples, as no other distinct band was detected in the blots (Fig.
S2). As final evidence for the expression of the Tet3 transcript
including the Cxxc10-1 ORF and the annotated exon 2 (hereafter
referred to as Tet3CXXCL) we amplified its entire coding sequence
as a single fragment (5412 bp encoding a polypeptide of 1803 aa)
using cDNA from NSCs as template and confirmed its primary
structure by sequencing (NCBI accession number JX946278).
These results show that the use of an alternative promoter and
alternative splicing lead to the expression of Tet3 transcripts
containing the Cxxc10-1 ORF (altogether referred to as
Tet3CXXC) and that these transcripts share the same splicing
organization with the previously annotated Tet3 transcript
(hereafter referred to as Tet3) downstream of its exons 2
(Tet3CXXCL) or 3 (Tet3CXXCS; Fig. 2A).
To characterize the expression patterns of Tet3 and Tet3CXXC
transcripts we performed real time PCR (qPCR) on cDNAs from
stem cell lines and various adult mouse tissues (Fig. 3A). We set
primer pairs for selective amplification of the Tet3CXXC transcript
including exon 2 of the Tet3 transcript, the Cxxc10-1 ORF and
exons 1–3 of Tet3. The levels of Tet3 and Tet3CXXC transcripts
varied widely across the samples and were very low in ESCs,
confirming our northern blot data. Notably, the ratio of Tet3 to
Tet3CXXC transcripts was higher in brain regions relative to other
tissues.
Cxxc4 interacts with Tet3 in vivo and is expressed in the
adult brain
The evolutionary association of Tet proteins with a distinct
group of CXXC domains in cis raises the question as to whether
they associate with this type of CXXC module also in trans.
Therefore we probed the interaction of each of the three Tet
proteins with Cxxc4 and Cxxc5 using a mammalian fluorescent
three hybrid assay (F3H). In this assay baits fused to GFP are
anchored to a lac operator array integrated in the genome of BHK
cells and challenged with preys fused to a red fluorescent protein
[31–33]. The colocalization of prey and bait at the lac operator
array reflects their interaction (Fig. 4 and Fig. S3). The pair Tet3-
Cxxc4 tested positive in both prey-bait combinations, while all
other Tet-Cxxc4/5 pairs showed no interaction. However, we
could not detect coimmunoprecipitation of Tet3 and Cxxc4
fluorescent fusion constructs overexpressed in HEK293T cells (not
shown), which may be due to the lack or limiting endogenous
levels of bridging factors in these cells. Cxxc4 and 5 have been
shown to antagonize canonical Wnt signaling by binding to
cytoplasmic Disheveled [25–27]. However, expression of fluores-
cent fusions revealed a prevalently nuclear localization of Cxxc4 in
BHK cells, C2C12 myoblasts and ESCs (Fig. 4 and Fig. S4). In
this regard we note that the KKKRK sequence (Fig. 1B) at the N-
terminus of the CXXC domain in both Cxxc4 and 5 is a perfect
match to the minimal prototypic nuclear localization sequence of
Tet3 and CXXC Domains
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the SV40 large T antigen [34,35], and that Cxxc5 was also found
to be predominantly nuclear in various cell types [27,36].
Next we determined the levels of Cxxc4 and Cxxc5 transcripts
in adult mouse tissues and stem cell lines (Fig. 3B). Interestingly,
among adult tissues Cxxc4 was expressed mainly in the brain,
where Tet3 transcripts that do not encode the CXXC domain
were more abundant relative to Tet3CXXC transcripts. In contrast,
Cxxc5 mRNA was detected ubiquitously and apart from ESCs its
levels were substantially higher than those of Cxxc4. No obvious
correlation could be found between the levels of Cxxc5 transcripts
and those of any of the Tet transcripts analyzed (Fig. S5).
The CXXC domains of Tet1, Tet3CXXC, CXXC4 and CXXC5
bind CpG containing DNA substrates
Previously, we showed that a construct corresponding to the
isolated CXXC domain of mouse Tet1 (aa 561–614) with an N-
terminal GFP tag (GFP-CXXCTet1) has very low DNA binding
activity in vitro [24]. In contrast, Xu et al. showed that a larger
fragment of mouse Tet1 including the CXXC domain (aa 512–
671) binds CpG rich DNA sequences [37]. To resolve this
discrepancy we directly compared the DNA binding activity of the
isolated CXXC domain of Tet1 with GFP fused either to its N-
terminus (the GFP-CXXCTet1 construct we used previously) or to
its C-terminus (CXXCTet1-GFP), as well as the same Tet1
fragment used by Xu et al. with an N-terminal GFP tag (GFP-
Tet1512–671; Fig. S6A). These constructs were overexpressed in
HEK293T cells, immunopurified and challenged with fluorescent
DNA substrates bearing a single CpG site that was either
unmodified, symmetrically methylated or symmetrically hydro-
xymethylated in direct competition [24,38–41]. GFP-Tet1512–671
and CXXCTet1-GFP showed similar and substantial binding
activity toward substrates containing unmodified and symmetri-
cally methylated CpG sites and were preferred to the substrate
with the hydroxymethylated CpG, consistent with previous data
[37]. Instead, a much lower DNA binding activity was confirmed
for GFP-CXXCTet1 (Fig. S6B). We conclude that the DNA
binding properties observed for the Tet1512–671 fragment are
attributable to the CXXC domain and that direct fusion of GFP at
the N-terminus of the isolated CXXC domain interferes with
DNA binding.
These results and the high similarity shared by the CXXC
domains of Tet1, Tet3CXXC and the Tet3 interactor Cxxc4
prompted us to compare their DNA binding properties. Cxxc4-
GFP, Cxxc5-GFP, GFP-Tet1, CXXCTet1-GFP as well as full
Figure 1. Genomic arrangement of mouse Tet genes and adjacent Cxxc loci (A) and homology of CXXC domains from mouse Cxxc4,
Cxxc5 and Tet homologues in various animal species (B). (A) Schematic representation of mouse Tet1, Tet2/Cxxc4 and Tet3/Cxxc10 loci. Exons
are depicted as blue rectangles. Annotated transcriptional start sites and transcription orientation are indicated with half arrows. (B) Alignment of
CXXC domains from mouse Cxxc4, Cxxc5 and Tet homologues in various animal species (Mm, Mus Musculus; Hg, Heterocephalus glaber; Xt, Xenopus
tropicalis; Hm, Hydra mangipallata). The alignment was generated with Unipro UGENE [64]. Numbers on the right side indicate the position of the last
amino acid in the corresponding protein. The KTXXXI motif, previously identified as determinant for the interaction of Cxxc4 with Dvl [54], is boxed
(see Discussion). The scale at the bottom indicates the upper limit of percent identity represented by each color. GenBank accession numbers:
MmCxxc10, JX946278; XtTet3, NP_001090656.1; HgTet3, EHB01729.1; MmTet1, NP_081660.1; MmCxxc4, NP_001004367; MmCxxc5, NP_598448;
HmTet, XP_002161163.1.
doi:10.1371/journal.pone.0062755.g001
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length Tet1, Tet3 and Tet3CXXCL constructs with an N-terminal
GFP tag were subjected to similar DNA binding assays as above
(Fig. 5 and Fig. S7). CXXCTet3-GFP corresponds to the isolated
CXXC domain of the Cxxc10-1 ORF with GFP fused to its C-
terminus and is therefore analogous to CXXCTet1-GFP. Although
we could not detect interactions between Tet proteins and Cxxc5,
we investigated the DNA binding potential of the latter as its
CXXC domain is also highly homologous to that of Tet1. CXXC
domains belonging to a distinct homology class, including the
CXXC domain of Dnmt1 (CXXCDnmt1), were shown to
preferentially bind CpG-containing sequences [24,42–46]. There-
fore, we first determined the binding preference of our constructs
with respect to DNA substrates differing only for the presence or
absence of a single central CpG site and compared it to that of the
CXXC domain of Dnmt1 (GFP-CXXCDnmt1; Fig. S7). Cxxc4,
Cxxc5 and all Tet constructs showed higher DNA binding activity
as well as similar and substantial preference for the substrate
containing a CpG site as compared to GFP-CXXCDnmt1.We then
determined the binding preference with respect to substrates
containing a single central CpG site with distinct cytosine
modifications as shown above for CXXCTet1 constructs. Cxxc4-
GFP, Cxxc5-GFP and CXXCTet3-GFP displayed similar binding
properties, with decreasing preference for substrates with the
unmodified, symmetrically methylated and symmetrically hydro-
xymethylated CpG site. In contrast and as shown above,
CXXCTet1-GFP did not discriminate between substrates with
unmodified and symmetrically methylated CpG. In the case of full
length Tet1, Tet3 and Tet3CXXCL constructs, incubation with a 4-
fold molar excess of DNA substrates is expected to minimize
potential competition among multiple DNA binding sites. GFP-
Tet1 displayed the same substrate preference as the isolated
CXXC domain of Tet1 (CXXCTet1-GFP), albeit with an 8-fold
increase in binding activity, indicating that sequences outside the
CXXC domain (very likely the catalytic domain) contribute to the
affinity for DNA without altering the substrate preference. In
contrast, both GFP-Tet3 and GFP-Tet3CXXCL showed a relative
increase in binding activity toward the substrate with methylated
CpG site as compared to CXXCTet3-GFP. Thus, in Tet3CXXCL
features outside the CXXC domain override the binding
preference of the latter.
Figure 2. Identification of mouse Tet3 transcript variants encoding a CXXC domain. (A) Drawing illustrating the generation of alternative
transcripts from the Tet3/Cxxc10-1 locus. The positions of primers used in B are reported. The lower part reports a schematic representation of
alternative Tet3 transcripts. The positions of the probes used for northern blotting in C are reported. (B) Amplification of fragments from NSCs cDNA
identifying Tet3 transcripts that include the Cxxc10-1 ORF. (C) Northern blot detection of alternative Tet3 transcripts in ESCs and NSCs (see Fig. S1 for
full and additional blots).
doi:10.1371/journal.pone.0062755.g002
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Tet3CXXC oxidizes genomic mC in vivo and shows slightly
lower mobility than the Tet3 isoform lacking the CXXC
domain
We then compared the activity of Tet1 and Tet3 isoforms with
or without CXXC domain by determining global levels of
genomic hmC in HEK293T cells transiently transfected with
GFP-tagged constructs (Fig. 6). A similar increase of hmC levels
was observed in cells transfected with GFP-Tet1, GFP-Tet3 and
GFP-Tet3CXXCL, the latter possibly showing higher conversion of
mC to hmC. As further characterization of Tet3 isoforms we
compared nuclear localization and mobility of GFP-Tet3 and
GFP-Tet3CXXCL in C2C12 myoblasts. Both constructs were
diffusely distributed throughout the nucleus with exclusion of
nucleoli and large clusters of pericentric heterochromatin (chro-
mocenters; Fig. S8A). After photobleaching half of the nucleus the
fluorescence of GFP-Tet3CXXCL recovered more slowly and
reached a plateau at a lower level than that of GFP-Tet3 (Fig.
S8B). These differences were small, but reproducible.
Thus, the presence of the CXXC domain in Tet3 does not
affect and perhaps promotes conversion of mC to hmC, while it
reduces its mobility and slightly increases the immobile fraction,
suggesting that the CXXC domain contributes to additional
nuclear interactions.
Discussion
Very limited information is available as to how Tet family
dioxygenases target selected genomic loci in distinct developmen-
tal and cellular contexts. CXXC-type zinc finger modules have
been shown to direct chromatin modifying activities, including
Tet1, to CpG rich sequences where they contribute to the
establishment of a transcriptionally competent environment
[37,46–48]. We now provide evidence that alternative mouse
Tet3 isoforms associate with distinct CXXC modules also
endowed with DNA binding activity. Alternative presence of an
intrinsic CXXC domain or interaction with Cxxc4 may constitute
the basis for differential targeting of Tet3 isoforms. In this regard
we note that the ratio of Tet3 to TetCXXC transcripts was higher in
brain tissues where Cxxc4 transcripts were more abundant.
However, we found that in vitro Cxxc4 and the CXXC domain
of Tet3CXXC isoforms have similar binding preference with respect
to the modification state of cytosine at CpG sites and that DNA
binding elements other than the CXXC domain dominate the
global DNA substrate preference of Tet3CXXC. Further investiga-
tion is required to assess how DNA binding by Cxxc4 and the
CXXC domain of Tet3CXXC contribute to Tet3 function in vivo.
While the current manuscript was under review a report was
published showing a role for CXXC domain-containing Tet3
orthologues in early neural and eye development of Xenopus [49].
In the same publication the cloning of human and mouse Tet3
isoforms containing a CXXC domain was reported, the latter
being identical to our mouse Tet3CXXCL, but no expression or
functional data were provided for these mammalian isoforms.
Importantly, their isothermal titration calorimetry data on the
DNA binding properties of the CXXC domain from Xenopus and
human TET3 isoforms are fully consistent with the results of our
DNA binding assays with the CXXC domain of mouse Tet3CXXC.
Association with distinct CXXC domains may also modulate
Tet protein function by additional mechanisms. Interestingly,
Cxxc4 and Cxxc5 were shown to antagonize Wnt signaling by
competing with Axin for binding to Dishevelled (Dvl), thus leading
to destabilization of b-catenin [25–27]. Although b-catenin
stabilization by Dvl occurs in the cytoplasm, nuclear Dvl has
been shown to interact with a two megadalton TCF/b-catenin
transcriptional complex and to be required for activation of Wnt
pathway target genes [34,50,51]. Importantly, we found that
Cxxc4, like Cxxc5, is predominantly nuclear. Interestingly, other
factors interacting with Dvl such as DP1 and NFAT are known to
shuttle between cytoplasm and nucleus [52,53]. DP1 was shown to
play dual regulatory roles in Wnt signaling depending on its
nucleocytoplasmic localization, while dephosphorylated NFAT
was proposed to inhibit canonical Wnt signaling by sequestering
Dvl from transcriptional complexes in the nucleus. Therefore, it
will be interesting to investigate whether Cxxc4 and Tet3 are
involved in nuclear TCF/b-catenin complexes and affect tran-
scription of their target genes. A KTXXXI motif within the
CXXC domain of Cxxc4 was previously shown to be minimally
required for the interaction with Dvl [54], but is poorly conserved
in the CXXC domain of vertebrate Tet3CXXC isoforms (Fig. 1B).
Differential expression of Tet3 isoforms and interaction with
Cxxc4 may therefore modulate the recruitment of Tet3 to TCF/
b-catenin complexes. Thus, our results warrant further investiga-
tion on the functional relevance of the association between Tet
proteins and CXXC modules.
Figure 3. Levels of Tet3, Cxxc4 and Cxx5 transcripts in mouse
adult tissues, NSCs and ESCs. Transcript levels were determined by
qPCR analysis of total cDNA. (A) Amplfied fragments identify the Tet3
mRNA refseq NM_183138 (Tet3), the alternative Tet3 transcript
containing the Cxxc10-1 ORF and exon 2 of NM_183138 (Tet3CXXCL)
and all transcripts including the Cxxc10-1 ORF. (B) Cxxc4 and Cxx5
transcript levels. Data relative to kidney, liver, cerebellum and cortex
samples are from three biological replicates (two 6 week old 129Sv mice
and a 30 week old C57BL/6 mouse). Data relative to spleen, heart, lung
and hippocampus are from two biological replicates (a 6 week old 129/
Sv mouse and a 30 week old C57BL/6 mouse). Data relative to NSCs and
ESCs are from three independent cultures each. Shown are mean values
and standard errors of the mean (SEM).
doi:10.1371/journal.pone.0062755.g003
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Materials and Methods
Ethics statement
Collection of animal tissues was performed in accordance with
the German Animal Protection Law. No experiment was
performed on live animals. Mice were painlessly killed under
anesthesia with Isofuran before harvesting organs and tissues.
According to the German Animal Welfare Act (Part III: ‘‘Killing
of animals’’, Section 4, May 18, 2006) postmortem collection of
tissues and organs does only require summary notification to the
animal protection institution, but does not require any special
permission. Therefore, this study was not registered as an animal
experiment and the animal tissues used are registered only in the
annual report of animals sacrificed for research and study to the
relevant authority.
Cell culture
E14 [55] and CGR8 [56] ESCs were maintained in gelatin
coated flasks with DMEM high glucose containing 16% FBS,
2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin
(all from PAA Laboratories GmbH), 16 MEM Non-essential
Amino Acid Solution and 0.1 mM b-mercaptoethanol (both from
Invitrogen) and supplemented with 3 mM CHIR 99021 and 1 mM
PD0325901 (‘‘2i’’; both from Axon Medchem). The NSC line
ENC1 used throughout this study was derived from E14 ESCs as
described [57] and was maintained in Knockout-DMEM/F12
containing 2 mM GlutaMAX-I (both from Invitrogen) 100 U/ml
penicillin, 100 mg/ml streptomycin, and supplemented with 1%
N2 (custom made according to [58]) and 20 ng/ml each FGF-2
and EGF (PeproTech). ENC1 cells homogeneously expressed
NSC markers Nestin, Pax6 and Olig2 (Fig. S1). C2C12 myoblasts
[59] HEK293T [60] cells and BHK cells with a stably integrated
lac operator array [61] were cultured as described [24,32,33].
Expression constructs
Throughout this study enhanced GFP and monomeric Cherry
fusion constructs were used and are referred to as GFP and Cherry
fusions, respectively, for brevity. GFP-Tet1 and GFP-CXXCTet1
were described previously [24]. For other GFP and Cherry fusions
cDNA was generated from either ENC1 NSCs (Tet3, Tet3CXXCL,
CXXCTet3, Cxxc5) or parental E14 ESCs (Cxxc4) with the
RevertAid Premium First Strand cDNA Synthesis kit (Thermo
Scientific). Coding sequences were amplified using Phusion High-
Fidelity DNA polymerase (New England Biolabs) and primers
listed in Table S1. Sequences coding for Tet3, Tet3CXXCL and
Tet1512–671 were inserted into the pCAG-GFP-IB vector [62] or
the derived pCAG-Cherry-IB vector to generate N-terminal GFP
and Cherry fusions, respectively. Sequences coding for CXXCTet1
CXXCTet3, Cxxc4 and Cxxc5 were inserted into pCAG-Tev-GFP
(derived from pCAG-GFP-IB) to generate C-terminal GFP
Figure 4. Tet3 and Cxxc4 interact in vivo. The interaction was detected by the F3H assay in BHK cells harboring a lac operator array (see text and
Fig. S2 for explanations). (A) An N-terminal fusion of Tet 3 with Cherry (Ch) was used as prey and GFP-Cxxc4 (upper row) or GFP (as control; lower row)
as baits. Localization patterns are representative of 8 (upper row) and 9 (lower row) out of 10 imaged cells. (B) Ch-Cxxc4 was used as prey and GFP-
Tet3 (upper row) or GFP (as control; lower row) as baits. Localization patterns are representative of 4 out of 5 (upper row) and 6 out of 7 (lower row)
imaged cells. Arrowheads indicate the position of the lac operator array as identified by bait signals (GFP channel). Scale bars: 5 mm.
doi:10.1371/journal.pone.0062755.g004
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fusions. Cxxc4 and Cxxc5 coding sequences were also inserted
into pCAG-Cherry-IB to generate N-terminal Cherry fusions. All
constructs were verified by DNA sequencing and their expression
by western blotting (Fig. S9).
Northern blotting, cDNA synthesis and qPCR
Total RNA was extracted using the NucleoSpin Triprep Kit
and the poly(A)+ fraction was enriched with the Nucleotrap
mRNA Mini kit (both from Macherey-Nagel). Northern blotting
was performed according to the DIG Application Manual for
Filter Hybridization (Roche). Probes were generated and labeled
by PCR using DIG-dUTP and primers listed in Table S2. Ten
micrograms each of total RNA from ESCs and NSCs were
separated on formaldehyde-agarose gels, transferred to Hybond-
N+ nylon membranes (GE healthcare) and immobilized by UV
crosslinking. Blots were prehybridized with DIG Easy hyb (Roche)
at 50uC for 30 min followed by overnight hybridization at 50uC.
Probes were applied at a final concentration of 100 ng/ml in DIG
Easy hyb. After washing, the blots were incubated with blocking
solution (Roche) for 30 min, followed by incubation with alkaline
phosphatase conjugated anti-digoxygenin antibody (Roche) for
30 min at room temperature. The membrane was washed twice,
equilibrated with detection buffer (0.1 M Tris-HCl, 0.1 M NaCl,
pH 9.5) and chemiluminescence with CDP-Star substrate (Roche)
was used to detect the bound antibody.
Tissue samples were prepared from 6 week old 129Sv and 30
week old C57BL/6 mice (see legend to Fig. 3 for details). Total
RNA (500 ng) was reverse transcribed with High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems) according to the
manufacturer’s instruction. Primers for conventional PCR indi-
cated in Fig. 2A,B are listed in Table S2. Real-time PCR was
Figure 5. In vitro DNA binding properties of Cxxc4 and 5, isolated CXXC domains and full length constructs of Tet1 and Tet3CXXC. All
proteins were expressed as GFP fusion constructs in HEK293T cells and affinity purified using a GFP-trap. Fluorescently labeled DNA substrates with
the same sequence and a single CpG site either unmethylated, symmetrically methylated or symmetrically hydroxymethylated were incubated in
direct competition. Shown are mean values of bound substrate/protein ratios and SEM from n independent replicate experiments: Tet1, n = 10; Tet3,
CXXCTet3, n = 6; Tet3CXXCL, n = 7; CXXCTet1, Cxxc4 and GFP, n = 3; Cxxc5, n = 2.
doi:10.1371/journal.pone.0062755.g005
Figure 6. Tet3CXXC oxidizes genomic mC in vivo. GFP or GFP-Tet fusions were transiently overexpressed in HEK293T cells and genomic hmC
levels were determined using an in vitro glucosylation assay with T4 b-glucosyltransferase and UDP-[3H]glucose. Shown are mean percentages and
SEM of hmC over total C from 2 (GFP-Tet1) or 3 (all others) independent transfections.
doi:10.1371/journal.pone.0062755.g006
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performed using Power SYBR Green PCR Master Mix (Applied
Biosystems) on a 7500 Fast Real-Time PCR System (Applied
Biosystems) with primers listed in Table S3. Glyceraldehyde
phosphate dehydrogenase (GAPDH) was used for normalization
and the comparative CT method was used to analyze expression
data.
59 RACE
59 RACE was performed as described [63] and primers are
listed in Table S2. Briefly, 100 ng of total RNA from ENC1 NSCs
were reverse transcribed as described above, but using the gene-
specific primer1 (GSP1). To remove excess primer, the reaction
was purified with a silica mini-column (Nucleospin Gel and PCR
Clean-up; Macherey-Nagel). After tailing with terminal deoxynu-
cleotide transferase and dATP the tailed cDNA was subjected to
nested PCR reactions with Phusion High-Fidelity DNA Polymer-
ase (New England Biolabs). In the first reaction the upstream
primers were (dT)17-adaptor primer and adaptor primer, while the
downstream primer was gene-specific primer2 (GSP2). Cycling
parameters were as follows: one cycle of 98uC for 30 s, 94uC for
5 min, 50uC for 5 min, and 72uC for 40 min, followed by 30
cycles of 94uC for 40 s, 54uC for 1 min, and 72uC for 3 min, with
a final cycle of 94uC for 40 s, 54uC for 1 min, and 72uC for
15 min. In the second reaction the upstream primer was adaptor
primer and the downstream primer was gene specific primer 3
(GSP3). Cycling parameters were as follows: 98uC for 30 s, (98uC
for 15 s, 55uC for 20 s, and 72uC for 30 s) 30 cycles, 72uC for
10 min. PCR products were purified by gel electrophoresis
followed by silica column purification, cloned into pCR-Blunt
with Zero Blunt PCR Cloning Kit (Invitrogen) and analyzed by
sequencing.
F3H assay
F3H assay (Fig. S3) was performed as described [33]. Briefly,
BHK cells with a stably integrated lac operator array [61] were
seeded on coverslips, cotransfected with GFP binding protein
(GBP)-lacI, GFP-bait and Ch-prey constructs, fixed and imaged
16 h after transfection.
In vitro DNA binding assay
In vitro DNA binding assays were performed as described
previously [24,38,39]. Briefly, two or three double stranded DNA
oligonucleotides labeled with different ATTO fluorophores were
used as substrates in direct competition. DNA oligonucleotide
substrates with identical sequence contained an unmodified,
symmetrically methylated or symmetrically hydroxymethylated
cytosine at a single, central CpG site (CG, mCG and hmCG
substartes), while the noCG substrate contained a TpG site at the
same position and had otherwise the same sequence (Tables S4,
S5, and S6). GFP fusion constructs were expressed in HEK293T
cells by transient transfection and immunopurified from cell lysates
using the GFP-trap (ChromoTek). GFP-trap beads were washed
three times before incubating with DNA substrates at a final
concentration of 160 nM each. After removal of unbound
substrates, protein amounts (GFP fluorescence) and bound DNA
were measured with an Infinite M1000 plate reader (Tecan).
Determination of global genomic hmC levels
Global hmC levels in genomic DNA from transiently transfect-
ed HEK293T cells were determined by the in vitro glucosylation
assay as described previously [11,24] with minor modifications.
Briefly, 50 ml reactions containing 150 mM NaCl, 20 mM Tris,
pH 8.0, 25 mM CaCl2, 1 mM DTT, 3.5 mM UDP-[3H]glucose
(20 Ci/mmol; Hartmann Analytic GmbH), 500 ng of sheared
genomic DNA and 40 nM recombinant T4 b-glucosyltransferase
were incubated for 20 min at room temperature and terminated
by heating at 65uC for 10 min. DNA fragments were purified by
silica column chromatography (Nucleospin, Macherey-Nagel) and
radioactivity was determined by liquid scintillation. Radioactive
counts were converted to percentages of hmC over total C using
curves from PCR generated standards containing variable hmC/C
ratios as previously described [11]. The values for all GFP-Tet
constructs were corrected for differences in expression levels using
GFP-fluorescence measurements. This correction was not applied
to control samples transfected with GFP as the latter is expressed
at least at ten times higher levels than GFP-Tet1 constructs, which
would lead to artificially enhanced differences between basal hmC
levels and those resulting by overexpression of Tet constructs.
Supporting Information
Figure S1 Expression of NSCs markers in ENC1 cells.
Epifluorescence images of immunofluorescent stainings with
antibodies to the indicated markers. Antibody sources: Nestin,
mouse monoclonal antibody Rat-401 (Developmental Studies
Hybridoma Bank, University of Iowa); Pax6, rabbit polyclonal
antibody (PRB-278P, Covance). Olig2, rabbit polyclonal antibody
(AB9610, Millipore). Scale bars: 10 mm.
(EPS)
Figure S2 Northern blot analysis of Tet3 and Tet3CXXCL
transcripts in NSCs and ESCs (related to Fig. 2). On the
right the same blot as in Fig. 2D is shown uncropped. In this blot
total RNA was loaded [without poly(A)+ enrichment], resulting in
stronger crosshybridization with 28S and 18S ribosomal RNAs.
(EPS)
Figure S3 Schematic representation of the mammalian
F3H assay (related to Fig. 4).
(EPS)
Figure S4 Nuclear localization of GFP-Cxxc4 in C2C12
myoblasts and CGR8 ESCs (related to Fig. 4). Epifluores-
cence images of transiently transfected cells. Scale bars: 5 mm.
(EPS)
Figure S5 Transcript levels of Cxxc4, Cxx5 and Tet1–3
in adult mouse tissues ESCs and NSCs (related to Fig. 3).
In (A) the same plot as in Fig. 3B is reported for ease of
comparison between transcript levels of Cxxc4/5 (A) and Tet1–3
(B). In (B) cumulative levels of all Tet3 transcripts were determined
using a primer set spanning common sequences downstream exon
3 of the annotated Tet3 gene. Shown are mean values and SEM.
Sample sources and replicates are as for Fig. 3.
(EPS)
Figure S6 In vitro DNA binding properties of GFP-
Tet1512–671, GFP-CXXCTet1 and CXXCTet1-GFP. (A) Sche-
matic representation of assayed Tet1 constructs. Start and end
positions relative to full length Tet1 protein are reported. (B) DNA
binding assay as in Fig. 5. Shown are mean values and SEM from
4 independent experiments.
(EPS)
Figure S7 In vitro binding of various full length Cxxc
domain-containing proteins and isolated CXXC do-
mains to DNA substrates containing one or no CG site),
but otherwise identical sequence (related to Fig. 5). All
constructs are GFP fusions. Shown are mean values of bound
substrate/protein ratios and SEM from n independent replicate
experiments: GFP and CXXCTet3-GFP, n = 5; GFP-Tet1, Cxxc4-
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GFP, Cxxc5-GFP and GFP-CXXCDnmt1, n = 4; GFP-Tet3, GFP-
Tet3CXXCL and CXXCTet1-GFP, n = 3.
(EPS)
Figure S8 Localization and mobility of Tet3 and
Tet3CXXCL isoforms in C2C12 nuclei. (A) Optical sections
of fixed C2C12 cotransfected with GFP-Tet3CXXCL and Ch-Tet3
constructs as indicated. Arrowheads indicate the position of large
chromocenters from which GFP-Tet3CXXCL and Ch-Tet3 signals
are excluded. (B) FRAP curves of GFP-Tet3 and GFP-Tet3CXXCL
in transiently transfected C2C12 myoblasts. Images were taken
every 150 ms in the first 60 s, and then at intervals of 1 s for the
next 120 s. Shown are mean values and SEM from 12 (GFP-Tet3)
and 10 cells (GFP-Tet3CXXCL). Live cell imaging and FRAP
analysis was performed as described (Schermelleh et al., 2007,
Nucl Acids Res 35: 4301) with the following minor modifications.
The images were Gauss-filtered (2 pixel radius) and data sets
showing lateral movement were corrected by image registration
using the StackReg plug-in of ImageJ, starting with a time frame
where approximately half recovery was reached.
(EPS)
Figure S9 Western blot analysis of fluorescent fusion
proteins. (A) GFP-CXXCDnmt1, CXXCTet3-GFP, CXXCTet1-
GFP, Cxxc4-GFP, Cxxc5-GFP. (B) GFP-Cxx4 and GFP-Cxxc5.
(C) GFP-Tet1, GFP-Tet3 and GFP-Tet3CXXCL. (D) Cherry-Tet3.
Blots were probed with an anti-GFP antibody (A–C) or with an
anti-RFP antibody recognizing an epitope present in both RFP
and Cherry (D). In all cases the major reacting band migrated as a
peptide with the expected mass of the specific, full length
fluorescence fusion and in no case peptides with mass correspond-
ing to the fluorescent protein moiety (GFP or Cherry) were
detected.
(EPS)
Table S1 Primer sequences for cloning of coding
sequences in expression constructs.
(DOCX)
Table S2 Primer sequences for 59 RACE, conventional
RT-PCR, northern blotting probes.
(DOCX)
Table S3 Primer sequences for qPCR.
(DOCX)
Table S4 Sequences of oligonucleotides used for prep-
aration of double stranded DNA substrates.
(DOCX)
Table S5 CG, mCG and hmCG containing DNA sub-
strates used for in vitro binding assay (related to Fig. 5).
(DOCX)
Table S6 CG and noCG containing DNA substrates used
for in vitro binding assay (related to Fig. S7).
(DOCX)
Combined Supporting Information File S1
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Figure S1. Expression of NSCs markers in ENC1 cells. Epifluorescence images of 
immunofluorescent stainings with antibodies to the indicated markers. Antibody sources: 
Nestin, mouse monoclonal antibody Rat-401 (Developmental Studies Hybridoma Bank, 
University of Iowa); Pax6, rabbit polyclonal antibody (PRB-278P, Covance). Olig2, rabbit 
polyclonal antibody (AB9610, Millipore). Scale bars: 10 µm. 
  






Figure S2. Northern blot analysis of Tet3 and Tet3CXXCL transcripts in NSCs and ESCs 
(related to Fig. 2). On the right the same blot as in Fig. 2D is shown uncropped. In this blot 
total RNA was loaded [without poly(A)+ enrichment], resulting in stronger crosshybridization 
with 28S and 18S ribosomal RNAs. 
 
  






Figure S3. Schematic representation of the mammalian F3H assay (related to Fig. 4). 
 
  






Figure S4. Nuclear localization of GFP-Cxxc4 in C2C12 myoblasts and CGR8 ESCs (related 
to Fig. 4). Epifluorescence images of transiently transfected cells. Scale bars: 5 µm. 
 
  






Figure S5. Transcript levels of Cxxc4, Cxx5 (A) and Tet1-3 (B) in adult mouse tissues ESCs 
and NSCs (related to Fig. 3). In (A) the same plot as in Fig. 3B is reported for ease of 
comparison between transcript levels of Cxxc4/5 (A) and Tet1-3 (B). In (B) cumulative levels 
of all Tet3 transcripts were determined using a primer set spanning common sequences 
downstream exon 3 of the annotated Tet3 gene. Shown are mean values and SEM. Sample 
sources and replicates are as for Fig. 3. 
 
  






Figure S6. In vitro DNA binding properties of GFP-Tet1512-671, GFP-CXXCTet1 and 
CXXCTet1-GFP. (A) Schematic representation of assayed Tet1 constructs. Start and end 
positions relative to full length Tet1 protein are reported. (B) DNA binding assay as in Fig. 5. 
Shown are mean values and SEM from 4 independent experiments. 
 
  





Figure S7. In vitro binding of various full length CXXC domain-containing proteins and 
isolated CXXC domains to DNA substrates containing one or no CpG site (noCG; TpG 
instead of CpG), but otherwise identical sequence (related to Fig. 5). All constructs are GFP 
fusions. Shown are mean values of bound substrate/protein ratios and SEM from n 
independent replicate experiments: GFP and CXXCTet3-GFP, n=5; GFP-Tet1, Cxxc4-GFP, 
Cxxc5-GFP and GFP-CXXCDnmt1, n=4; GFP-Tet3, GFP-Tet3CXXCL and CXXCTet1-GFP, n=3. 
  






Figure S8. Localization (A) and mobility (B) of Tet3 and Tet3CXXCL isoforms in C2C12 nuclei. 
(A) Optical sections of fixed C2C12 cotransfected with GFP-Tet3CXXCL and Ch-Tet3 
constructs as indicated. Arrowheads indicate the position of large chromocenters from which 
GFP-Tet3CXXCL and Ch-Tet3 signals are excluded. (B) FRAP curves of GFP-Tet3 and 
GFP-Tet3CXXCL in transiently transfected C2C12 myoblasts. Images were taken every 150 ms 
in the first 60 s, and then at intervals of 1 s for the next 120 s. Shown are mean values and 
SEM from 12 (GFP-Tet3) and 10 cells (GFP-Tet3CXXCL). Live cell imaging and FRAP analysis 
was performed as described (Schermelleh et al., 2007, Nucl Acids Res 35: 4301) with the 
following minor modifications. The images were Gauss-filtered (2 pixel radius) and data sets 
showing lateral movement were corrected by image registration using the StackReg plug-in 
of ImageJ, starting with a time frame where approximately half recovery was reached. 
  





Figure S9. Western blot analysis of fluorescent fusion proteins. (A) GFP-CXXCDnmt1, 
CXXCTet3-GFP, CXXCTet1-GFP, Cxxc4-GFP, Cxxc5-GFP. (B) GFP-Cxx4 and GFP-Cxxc5. (C) 
GFP-Tet1, GFP-Tet3 and GFP-Tet3CXXCL. (D) Cherry-Tet3. Blots were probed with an 
anti-GFP antibody (A-C) or with an anti-RFP antibody recognizing an epitope present in both 
RFP and Cherry (D). In all cases the major reacting band migrated as a peptide with the 
expected mass of the specific, full length fluorescence fusion and in no case peptides with 
mass corresponding to the fluorescent protein moiety (GFP or Cherry) were detected. 
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5’-AAG CGA TCG CTT AGA TCT TAC CCA GGG-3’ 
5’-TTG CGG CCG CCA AAT CCA ACC TTT GC-3’ 
CXXCTet1 
5’-GGC GAT CGC ATG TCT ACG CCG CCA ATG-3’ 
5’-CGC GGC CGC CTG GCT TCT TTT TGA GCA-3’ 
Cxxc4 
5′-ATG CAC CAC CGG AAC GAC TCC CAG CG-3’ 
5’-TTA AAA GAA CCA TCG GAA CGC TTC AGC-3’ 
Cxxc5 
5′-AAG CGA TCG CAT GTC GAG CCT CGG CGG TGG-3′ 
5′-GCG CGG CCG CTC ACT GAA ACC ACC GGA AGG-3′ 
CXXCTet3 
5′-ATG CGA TCG CAT GCT GCG AGG GGG TGG AGA T-3′ 
5′-ATG CGG CCG CCC GCT TTT TTC TTC AGC ACC TC-3′ 
Tet3CXXCL 
5′-GGG CGA TCG CAT GAG CCA GTT TCA GGT GCC CTT GG-3′ 
5′-GCG GCC GCC TAG ATC CAG CGG CTG TAG GGG CC-3′ 
 
  
Liu et al.  Supplemental Information 
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Table S2. Primer sequences for 5′ RACE, conventional RT-PCR (primers a-d indicated in 
Fig. 2A,B) and generation of probes for northern blotting. 
Name Sequence 
GSP1 5′ -AGG TCC ATC AAC TGG GCT-3′ 
(dT)17-adaptor 5′-GAC TCG AGT CGA CAT CGA (T)17-3′ 
adaptor primer 5′-GAC TCG AGT CGA CAT CG-3′ 
GSP2 5′-AGC ACC TCA CAC TTG CG-3′ 
GSP3 5′-GCA GCT GGT ACA AGA CC-3′. 
Primer a 5′- GCG ATC GCA TGA GCC AGT TTC AGG -3′ 
Primer c 5′- AAG CGG CCG CCA GTC GGG CTT CTG GTC TAC -3′ 
Primer b 5′- ATG GCT GGG AGT GAG AC -3′ 
Primer d 5′- ATC GCA GGT GCA GTT GGG TG -3′  
CXXC10 probe for 5′-CAC ACC CAT TGG CTC ACC T-3′ 
CXXC10 probe rev 5′-GGG TCT CAC TCC CAG CCA-3′ 
Tet3 probe for 5′-GCT CTC AAC TAC CTG CTT CC-3′ 
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Table S3. Primer sequences for Real-time PCR. 
Name Sequence 
Gapdh forward* 5′-CAT GGC CTT CCG TGT TCC TA-3′ 
Gapdh reverse* 5′-CTT CAC CAC CTT CTT GAT GTC ATC-3′ 
Tet1 forward* 5′-CCA GGA AGA GGC GAC TAC GTT-3′ 
Tet1 reverse* 5′-TTA GTG TTG TGT GAA CCT GAT TTA TTG T-3′ 
Tet2 forward* 5′-ACT TCT CTG CTC ATT CCC ACA GA-3′ 
Tet2 reverse* 5′-TTA GCT CCG ACT TCT CGA TTG TC-3′ 
Total Tet3 forward* 5′-GAG CAC GCC AGA GAA GAT CAA-3′ 
Total Tet3 reverse* 5′-CAG GCT TTG CTG GGA CAA TC-3′ 
Cxxc4 forward 5′-ACC TGG CAC TTC GCT AGA GAG A-3′ 
Cxxc4 reverse 5′-TTG CCC TTC ATT CCC AAA TG-3′ 
Cxxc5 forward 5′-CAG CAG TTG TAG GAA CCG AAA GA-3′ 
Cxxc5 reverse 5′-TCC CGA CGG AAG CAT CAC-3′ 
Cxxc10 forward 5′-GTG GAG ATG GGC GGA AGA A-3′ 
Cxxc10 reverse 5′-GAT CTG GTG TGT GCG ACG AT-3′ 
Tet3CXXCL forward 5′-ATC GTC GCA CAC ACC AGA TC-3′ 
Tet3CXXCLreverse 5′-TCC TTC ACG AGC ATT TAT TTC CA-3′ 
Tet3 forward 5′-GCG GCC GAT GCA GTA GTG-3′ 
Tet3 reverse 5′-ATC AAC TGG GCT GAG CTC TGA-3′ 
 
* Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. (2010) Sensitive 
enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res., 
38, e181  
Liu et al.  Supplemental Information 
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Table S4. Sequences of oligonucleotides used for preparation of double stranded DNA 
substrates. 
M: 5-methylcytosine X: 5-hydroxymethylcytosine  
Name Sequence 
    
CGup 5’- CTCAACAACTAACTACCATCCGGACCAGAAGAGTCATCATGG -3’ 
 
um647N 5’- ATTO647N-CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -3’ 
MGup 5’- CTCAACAACTAACTACCATCMGGACCAGAAGAGTCATCATGG -3’ 
 
mC700 5'- ATTO700-CCATGATGACTCTTCTGGTCMGGATGGTAGTTAGTTGTTGAG -3' 
hmCGup 5'- CTCAACAACTAACTACCATCXGGACCAGAAGAGTCATCATGG -3' 
 
hmC550 5'- ATTO550-CCATGATGACTCTTCTGGTCXGGATGGTAGTTAGTTGTTGAG -3' 
um550 5’- ATTO550-CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -3’ 
um700 5’- ATTO700-CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -3’ 
um590 5’- ATTO590-CCATGATGACTCTTCTGGTCCGGATGGTAGTTAGTTGTTGAG -3’ 
noCGup 5’- CTCAACAACTAACTACCATCTGGACCAGAAGAGTCATCATGG -3’ 
noCG647N 5’- ATTO647N-CCATGATGACTCTTCTGGTCTGGATGGTAGTTAGTTGTTGAG -3’ 
 
Table S5. CG, mCG and hmCG containing DNA substrates used for in vitro binding assay 
(referes to Fig. 5). 
 
Name CpG site Label Oligo I Oligo II 
sample set 
647N-CG unmethylated 647N CGup um647N 
700-mC fully methylated 700 MGup mC701 







550-CG 550 um550 
700-CG 700 um700 
 
Table S6. CG and noCG containing DNA substrates used for in vitro binding assay (referes 
to Fig. S7). 
 
Name CpG site Label Oligo I Oligo II 
sample set 
590-CG ummethylated 590 CGup um590 
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Abstract    (203 words and 1479 characters) 
 
DNA methylation plays a central role in the epigenetic regulation of gene expression during 
development and disease and was considered as a relatively stable, repressive DNA 
modification. Recently, Ten-eleven translocation (Tet) proteins have been discovered to convert 
5-methylcytosine to 5-hydroxymethylcytosine (5hmC) and by further oxidation to 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC), likely contributing to an active DNA 
demethylation process. Using a set of newly generated monoclonal Tet antibodies we 
performed co-immunoprecipitation assays followed by mass spectrometry analyses and 
identified several interaction partners. Most prominently, we found O-linked N-
acetylglucosamine (GlcNAc) transferase (Ogt), an enzyme that catalyzes the addition of a 
regulatory GlcNAc to serine or threonine residues. In turn, O-GlcNAcase (Oga) removes O-
GlcNAc modifications. Using a fluorescent-3-hybrid (F3H) and biochemical assays, we could 
confirm the interaction of all three Tet proteins with Ogt and Oga. Fine-mapping experiments 
revealed the catalytic domain of Tets as major interaction surface with Ogt and Oga. 
Additionally, we could detect Ogt-mediated glycosylation of all Tet proteins mainly at the N-
terminus that can be removed by Oga, indicating the involvement of GlcNAc-cycling in Tet 
regulation. In summary, our results suggest a link between the new DNA modifications and 
glycosylation that could possibly alter gene regulation in response to changing environmental 




DNA methylation plays a central role in the epigenetic regulation of gene expression during 
development and disease (Bird et al., 2002; Rottach et al., 2009; Reik et al., 2011). Established 
and maintained by three DNA methyltransferases (Dnmts), cell type and differentiation-specific 
DNA methylation was considered as a relatively stable, repressive DNA modification. Then, 
Ten-eleven translocation 1–3 (Tet1–3) proteins have been discovered to convert 5-
methylcytosine to 5-hydroxymethylcytosine (5hmC) and by further oxidation steps modify 5hmC 
to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), leading to an active DNA 
demethylation process (Tahiliani et al., 2009; Mohr et al. 2011; Guo et al., 2011; Ito et al., 2011; 
Tan et al 2012; reviewed in Pastor et al., 2013). Several methods based on either purified 
enzymes, monoclonal antibodies (mAbs) or mass spectrometry analyses enabled a fast and 
accurate quantification and mapping of 5hmC in genomic DNA samples of various mouse 
tissues and differentiating embryonic stem cells (Sun et al., 2013; Szwagierczak et al., 2011; 
Szwagierczak et al., 2010; Jin et al., 2010). Here, 5hmC levels showed a correlation with 
differential expression of tet genes. Furthermore, sAML patients showed aberrant low hmC 
levels directly correlated with TET2 and IDH2 mutations (Konstandin et al., 2011).  
Although a large set of readers for the Tet oxidation products 5hmC, 5fC and 5caC has been 
identified (Valinluck et al., 2004; He et al., 2011; Spruijt et al., 2013), only little is known about 
the regulatory network controlling Tet proteins. That Tet proteins are highly regulated was 
demonstrated recently in Wang et al, showing a direct effect of calcium-dependent proteases, 
the calpains, on Tet protein stability (Wang et al., 2014). In addition, Zhang et al. (Zhang et al., 
2014) indicated a correlation between human Tet3 restriction to the cytoplasm and reduced 
5hmC levels. This effect was glucose dependent. Together with other publications, these data 
suggest a correlation between metabolism and epigenetic regulation of gene expression (Zhang 
et al., 2014; Hayakawa et al., 2013). 
O-linked N-GlcNAc transferase (Ogt), an enzyme that catalyzes the addition of a regulatory 
GlcNAc to serine or threonine residues was discovered recently as one potential interactor of 
Tet proteins (Chen et al 2013; Deplus et al 2013; Vella et al 2013 and Zhang et al 2014). The 
formation of this highly abundant post-translational modification is linked to nutrient availability 
and crosstalks with cell cycle progression, gene expression, splicing, chromatin remodeling, 
pluripotency and reprogramming (Lubas et al. 1997; Kreppel et al 1999; Hanover et al., 2005; 
Butkinaree et al., 2010; Jang et al., 2012; Krause et al., 2012). In turn, O-GlcNAcase (Oga) 
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removes O-GlcNAc modifications, making O-linked glycosylation a dynamic process known as 
O-GlcNAc cycling (Hart et al., 2011; reviewed in Hanover et al. 2012). In mammals, Ogt is 
present in three different isoforms: nuclear ncOgt, mitochondrial mOgt and a short sOgt 
(reviewed by Hanover et al., 1987; Lazarus et al., 2011; Holt et al. 1986). This compartmental 
restriction might also influence GlcNAcylation of different proteins in a spatial and or temporal 
context (Zhang et al., 2013). In line, ncOgt has been shown to directly glycosylate important 
nuclear core components like histones or transcriptional regulators including transcription 
factors (TFs) (e.g. PRCs, Sin3a, HDACs, HCF) and PolIICTDs, whereas the cytoplasmic 
isoform sOgt modifies mainly proteasomal proteins, pore components and e.g. MAP-kinases 
(Comer et al., 2000; Zeidan et al., 2010; Ranuncolo et al., 2012; Wysocka et al., 2012; Myers et 
al 2011; McDonel et al., 2011; Cole et al; reviewed in Hanover et al.,2012; Vella et al., 2013). 
Besides the three different isoforms of Ogt, the sheer number of potential binding partners 
reflects the involvement of Ogt in a multitude of cellular pathways. 
Functional studies of mOgt displayed its potential in inducing apoptosis and to be involved in the 
lipid/carbohydrate metabolism. Also, Ogt and O-GlcNAcylation seem to play an important role in 
onset of neurodegenerative disorders, cardiovascular diseases and insulin resistance (Cole et 
al., 2001; Lazarus et al., 2009; Fulop et al., 2007; Ngoh et al., 2010; Yang et al., 2008). In 
addition, the involvement of O-GlcNAc cycling in disease development might be causally linked 
with the Tet enzymes (Krzeslak et al.; 2012; Freudenberg et al., 2012; Li et al., 2011; Hart et al., 
2011). Even though there are several indications to a tight regulatory interplay between Tets 
and GlcNAc-cycling, the functional relevance of the interaction between Tets and Ogt/Oga and 
its contribution to epigenetic regulation of gene expression, however, remains unclear.  
In this study, we have addressed this question by generating a set of monoclonal antibodies 
against all three Tet proteins. Using these new tools, we performed co-immunoprecipitation 
assays of endogenous as well as overexpressed Tet proteins, followed by mass spectrometry 
analyses and identified several Tet interaction partners, including members of the Ogt/Sin3a 
complex. Using a previously developed cell biological F3H assay (Eskat et al., 2012; Zolghadr 
et al., 2008) and biochemical analyses, we could show the interaction of all three Tet proteins 
with Ogt and Oga, respectively. We further characterized the interaction and observed Ogt-
mediated direct glycosylation of all three Tet proteins. In summary, our results suggest a 
regulation of Tet proteins through GlcNAc-cycling, which might represent a mechanism affecting 
DNA demethylation, and possibly allows differential gene expression as an adaption to 
changing environmental situations.   
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Results and Discussion 
 
Interactome analysis reveals Ogt as major partner of all three Tet proteins. 
Tet proteins are involved in a step-wise conversion of 5mC to 5hmC and by further oxidation to 
5fC and 5caC (Fig. 1A). Even though the abundance of Tet proteins and their catalytic products 
are well characterized (Tahiliani et al., 2009; Xu et al., 2011; Wu et al., 2011; Ito et al., 2011; 
reviewed in Pastor et al., 2013), only little is known about Tet regulation, targeting or their 
interaction network. To investigate the functional role of Tet proteins together with their 
interactome in vitro and in vivo, we initially generated a set of monoclonal antibodies (mAbs) 
against all three Tet proteins via the hybridoma technology (Koehler and Milstein, 1975) (Fig. 
1B). These mAbs are suited for immunofluorescence stainings, western blot (WB) applications, 
or immunoprecipitation (IP) except for Tet3.  
First, we fluorescently stained endogenous Tet1 in wt J1 embryonic stem cells (ESCs) and 
found a distinct nuclear pattern. Furthermore, we could show a direct correlation between 
endogenous Tet1 localization, 5hmC and histone marks like H3K4me3 representing chromatin 
with actively transcribing genes (Fig. 1B and Suppl. Fig. 1). Similar results were obtained for 
Tet2 (Suppl. Fig. 2 and data not shown).  
Second, we performed co-IP assays with either endogenous Tet1 and Tet2 in ESC lines (Fig. 
1C, left panel) or transiently expressed GFP-Tet fusion proteins in HEK 293T cells (Fig. 1C right 
panel), followed by LC-MS/MS and identified a huge set of Tet interaction partners (Fig. 1D). 
Most prominently, we detected O-linked N-GlcNAc transferase (Ogt), an enzyme that catalyzes 
the addition of a regulatory GlcNAc to serine or threonine residues (Fig. 1D). The formation of 
this highly abundant post-translational modification is linked to nutrient availability and 
crosstalks with cell cycle progression, gene expression, splicing and chromatin remodeling (as 
reviewed by Hanover, Krause et al. 2012). In line with previous publications, we found a large 
number of known Ogt-complex members like Hdacs, Sin3a, Sap30, Hsp90 or Kpnb1 co-
purifying with Tets (Fig. 1D) (McDonel et al. 2011; Wysocka et al 2012; Vella et al 2013). Most 
of the isolated interaction partners were found in both, endogenous and GFP-fusion pull down 
experiments (Fig. 1D, right panel). Taken together, our data suggest that Tet proteins and Ogt 
are tethered together in a large complex.  
Notably, most of our identified Tet interactors are representatives of a repressive chromatin 
environment (Fig. 1D). However, Tet localization was associated mainly with euchromatin 
6 
marks, such as H3K4me3 (Fig. 1B and Suppl. Fig. 1 / 2). This is in accordance with previous 
findings (Wu et al., 2011; Shen et al., 2013) and suggests a dual role of Tet proteins in both, 
gene activation and silencing. Spatial and temporal complex composition as well as 
downstream regulatory pathways involving Tet proteins are still elusive.  
It is important to note, that all three Tet proteins showed an association with Ogt which was 
independently confirmed by co-IP analyses of GFP-Tets and mCh-Ogt as a short and long 
transcript variant using GFP-trap precipitation and an anti-Ogt/cherry antibody for detection 
(Dambacher et al., 2012) (Fig. 1D; 2A; 2B; and Suppl. Fig. 3). This is in contrast to previously 
published work, showing Ogt interaction with either only one or maximal two Tet proteins, but 
not with all three Tet family members (Chen et al., 2013; Deplus et al., 2013 and Vella et al., 
2013). No interaction of mCh-Ogt was observed with GFP-Dnmt1 and the negative control GFP 
alone (Fig. 2B). Moreover, even washing with high salt conditions (500 mM NaCl) was not 
sufficient to disrupt the interaction of Tet1 catalytic domain (CD) and mCh-Ogt, demonstrating a 
relatively strong interaction (data not shown). 
 
Ogt and Oga interact with all three Tet proteins in vivo. 
Since O-GlcNAcase (Oga) that in turn removes O-GlcNAc modifications is known to coexist with 
Ogt in higher metazoans (reviewed in Hanover et al., 2012), we focused on a potential 
involvement of Oga in Tet interaction and regulation. Using a previously developed cell 
biological F3H assay (Zolghadr et al., 2008; Eskat et al., 2012), we validated the interaction of 
all three Tet proteins with Ogt. In short, GFP-fusion proteins were recruited to the lac-operator-
array by the GFP-binder and used as bait for potential mCh-fused interaction partners (Fig. 2C). 
For the first time, we could show an interaction of Tet proteins with Oga, suggesting the 
involvement of both opposing partners in Tet regulation (Fig. 2B and 2D). Reciprocal F3H 
(bait/prey and color swop) analyses showed similar results (data not shown).  
Interestingly, both Ogt and Oga were mainly localized in the cytoplasm in control cells (lower 
panel). However, upon co-transfection, Ogt was translocated into the nucleus, even showing co-
localization at distinct Tet foci, indeed arguing for a strong interaction or even targeting of Ogt by 
Tet. In contrast, the cytoplasmic fraction of Oga remains unaffected, when Tet proteins are 
coexpressed. However, a nuclear depletion of Oga towards the F3H spot can be observed. 
Thus, also Tet proteins themselves are able to recruit Ogt/Oga and not only vice versa as 
suggested previously (Deplus et al., 2013; Vella et al., 2013; Chen et al., 2012). Interestingly, 
7 
this interaction is independent from Ogt enzymatic activity, since the inactive Ogt mutant 
(OgtH508A) shows unaffected association (Fig. 4A and 4D).  
 
Mapping the interaction interface between Ogt or Oga and Tets. 
To fine map the interaction interface between Tet and Ogt or Oga, we generated a series of 
single domain constructs and deletion mutants (Fig 3A), and applied an F3H interaction screen 
(Fig 3B and 3C). Here, we identified the catalytic domain (CD) of Tets as the major interaction 
platform for Ogt and Oga (Fig. 3 and Suppl. Fig. 3). This is in line with a previous publication 
showing the DSBH of Tet2 as main interaction domain (Chen et al., 2012). However, subtle 
differences were observed for the subdomains forming the CD. The large and unstructured 
insert domain of Tet2 shows a similar localization pattern as full length (FL) Tet2 and is 
sufficient to mediate the interaction with Ogt. In contrast, Oga cannot be targeted by the Tet2 
insert domain. The same results were obtained with the N-terminal region of Tet2. Taken 
together, our results point to a multi-domain interaction interface of Tet2, where the individual 
subdomains likely act in a cooperative manner. 
 
Interaction with Ogt / Oga regulates the glycosylation status of Tet proteins. 
Since we found a strong association of both counteracting proteins Ogt and Oga with Tet 
proteins, we investigated potential direct GlcNAcylation of Tet proteins in vitro and in vivo. In co-
IP experiments we found a strong GlcNAcylation of Tet1 upon co-expression of wt Ogt. In 
contrast, only basal O-GlcNAc levels on Tets were observed with the catalytic inactive variant of 
Ogt (OgtH508A) and Oga (Fig. 4A). Similar results were obtained for Tet2 and Tet3 (Fig. 4B and 
data not shown). Fine-mapping experiments revealed that O-GlcNAc sites are mainly present in 
the N-terminal region of Tets. As an exception, Tet2 harbors O-GlcNAcylation also in the CD, 
arguing for an additional regulation mechanism (Fig. 4B and 4C). Furthermore, we could show a 
direct glycosylation of all Tets in vivo (Fig. 4D).  
In general, post-translational modifications such as O-GlcNAcylation are known to act in a 
complex crosstalk, highly coordinated and to be involved in the regulation of e.g. protein 
localization, activity and stability (Hanover et al., 2005; Wang et al. 2008; Hu et al., 2010; Hart et 
al., 2011). In summary, we can show a tight association of Tets with Ogt and Oga, mainly 
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mediated by the CDs of Tets (Fig. 5A, 5B and 5C). In addition, attachment of GlcNAc moieties 
to serine/threonine residues could be narrowed down to the N-terminus of Tets. This covalent 
addition is also reflected by a band shift of the bound Tet protein fraction. Together, our data 
suggest a potential O-GlcNAc-cycling mechanism on Tet proteins mediated by Ogt and Oga 
(Fig. 5C).  
So far it has been shown, that Tet proteins display differential expression patterns in different 
tissues and during development (Sun et al., 2013; Szwagierczak et al., 2011; Szwagierczak et 
al., 2010; Jin et al., 2010). Thus Tet proteins are highly regulated on transcriptional levels. Here, 
we provide evidence for an additional layer of regulation on posttranslational/protein levels, 
namely glycosylation of Tets by Ogt. In accordance with Chen et al., 2012, we could not detect 
a direct effect of Ogt complex formation on Tet catalytic activity (data not shown), hence arguing 
for another regulatory mechanism. In line, Zhang et al indicated a glucose-dependent restriction 
of Tet3 in the cytoplasm mediated by Ogt interaction. As major interacting partner, Ogt might 
thus be a key regulator of Tet proteins, and therefore have indirect effects on DNA methylation 
patterns. Furthermore, this complex formation might specifically regulate Tet protein activity, 
localization and/or stability, resulting in an adaption of gene expression to the environmental 




Materials and Methods 
 
Expression constructs.  
Expression constructs for GFP-Tet1 (wt, full length), GFP-Tet2, GFP-Tet3, GFP-Dnmt11-1111, 
GFP and mCherry (mCh) were described previously (Frauer et al., 2011; Liu et al., 2013; Spruijt 
et al., 2013). To generate the mCh-ncOgtshort, mCh-ncOgtong and mCh-Oga constructs, the 
coding sequences were amplified using cDNA from mouse E14 ESCs as template and 
subcloned into the pCAG-Cherry-IB vector (Frauer et al., 2011). Expression constructs for mCh-
OgtH508A were derived from mCh-ncOgtlong by overlap extension PCR. Expression constructs for 
mCherry or GFP fusions of the various Tet fragments were cloned into pCAG-Cherry-IB vector 
or pCAG-GFP-IB by PCR amplification. All constructs were verified by DNA sequencing. 
  
Antigen purification, immunization, generation of hybridomas and ELISA screening. 
The His-tagged insert region in the CD of each Tet protein was expressed in E. coli BL21 (DE3) 
cells (Novagen, Darmstadt, Germany) and purified with the TALONTM Superflow Metal Affinity 
Resin system (Clontech, Saint Germain, France) under native conditions as described in 
Rottach et al 2007a, b, Jost et al 2012. Approximately 100 µg of each antigen was injected both 
intraperitoneally (i.p.) and subcutaneously (s.c.) into Lou/C rats using CPG2006 (TIB MOLBIOL, 
Berlin, Germany) as adjuvant. After eight weeks a boost was given i.p. and s.c. three days 
before fusion. Fusion of the myeloma cell line P3X63-Ag8.653 with the rat immune spleen cells 
was performed using polyethylene glycol 1500 (PEG 1500, Roche, Mannheim, Germany). After 
fusion, the cells were plated in 96 well plates using RPMI1640 with 20% fetal calf serum, 
Penicillin/streptomycin, pyruvate, nonessential amino acids (PAA, Linz, Austria) supplemented 
by aminopterin (Sigma, St. Louis, MO). Hybridoma supernatants were tested in a solid-phase 
immunoassay. Microtiter plates were coated over night with His-tagged Tet proteins at a 
concentration of 3-5 µg/ml in 0.1 M sodium carbonate buffer, [pH 9.6]. After blocking with non fat 
milk (Frema, Neuform, Zarrentin, Germany), hybridoma supernatants were added. Bound rat 
mAbs were detected with a cocktail of biotinylated mouse mAbs against the rat IgG heavy 
chains, avoiding IgM mAbs (α-IgG1, α-IgG2a, α-IgG2b (ATCC, Manassas, VA), α-IgG2c 
(Ascenion, Munich, Germany)). The biotinylated mAbs were visualized with peroxidase-labelled 
avidin (Alexis, San Diego, CA) and o-phenylenediamine as chromogen in the peroxidase 
reaction. Tet1 5D6 (rat IgG2a), Tet2 9F7 (rat IgG2a), Tet3 23B9 (rat IgG2a) were stably 
subcloned and further characterized. 
  
10 
Cell culture, transfection and F3H assay.  
HEK293T, BHK and ESCs were cultured and transfected as described (Meilinger et al., 2009; 
Szwagierczak et al., 2010). F3H assay was performed as described in Dambacher et al., 2012. 
 
Co-immunoprecipitation (Co-IP). 
For detection of glycosylated Tet-GFP fusion proteins and interaction partners, cells were lysed 
in buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH7.4), 5mM MgCl2, 0,1% Np40, 1xPI. Cell 
lysates were cleared by centrifugation at 4°C for 10 min and supernatants were incubated with 
GFP-trap® beads for 2 h at 4°C with gentle rotation as described in Dambacher et al., 2012. The 
beads were then washed three times with lysis buffer and resuspended in SDS-PAGE sample 
buffer. Endogenous Tet1 and Tet2 proteins were pulled out via monoclonal antibodies (5D6 and 
9F7, respectively) coupled to protein G sepharose beads as described in Rottach et al., 2007. 
 
Mass spectrometry.  
After Co-IP, protein samples were digested on beads with trypsin according to standard 
protocols. Peptide mixtures were analyzed using electrospray tandem mass spectrometry in 
collaboration with the Core Facility of the Max-Planck-Institute for Biochemistry, Martinsried. 
Experiments were performed with an LTQ Orbitrap mass spectrometer (Thermo Scientific). 
Spectra were analyzed with the Mascot™ Software (Matrix Science) using the NCBInr Protein 
Database.  
Western blot (WB) and immunofluorescence (IF) analysis.  
For WB analyses, proteins samples were separated by SDS-PAGE and blotted onto a 
nitrocellulose membrane. Antigens were detected with a mouse monoclonal anti-GFP antibody 
(Roche) and a rat monoclonal anti-red antibody (Rottach et al., 2008). GlcNAc modification was 
detected using a mouse antibody (RL2), Ogt was detected via a rabbit polyclonal antibody 
(Abcam; ab96718). Alexa488-, 594-, or 647N-conjugated secondary antibodies (Sigma) were 
used for fluorescence detection via the typhoon (GE Healthcare). For IF stainings, cells were 
grown on cover slips, fixed with 3.7 % formaldehyde in PBS for 10 minutes and permeabilized 
with 0.5 % Triton X-100 for 5 minutes. After blocking with 3% BSA in PBS for 1 h same primary 
and secondary antibodies were used as for WB. Cells were counterstained with DAPI and 
mounted in Vectashield (Vector Laboratories). Images were obtained using a TCS SP5 AOBS 
confocal laser scanning microscope (Leica) using a 63x/1.4 NA Plan-Apochromat oil immersion 
objective. Fluorophores were excited with 405, 488, 561 or 633 nm lasers.   
11 
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Figure 1: Generation of Tet specific antibodies applied to co-precipitate Tet interaction 
partners. 
(A) Step-wise conversion of 5mC to 5hmC, 5fC and 5caC. Methylation of cytosine is set by 
Dnmts. Further oxidation steps are catalyzed by the Tet protein family. (B) Generation of 
monoclonal antibodies (mAbs) by the hybridoma technology. Shown is a typical workflow 
starting from immunization of Tet antigen until the final application of the mAbs in either ELISA, 
immunofluorescence, immunoprecipitation (IP) or western blot (WB). Lower panel shows 
immunostaining of endogenous Tet1 using a 5D6 mAb in wt J1 embryonic stem cells. Cells are 
co-stained with an anti-5hmC antibody. DNA was counterstained with DAPI. Scale bar 
represents 5 µm. (C) Schematic outline of two different co-immunoprecipitation approaches. 
The left panel shows a classical pulldown of endogenous Tet proteins using protein G 
sepharose beads coupled with a specific Tet-antibody. On the right, a GFP-trap pulldown of 
transiently expressed GFP-Tets from HEK239T cells is shown. (D) Ogt and other Ogt complex 
members are identified as major Tet interaction partners by mass spectrometry. Unique peptide 
counts are indicated.  
 
Figure 2: Ogt and Oga interact with all three Tet proteins in vitro and in vivo. 
(A) Domain structure of the Tet protein family, Dnmt1, Ogt and Oga shown as either GFP or 
mCherry fusions. CxxC: zinc finger domain; Cys-R: cystein rich region; D: Dioxygenase domain; 
I: insert domain; CD: catalytic domain; PBD: PCNA-binding domain; TS: targeting sequence; 
BAH: bromo-adjacent homology domain; TPR: tetratricopeptide repeat; NLS: nuclear 
localization signal; NB: nucleotide binding domain; PB: phosphatidylinositol-3,4,5-triphosphate 
binding; HAT: histone acetyl transferase. (B) Co-immunoprecipitation analyses shows 
interaction of Ogt with all three Tet proteins but not with Dnmt1 and GFP alone. Similar results 
were obtained for Oga. The blots were probed with an anti-GFP antibody and an anti-red 
monoclonal antibody that recognizes several red fluorescent proteins including mCherry. 
I=input; FT=flow-through and B=bound fractions. (C+D) Co-IP results were confirmed by a 
fluorescent -3-hybrid assay (F3H) in BHK cells harboring a stably integrated lac-operator-array. 
Positive or negative interaction is marked by a solid or empty arrowhead, respectively.  
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Figure 3: Mapping the interaction interface between Ogt and Tets. 
(A) Schematic depiction of the Tet2 domain structure, single domains and deletion constructs 
used for fine-mapping the interaction with Ogt and Oga. (B+C) The interaction was detected by 
the F3H assay in BHK cells harboring a lac-operator-array. GFP-fused Tet2 domains or GFP 
alone was used as bait. A fusion of Ogt/Oga with mCherry (mCh) was used as prey. Scale bar 
represents 5 µm. Positive or negative interaction is marked by a solid or empty arrowhead, 
respectively. 8-10 BHK cells were imaged for each sample. Percentages indicate the number of 
cells that show positive interaction. 
 
 
Figure 4: GlcNAcylation of Tet proteins is regulated by Ogt and Oga. 
(A) Direct glycosylation of Tet1 is shown after co-immunoprecipitation with Ogt. Basal 
endogenous glycosylation levels were similar in samples coexpressing either the catalytic 
inactive Ogt mutant (OgtH508A), Oga or in the Tet1 sample without coexpression. The blots were 
probed with an anti-GlcNAc antibody, an anti-GFP antibody, an anti-Ogt antibody and an 
anti-red monoclonal antibody that recognizes both mCherry-Oga and mCh-Ogt/OgtH508A fusion 
proteins. I=input; FT=flow-through and B=bound fractions. Molecular weight of the fusion 
proteins is indicated on the right. (B) Glycosylation was shown after co-IP experiments for all 
three Tet proteins and could be fine-mapped mostly to the N-terminal domains. Endogenous 
GlcNAc-levels are depicted on the right. (C) Quantitative evaluation of GlcNAc-levels of the Co-
IP experiment shown in (B). Mean intensities were detected as mean grey values by the Image 
J software. Values were substracted by background intensities, normalized to GFP input signal. 
The strongest intensity signal was set to 100 %. (D) In vivo glycosylation assay using the F3H 
as targeting system. GlcNAc staining was detected as focal enrichment at the Lac-operator 
array in the mCh-Ogt coexpression sample (solid arrowhead). mCh-OgtH508A shows co-
localization with Tet2 (asterisk), but no catalytic activity (empty arrowhead). Scale bar 




Figure 5: Reversible and dynamic O-GlcNAcylation on Tet proteins. 
(A) Schematic depiction of the Tet proteins, domain structure and single domains used for fine-
mapping the interaction with Ogt. (B) Glycosylation and interaction was shown after co-IP 
experiments for all three Tet proteins. GlcNAcylation occurs mainly on the N-terminus, whereas 
Ogt interaction is mediated by the catalytic domains of Tets. Relative intensities are given on the 
right: ++ reflects very strong signal; + reflects strong signal; +/- reflects medium signal and - 
reflects no signal. Green color code indicates major GlcNAc signal or interaction signal 
comparing N- or C-terminus of the respective Tet protein. (C) Levels of O-GlcNAcylation on Tet 
proteins are regulated by the opposing functions of Ogt and Oga. Ogt interacts with the C-
terminal part of Tet proteins and attaches GlcNAc on serine/threonine residues predominantly at 
the N-terminal domain. The removal of O-GlcNAc is catalyzed by Oga resulting in a dynamic 
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Supplementary Figure 1: Sub-cellular distribution of endogenous Tet1 in respect to  
H3K4 me³, H3K9 me³, H3K27 me³ in wild type mouse embryonic stem cells. 
(A+B+C) show immunostainings of endogenous Tet1 using a 5D6 mAb in wt J1 embryonic stem 
cells. Cells are co-stained with antibodies against the respective chromatin modification. DNA 
was counterstained with DAPI (blue). Secondary antibodies are either coupled to Alexa Fluor® 
488 or Alexa Fluor® 594. Scale bar represents 5 µm. (A) shows wt J1 ESCs stained for H3K4 
me³ (green) and Tet1 (red). (B) shows stainings against H3K9 me³ (green) and Tet1 (red). (C) 




Supplementary Figure 2: Sub-cellular distribution of endogenous Tet2 in respect to  
H3K4 me³, H3K9 me³, H3K27 me³ in wild type mouse embryonic stem cells. 
(A+B+C) show immunostainings of endogenous Tet2 using a 9F7 mAb in wt J1 embryonic stem 
cells. Cells are co-stained with antibodies against the respective chromatin modification. DNA 
was counterstained with DAPI (blue). Secondary antibodies are either coupled to Alexa Fluor® 
488 or Alexa Fluor® 594. Scale bar represents 5 µm. (A) shows wt J1 ESCs stained for H3K4 
me³ (green) and Tet2 (red). (B) shows stainings against H3K9 me³ (green) and Tet2 (red). (C) 






Supplementary Figure 3: The short isoform of Ogt interacts with all three Tet proteins in 
vitro and in vivo. 
(A) Co-immunoprecipitation analyses shows interaction of the short isoform of Ogt (Ogtshort) with 
all three Tet proteins but not with Dnmt1 or GFP alone. The blots were probed with an anti-GFP 
antibody and an anti-red monoclonal antibody that recognizes several red fluorescent proteins 
including mCherry (mCh). I=input; F=flow-through and B=bound fractions. (B) Co-IP results 
were confirmed by a fluorescent -3-hybrid assay (F3H) in BHK cells harboring a stably 
integrated lac-operator-array. Also, the catalytic domain (CD) of Tet1 shows an interaction with 
Ogtsi, thus mapping a potential interaction surface. Upon co-expression, Tet3 shows either a 























The domain structure and cell cycle of Tet proteins 
 
Introduction: 
During early embryonic development, dynamic changes of the epigenetic profile take 
place. The epigenome confers stability of gene expression and is very crucial for toti- and 
pluripotency, correct initiation of gene expression, and is involved in early lineage 
differentiation in the embryo (Feil, 2009; Feng et al., 2010; Shi and Wu, 2009). Cells 
undergo chromatin reprogramming during the life cycle in two phases: during 
gametogenesis and preimplantation development, which involves the erasure and 
remodeling of epigenetic marks (Morgan et al., 2005). The landmark events of these two 
reprogramming processes are the waves of large-scale active DNA demethylation that 
occur in the zygotic paternal pronucleus and primordial germ cells (Santos et al., 2002; 
Oswald et al., 2000; Surani, 2001). Among several hypotheses and enzyme candidates, 
oxidative demethylation of 5mC catalyzed by Tet proteins is a well-studied and creditable 
mechanism (Tahiliani et al., 2009; Ito et al., 2010). Although the enzymatic function of Tet 
proteins has been recently discovered, the exact mechanism how Tet proteins are 
regulated in the cellular context is still elusive. 
To address this question, we investigated Tet proteins by several methods. For this aim I 
developed monoclonal antibodies against mouse Tet proteins, together with Dr. Elizabeth 
Kremmer (Helmholtz). After identifying the best antibodies for immunofluorescence, we 
stained for Tet1 and Tet 2 in pluripotent ES cell. This staining analysis demonstrated that 
Tet1 and Tet2 express in pluripotent ES cells and are enriched at scattered regions, 
independently from the replication foci. Furthermore, a direct DNA competition binding 
assay revealed that hydroxymethylation cytosine has a specific inhibitory effect on DNA 
affinity of Tet proteins. This phenomenon is hypothesized to enable Tet proteins to 
discriminate between target genes. Using an in vivo mammalian fluorescent three hybrid 
assay (F3H assay) for protein-protein interaction, we provided experimental evidence that 
Tet1 is not a target of multimerization. These findings will provide new insights in 




Generation of rat monoclonal antibodies against mouse Tet1 and Tet2 
The understanding of the complicated Tet proteins is highly dependent on the ability to 
detect and visualize them in cellular context. Antibodies are an essential tool in many 
biochemical and cellular researches. A loop fragment of the Tet protein, which is located 
in the C-terminal catalytic core and of low evolutionary conservation (Figure 7), was 
cloned into N-terminal His6-tag construct, expressed in Escherichia coli, and purified for 
antigen production of Tet1/2/3. The recombinant proteins were precipitated into inclusion 
body. Therefore the proteins were denatured and later refolded in native conditions. After 
concentrating, refolded proteins were finally purified via a gel-filtration chromatography. 
Elution fractions with correct molecular weights were collected, and then tested by SDS-
PAGE. The yield of purified protein was approximately 0.8-1mg/ml (Figure 7). 
 
 
Figure 7: Purification of antigens against mouse Tet proteins (a) scheme of corresponding fragments for antigens. 
Mammalian Tet family members share similar domain structure, including an N-terminal domain, an extension cysteine-rich 
domain and a core double stranded β-helix (DSBH) of catalytic domain at C-terminus. The loose-loop insert part, which 
locates in the C-terminal DSBH and varies of size and sequence among Tet family members, was used to immunize rats. 
The corresponding domains are boxed. (b) Purified loop fragment of Tet proteins were subjected to gradient SDS-PAGE 
and stained with coomassie. The molecular weight markers are indicated on the left. 
Dr. Kremmer generated the antibodies as described in early reference (Rottach et al., 
2008). For this purpose, His-tagged fragments of Tet1/2/3 were injected into rats, 
hybridomas generated and were cultured, and different supernatants produced by the 
hybridoma technology were initially screened by the enzyme-linked immunosorbent 
assay (ELISA) (Rottach et al., 2008). The positive hybridoma supernatants were tested 
by immunoblotting assay using HEK293T cell extraction with exogenous expression of 
GFP-fused Tet1/2/3 proteins, as well as whole cell extraction from mouse ES cells. After 
comparison among these supernatants, single clones of Tet1 (code: Tet1-5D6) and Tet2 












Figure 8: The localization pattern of endogenous Tet1 and 2. Immunofluorescence staining was performed in the J1 ES cell 
line. Rat monoclonal antibodies Tet1-5D6 and Tet2-9F7 were applied to detect Tet1 and Tet2 proteins, respectively. Anti-
rat second antibody was labeled with ATTO488 fluorescence group. RFP-PCNA was excessively expressed in cells as a 
marker to distinguish cell cycle stages. Scale bars: 5 µm. 
As described in chapter 1.3, Tet1 and 2 are expressed in pluripotent embryonic stem 
(ES) cells, which are derived from the inner cell mass of blastocysts, and play a very 
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important role in pluripotency maintenance and lineage determination. To investigate how 
the Tet1 and Tet2 get regulated according to the cell cycle and DNA replication, I 
performed in vivo immunofluorescence staining of endogenous Tet1 and 2 in ES cells, 
using the previously described antibodies Tet1-5D6 and Tet2-9F7. 
RFP-PCNA was used as marker to distinguish cell cycle stages. PCNA is a key factor of 
the nuclear replication machinery and accumulates at DNA replication foci. Replication 
foci are stably localized in the nucleus and the pattern changes throughout S phase 
(Leonhardt et al., 2000). 
From the immunofluorescence staining profile, I conclude that Tet1 and Tet2 are 
expressed in ES cells and are located in nucleus, which is consistent with published 
mRNA expression data (Szwagierczak et al., 2011). Tet1 and 2 show recruitment pattern 
throughout S phase and also in non-replicating cell cycle stages. The scattered 
enrichment spots do not co-localize with DNA replication foci (Figure 8). 
 
Tet proteins bind to DNA substrates in vitro 
I examined the in vitro DNA binding capability of mouse Tet1/2/3 and their domains by a 
direct competition binding assay. Differentially fluorescently labeled DNA substrates were 
incubated with GFP labeled Tet constructs that purified from HEK293T cells by GFP-trap 
as previously described (Liu et al., 2013, see chapter 2.2). 
 
Figure 9: In vitro DNA binding properties of Tet family proteins and isolated domains. All constructs were expressed as 
GFP fusion proteins in HEK293T cells and affinity-purified with a GFP-trap. Direct competition binding assay was 
performed by incubating proteins with fluorescently labeled DNA substrates, which harbor the same sequence with a single 
CpG site either unmethylated, symmetrically methylated or symmetrically hydroxymethylated. Shown are mean values of 





The above data shows that GFP-Tet1/2/3 have similar and dominant binding affinity 
towards substrates containing unmodified and methylated CpG sites, but the binding was 
inhibited by the substrate with the hydroxymethylated CpG (Figure 9). This preference 
shared by the isolated domains of N- and C-terminus of Tet proteins. Tet11-1366, Tet21-1041, 
Tet31-692, Tet11367-2057, Tet21042-1921 and Tet3693-1668 were subjected to similar DNA binding 
assay as described above. GFP- Tet11-1366, Tet21-1041 and Tet31-692 constructs respectively 
correspond to the N-terminal domains of Tet1, 2 and 3 with GFP fused to its N-terminus, 
and Tet11367-2057, Tet21042-1921 and Tet3693-1668 correspond to the catalytic part constructs 
(Cys-rich region and DSBH) of Tet1/2/3, respectively. 
Therefore, I firstly determined the binding preference of our constructs towards substrates 
containing unmodified and methylated CpG sites. Secondly, I determined that the 
catalytic fragments of Tet proteins contribute to the affinity for DNA without altering the 
substrate preference. Thirdly, Tet1 N-terminus shows significant affinity with DNA 
substrates, which might be due to the presence of CXXC domain in Tet1 or also with 
some other unidentified structures in the N-terminal domain of Tet1. 
 
Multimerization was not detected in Tet1 by in vivo F3H assay 
Previous studies demonstrated that Tet proteins are multi-domain structural (Iyer et al., 
2009; Iyer et al., 2011). For better understanding of the function and interaction between 
domains (Figure 12, see chapter 3.2), I checked whether Tet1 forms multimerization or 
whether interaction exists within the domains of Tet1.  
 
Figure 10: The interaction was detected by the F3H assay and was performed as described, in BHK cells harboring a lac 
operator array (Dambacher et al., 2012). A full-length Tet1 with mCherry-labeling was used as prey, and GFP-fused Tet1 
domain constructs (upper rows) or GFP (as control; lower row) as baits. N: N-terminal domain; C: Cys-rich region; D: 
DSBH. Scale bars: 5 µm. 
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I tested the interaction of mouse Tet1 protein with each subcloned domain using a 
mammalian fluorescent three hybrid assay (F3H) (Dambacher et al., 2012). In this assay, 
GFP fused baits are anchored to a lac operator array, which is integrated in the genome 
of BHK cells, and challenged with preys fused to a red fluorescent protein. All the tested 
pairs did not show interaction (Figure 10). Meanwhile expression of fluorescence-fused 
proteins revealed a nuclear localization of full-length, N-terminal and DSBH domains of 




Although the sequence of the mammalian Tet protein family has been reported and its 
function in the oxidative DNA demethylation has been explosively studied, the exact 
mechanism of Tet proteins’ regulation and the domain structure remains to be elucidated. 
In my Ph.D work, the regulatory mechanisms of Tet proteins were investigated. The 
impacts of CXXC-type zinc finger domains in Tet1 and Tet3 were studied, including the 
cellular localization, gene expression, transcription, interaction partners and molecular 
mobility. In this research, a new transcription isoform of Tet3 was discovered and 
influence of CXXC domain on dioxygenation activity of Tet1 and Tet3 was reported. I 
optimized our powerful 5hmC detection assay, and thus provide insight into the complex 
regulation on dioxygenase activity of Tet proteins. A similar CXXC domain in the DNA 
methyltransferase Dnmt1 was also investigated for structure and functions. Furthermore, 
the interaction partners of Tet1/2/3, Ogt and Oga, were characterized. For these 
purposes, we purified peptides from Tet proteins to produce specific antigens, in order to 
elucidate the biochemical and cellular properties of Tet proteins.  
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3.1 Zinc finger domain: a widespread motif in chromatin-binding 
proteins 
The main objective of this study is to investigate the role of CXXC-type zinc finger 
modules in the regulation of DNA methyltransferase Dnmt1 and Tet methylcytosine 
dioxygenases. To address this question, we cloned the isolated CXXC domains and their 
corresponding elimination mutants for our objective proteins. Various technologies were 
applied with these constructs to demonstrate their in vivo and in vitro properties. In 
addition, conventional PCR and northern hybridization provided evidence for alternative 
mouse Tet3 transcripts, which contains a CXXC sequence in open reading frame (ORF). 
3.1.1 CXXC motif is important for Tet family 
CXXC modules have been shown to mediate chromatin binding. Even though several 
CXXC-type domains show a high sequence similarity, they differ drastically in their 
binding specificity (Lee et al., 2001; Ono et al., 2002; Thomson et al., 2010; Lorsbach et 
al., 2003; Birke et al., 2002). In our study, a homology tree was generated from the 
sequence alignment and structural models were based on the reported MLL1 CXXC 
domain structure. MLL1 contains a zinc finger with the KFGG motif, which is shown to be 
essential for DNA binding activity (Ayton et al., 2004). Additionally, there are two highly 
evolutionary conserved CGXCXXC motifs through the CXXC family, which was also 
demonstrated by our study (Frauer et al., 2011, see chapter 2.1). Structure of MLL1 
CXXC was resolved by multidimensional NMR spectroscopy in 2006, and the DNA-
binding interface was determined by combination of many techniques (Allen et al., 2006). 
The structure reveals that each of the two CGXCXXC motifs chelates a zinc ion within a 
small helix. In addition, the so-called extended residues, which are situated between the 
KFGG motif and the two distal cysteines, form a surface loop that is in close contact with 
the DNA (Allen et al., 2006). This structure study provides basic information of CXXC 
modules, and therefore we used MLL1 CXXC domain as a template to generate the 
structural model of mouse Dnmt1 and Tet1. 
The chromatin-binding proteins containing CXXC domains are divided into three 
subgroups (Frauer et al., 2011, see chapter 2.1). The first subgroup includes the first and 
second ZnF domains of Mbd1, namely Mbd1_1 and Mbd1_2, which were reported to 
have no DNA binding activity (Jorgensen et al., 2004). The second set includes CXXC 
domains of many chromatin-related proteins such as Mbd1_3, CXXC domains of Dnmt1, 
Mll1, CXXC finger protein 1 (CXXC1, also named as Cfp1) and Lys-specific demethylase 
(Kdm2) family proteins. These CXXC domains are mostly found to specifically recognize 
unmodified CpG sequences and target the proteins to CpG-rich locus in DNA (Lee et al., 
2001; Birk et al., 2002; Jorgensen et al., 2004). The third subgroup is consisted with the 
Tet-related CXXC, such as CXXC domain in Tet1 (CXXC6), CXXC4 protein and 
CXXC10-1 motif. This data clearly demonstrates the sequence similarity of intrinsic and 
extrinsic CXXC domains of Tet1/2/3 (Frauer et al., 2011, see chapter 2.1).  
The CXXC domains are characterized by two clusters of 6 and 2 cysteine residues. 
These two clusters are separated by an extending sequence, which varies among 
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different types of CXXC modules (Lee et al., 2001). According to the reported human 
MLL1 structure (Allen et al., 2006), the CXXC domains are delimited by an antiparallel β-
sheet, and therefore we reasoned that the motif forming this discrete structure element 
could present the properties of CXXC domains. Based on the homology and structural 
models, we designed isolated CXXC motifs of Dnmt1 (AA 645-696) and Tet1 (AA 561-
614) proteins, cloned them into mammalian expression constructs and characterized the 
binding activity and biological functions in vivo and in vitro by different experimental 
approaches. The paralogues of CXXC domains in Tet proteins lack a KFGG motif and 
are expected to have distinct properties in comparison to other subgroups. In my Ph.D 
study, I focused on DNA binding, protein interaction, cellular localization and mobility of 
the CXXC motifs in Tet family. 
Our research in 2011 showed that a construct encoding the isolated CXXC domain of 
mouse Tet1 (AA 561-614) with an N-terminal GFP-tag has very low DNA affinity in an in 
vitro DNA binding assay (Frauer et al., 2011, see chapter 2.1). Discrepant results showed 
DNA binding activity of a larger fragment containing CXXC6 domain in Tet1 (Xu et al., 
2011; Zhang et al., 2010). To resolve this contradictive result, we cloned the expanded 
fragment (AA 512-671) and our defined CXXC6 domain (AA 561-614) into different GFP-
tag vectors. The results confirmed that both the expanded fragment with N-terminal GFP-
tag and CXXC6 domain (AA 561-614) with C-terminal GFP-tag showed a similar and 
substantial DNA binding activity (Liu et al., 2013, see chapter 2.2). We conclude that 
direct fusion of GFP fluorescent group at the N-terminus of the CXXC domain might 
interfere with its DNA binding property, and the extra separation sequence between GFP 
and CXXC6 might prevent this obstruction.  
Our studies also demonstrated that the CXXC4, CXXC5, CXXC6 and CXXC-10 bind 
CpG-rich DNA sequences. Among the unmodified, symmetrically methylated or 
symmetrically hydroxymethylated DNA substrates, isolated CXXC domains share a 
similar preference for a cytosine modification in the in vitro direct competition assay. 
Hydroxylated 5mC shows a significant inhibition effect on DNA binding. Considering the 
fact that hydroxymethylated cytosine is the main product of the oxidation catalyzed by Tet 
proteins (Tahiliani et al., 2009; Ito et al., 2010), the DNA binding preference of CXXC 
modules is consistent with the enzymatic function of Tet proteins. Therefore, this data 
might provide evidence on the mechanism for how Tet dioxygenases are targeted to 
specific genomic loci in different cellular contexts. The specific DNA affinity of CXXC 
modules may contribute to the cellular and subcellular distribution of Tet proteins and 
5hmC, which is observed in different tissues (Globisch et al., 2010; Ficz et al., 2011). In 
addition, it was also assumed that the alternative association between Tet3 and an 
intrinsic CXXC domain or interaction with CXXC4 might contribute to the differential DNA 
binding of Tet3 isoforms. However, in vitro DNA binding assays suggested that CXXC4 
and the CXXC-containing Tet3 isoform have similar DNA targeting (Liu et al., 2013, see 
chapter 2.2).  
We not only reported the evidence for in cis association of mouse Tet3 with CXXC10-1, 
but also demonstrated the in trans interaction between Tet3 and CXXC4. Hence, other 
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possibilities in explaining the mechanism for how zinc fingers regulate Tet proteins are 
conceivable. Neural system cells present a high abundance of 5hmC in comparison to 
other somatic tissues (Szwagierczak et al., 2010; Kriaucionis and Heintz, 2009; Globisch 
et al., 2010). We note that the ratio of CXXC-10 to Tet3 transcripts is lower in brain 
tissues, and in contrast CXXC4 transcripts are more expressed. A recent publication 
described the down-regulation effect of CXXC4 and CXXC5 to Tet2 stability on protein 
level and 5hmC level in vivo (Ko et al., 2013). Therefore, it could be hypothesized that the 
different CXXC motifs play regulatory functions in expression and stability of the three Tet 
proteins, or even in an antagonistic manner. In addition, CXXC4 and CXXC5 were 
previously found to be modulators of Wnt signaling pathway, by inhibiting the Dvl and 
Axin complex (Hino et al., 2001; Michiue et al., 2004; Andersson et al., 2009). We found 
that subcellular localization of CXXC4 and CXXC5 is predominantly nuclear. Although 
many Wnt signaling factors are found in the cytoplasm (Itoh et al., 2005; Sokol 2011), it 
still needs further elucidation of the functional link between the Tet proteins, CXXC 
modules and Wnt/β-catenin signaling transduction system. 
Our data suggested that interactions with distinct CXXC domains may modulate Tet 
function (Liu et al., 2013, see chapter 2.2; Frauer et al., 2011, see chapter 2.1). In line 
with our own publications, a recent manuscript reported cloning of human and mouse 
Tet3 isoforms containing a CXXC domain (Xu et al., 2012) and showed that Tet3 is 
essential in Xenopus laevis early eye and neural development by hydroxymethylating the 
promoters of many neuronal developmental genes. Not only the catalytic domain, but 
also the Tet3 zinc finger (CXXC) domain is found to be critical for Tet3 targeting and 
regulating genes. Tet3 protein comprising CXXC mutations or deletions loses the specific 
association with target gene promoters as well as functional rescue ability in vivo (Xu et 
al., 2012). These evidences indicate the importance of CXXC domain in biological 
functions of Tet3 protein, which is consistent with our research (Liu et al., 2013, see 
chapter 2.2). 
In addition to the study on isolated CXXC motifs, we reported the co-transcription of 
CXXC domain with Tet3. As discussed above (chapter 1.3), Tet family members either 
comprise an N-terminal CXXC domain or are genetically situated in close proximity to a 
separated CXXC motifs. Tet1 includes an intrinsic CXXC-type zinc finger in N-terminal 
part (Iyer et al., 2009); tet2 is 700 and 800 kb apart from an isolated cxxc4 in human and 
mouse chromosome location, and cxxc4 is proposed to be originally encoded within an 
ancestral tet2 gene and separated later (Ko et al., 2013). Although human and mouse 
tet3 has also been predicted to harbor ORF adjacent to the cxxc-10 gene (Williams et al., 
2011; Tan et al., 2012), our data were among the first to report the experimental claims 
for intrinsic connection of Tet3 with CXXC-10 motifs, and thus proved that Tet3 also 
contains an ancestral CXXC domain, which is confirmed by both conventional PCR and 
northern hybridization (Liu et al., 2013, see chapter 2.2).  
The specific inhibitory effect of 5hmC on DNA binding of CXXC domains represents a 
possible mechanism of substrate discrimination, in which CXXC domain could act as 
regulatory factor by blocking Tet3 from interacting with hydroxymethylated cytosine 
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associated genomic elements. To examine this hypothesis, we cloned the two isoforms of 
Tet3, with or without the CXXC-10 motif, and compared their catalytic activity, nuclear 
localization, mobility and DNA binding activity by a series of in vivo and in vitro methods. 
Surprisingly, data showed that the CXXC domain is dispensable from Tet3’s DNA binding 
specificity in vitro and the nuclear localization in vivo. Moreover the dioxygenase activity 
on genomic DNA shows similarity between the two isoforms when ectopically expressed 
in cells. However, FRAP analysis showed a slightly lower mobility and weakly increasing 
in the immobile fraction of the CXXC-10 encoding Tet3 isoform. This difference in the in 
vivo binding kinetics between these two isoforms might indicate the involvement of the 
CXXC domain in other nuclear interactions. Further investigation is required to assess 
how the CXXC domain contributes to Tet3 function in vivo. For example, we are 
generating the antibody against CXXC-10, for further investigation on the properties of 
CXXC-10 in different cell lineages and throughout cell cycle.
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3.1.2 Dnmt1 contains a zinc finger in the regulatory domain 
Dnmt1 contains a zinc finger domain of the CXXC type, which is highly conserved among 
Dnmt1 sequences from various animal species (Pradhan et al., 2008). As described in 
the homology model (Frauer et al., 2011, see chapter 2.1), some of CXXC modules, 
which are shown to mediate specific binding to double stranded DNA templates 
containing unmethylated CpG site, are clustered in a distinct homology subset and share 
a KFGG motif, which is found to be essential for DNA binding of CXXC domain in human 
MLL1 (Allen et al., 2006).  
As previously reported, the deletion mutant lacking up to the first 580 amino acids in N-
terminal part of human DNMT1 can still function similar to the full-length protein regarding 
catalytic activity and binding preference, but the mutant lacking the 672 amino acids in N-
terminus could no longer form covalent complex with the DNA methylation cofactor SAM 
(Pradhan and Esteve, 2003). The core CXXC motif that contains a cluster of eight 
cysteine residues (AA 652-697) is partially disrupted in the elimination of 672 amino 
acids, indicating the function of CXXC domain in the enzymatic activity of Dnmt1 
(Pradhan et al., 2008). However, the binding preference of CXXC was conflictingly 
reported in earlier studies (Pradhan et al., 2008; Fatemi et al., 2001). In our own 
research, we showed that this isolated mouse Dnmt1 CXXC domain preferentially binds 
to unmethylated DNA, which was also demonstrated for many other CXXC-containing 
mammalian proteins, including the methyl-CpG binding protein Mbd1 (Jorgensen et al., 
2004), the histone H3K4 methylase Mll1 (Allen et al., 2006; Ayton et al., 2004; Cierpicki et 
al., 2010) and Cfp1 (Butler et al., 2008; Lee et al., 2001). In addition, using quantitative 
FRAP analysis, we showed that the Dnmt1 CXXC module interacts with chromatin 
structure in vivo. 
This DNA binding preference of the Dnmt1 CXXC domain to unmethylated DNA 
substrates provided a possible mechanism of nucleotide discrimination and targeting, 
which properties are necessary for Dnmt1’s biological function. To test this hypothesis, 
we defined and constructed a deletion mutant of Dnmt1, which lacks the corresponding 
CXXC motif, trying not to disrupt the folding of remaining Dnmt1 domains. When 
comparing the functions of wide-type Dnmt1 and its deletion mutant by in vitro and in vivo 
approaches, we found it is surprising that the CXXC domain is dispensable for Dnmt1’s 
DNA binding activity and many functional representations, including intramolecular 
interaction, covalently binding to substrate, methyltransferase activity and DNA 
methylation rescue ability for dnmt1-/- ES cells (Frauer et al., 2011, see chapter 2.1).  
This result is discrepant with previous researches, which demonstrate even point 
mutations in CXXC domain or the complete deletion could abolish the DNA 
methyltransferase activity of Dnmt1 (Fatemi et al., 2001; Pradhan et al., 2008). This 
inconsistence of CXXC domain functions could be resulted from the experimental setups. 
The difference between our and Pradhan’s results might originate from the extent of 
CXXC motif. The larger size of human DNMT1 (AA 647-690) might disrupt protein folding 
or surrounding protein structure (Pradhan et al., 2008). 
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3.1.3 MLL-TET1: another combination of CXXC and TET1 catalytic activity 
As described in previous chapters (chapter 2.1 and 3.1.1), the CXXC domain structure in 
histone H3K4 methylase MLL1 has been resolved and provides a fundamental 
understanding for other CXXC modules. MLL1 CXXC domain shows specific binding to 
unmethylated DNA substrate and contains a KFGG motif. In contrast, the Tet1 CXXC 
domain belongs to another homology group, which lacks the KFGG motif and 
demonstrates distinct DNA binding preference in respect to the cytosine modification 
state. Therefore, a chimeric protein between mixed lineage leukemia (MLL) and TET1, 
which was discovered in human acute myeloid leukemia (AML), evokes research interest 
(Lorsback et al., 2003; Ono et al., 2002).  
This human MLL1-TET1 translocation is generated by an in-frame fusion of the amino-
terminus of MLL with the catalytic part of TET1. MLL1 has been reported to be fused with 
over 30 different partners and frequently been discovered to be involved in translocated 
leukemia (Daser and Rabbitts 2005). Those fusion proteins, including MLL-TET1, 
consistently retain the AT hook and CXXC motif of MLL1. Intriguingly, the CXXC appears 
to be essential for myeloid transformation (Ayton and Cleary, 2001; Ayton et al., 2004). 
The MLL1-TET1 fusion protein lacks the CXXC domain of TET1, but keeps the CXXC 
from MLL1 (Figure 11a). At the C-terminus, the fusion protein retains the entire double 
strand β-helix domain, particularly the characteristic His-Xxx-Asp/Glu...His triad 
dioxygenase catalytic motif. 
 
Figure 11: (a) Schematic presentation of human MLL, TET1, and the rearranged MLL-TET1 fusion protein. The arrowhead 
indicates the translocation breakpoint. This translocation is generated by an in-frame fusion of N-terminus of MLL with 
catalytic part of TET1. SET: Suvar3-9, Enhancer-of-zeste, Trithorax; PHD: plant homeodomain. Protein sequences are 
aligned by online server ClustalW version 2 (Larkin et al., 2007). (b) Scheme of DNA methylation analysis of hoxa9 gene 




Considering the predominant DNA binding function of the CXXC superfamily, the 
substitution of CXXC type in TET1 N-terminus represents a possible mechanism of 
leukemia transformation, where the replaced N-terminus, including CXXC motif, might 
alter target genes of TET1, for example gene homeobox A9 (HOXA9). The HOXA9 gene 
has been reported as the most important specific regulation targets of MLL1 (Milne et al., 
2002). HOXA9 belongs to the HOX gene cluster and is essential for normal embryonic 
development. MLL1-mediated leukemia is frequently accompanied with persistent 
expression of HOXA9 (Krivtsov and Armstrong, 2007), and in leukemia the HOXA9 gene 
is directly bound and activated by MLL1 fused proteins (Milne et al., 2005). Importantly, 
HOXA9 indicates an essential role in human MLL-rearranged leukemias survival (Faber 
et al., 2009). 
Therefore assumingly, the transformation of MLL-TET1 could facilitate incorrectly 
targeting of TET dioxygenase, and consequentially leads to human tumorigenesis. My 
hypothesis is: if the MLL1 N-terminus navigates MLL-TET1 chimeric protein to HOXA9 
gene instead of normal TET1 target genes through either a direct CXXC-binding or an 
indirect protein interaction via N-terminus of MLL1, the retaining catalytic domain of TET1 
could hydroxylate the methylcytosines in the promoter of HOXA9 gene, followed by a loci-
specific demethylation and abnormal activation of HOXA9. A supporting report was that a 
Tet1 fragment, lacking the N-terminal domain, can still catalyze the hydroxylation of 5mC 
(Tahiliani et al., 2009). Considering the importance of HOXA9 in development and 
hematopoietic tumorigenesis (Faber et al., 2009; Krivtsov and Armstrong, 2007), it might 
provide us a very good model in understanding the pathological function of CXXC domain 
and MLL-TET1 translocation. 
To test this hypothesis, the methylation status of hoxa9 promoter from mouse genomic 
DNA samples (obtained from Prof. Bohlander’s group) was examined using bisulfite 
sequencing assay. The genomic DNA was isolated from a BaF3 mouse cell line 
harboring transgenic human MLL-TET1. The analyzed CpG-rich region includes both 
promoter and coding DNA sequence (CDS) (Figure 11b). Unexpectedly, I could not 
detect significant demethylation in this region, indicated by unconverted CpG sites after 
bisulfite treatment, which is similar to the negative control (data not shown). Hence, this 
data indicated that with human MLL-TET1 translocation, no obvious complete erasure of 
methylation marks in hoxa9 gene. However, the outlook of this investigation is to test the 
in situ hydroxylation of 5mC on the hoxa9 gene promoter. 
In contrast to my results, a recent research partially supported my earlier hypothesis 
about TET1’s local activation on HOXA9 in MLL-rearranged leukemia. There, Huang et 
al. published evidence that TET1 is a direct target of MLL-fusion proteins, and is up-
regulated in MLL-rearranged leukemia (Huang et al., 2013). Importantly, although direct 
loci methylation analysis of HOXA9 promoter was not shown, TET1 was confirmed to play 
a pivotal role through interaction with MLL1-fusion proteins in transcriptional activating a 
set of important oncogenic co-targets including HOXA9, which usually indicates the 
unmethylated status of the gene promoters (Busslinger et al., 1983; Jaenisch and Bird, 
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2003; Naveh-Many and Cedar, 1981). However, the mechanism of this regulation was 
not elucidated.  
The inconsistence between my preliminary data and the Huang’s paper could be due to 
many reasons. Firstly, it was human MLL-TET1 translocated in a mouse BaF3 cell line in 
our research. The BaF3 cell line is a bone marrow-derived pro-B-cell line. Both, the 
species difference and the differentiated cell lineage could alter the methylation status of 
hoxa9. Another possible explanation is that 5mC and 5hmC are indistinguishable in the 
bisulfite conversion (as discussed in chapter 3.3). Thus, if TET1 catalytic domain only 
catalyzes partial demethylation process in this cell line, it cannot be reflected from this 
traditional assay. Although our data can not represent evidence for complete 
demethylation of hoxa9 gene promoter, the re-targeting of TET dioxygenase activity is 
still very likely to be an important mechanism for regulating oncogenic genes during 
tumorigenesis. It warrants further investigation on the functional and pathological 
relevance between Tet proteins and CXXC modules.
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3.2 Domain architecture and biological functions of Tet proteins 
3.2.1 General review of Tet domain structure 
As introduced in chapter 1.3, Tet methylcytosine dioxygenase family-mediated oxidation 
of 5mC is a well-characterized DNA modification, likely involved in active DNA 
demethylation pathways. In most animals, the Tet family undergoes a triplication to 
spawn the Tet1, Tet2 and Tet3 genes, which are characterized by an amino-terminal 
domain and a carboxyl-terminal catalytic dioxygenase double stranded β-helix (DSBH) 
domain, harboring an inserted cysteine-rich domain that contains 9 conserved cysteines 
and 1 histidine (Cys-rich domain) between N-terminus and DSBH (Iyer et al., 2009; Iyer et 
al., 2011; Figure 12). 
The N-terminus varies among the Tet family members and is largely uncharacterized. 
The N-terminal domains occupy large fragments, which might indicate a functional 
relevance of protein interaction, activity regulation or post-translational modification 
(PTM). But to date, only little is known about N-terminal domains of Tet proteins. In this 
study, we analyzed the function, structure and DNA binding preference of the known Tet1 
CXXC motif (also referred to CXXC6) that is situated in N-terminus (Frauer et al., 2011, 
see chapter 2.1). We also described for the first time an additional transcript variant in 
Tet3 including another motif called CXXC-10 in N-terminus, proving that Tet3 contains an 
ancestral CXXC domain (Liu et al., 2013, see chapter 2.2). In addition, our research 
demonstrated that glycosylation of Tet proteins mainly presents in the N-terminal regions 
(chapter 2.3). These results provide a further understanding on the regulatory mechanism 
of Tet proteins by their domain structure.  
 
Figure 12: Domain structure of the mouse Tet1/2/3. Mammalian Tet family members share similar domain structure, 
including a low-conserved N-terminal domain, an extension with 9 conserved cysteines and 1 histidine (Cys-rich domain) 
and a core double stranded β-helix (DSBH) of catalytic domain at C-terminus. Length of domain is scaled to its real size 
(Tet1: NP_001240786; Tet2: NP_001035490; Tet3: NP_898961; Tet3 transcript variant: Liu et al., 2013 (see chapter 2.2). 
Metazoan Tet proteins are distinguishable from other members in the Tet/Jbp family by a 
Cys-rich domain that extends from the N-terminus to the DSBH core (Iyer et al., 2009). 
The multiple alignment and bioinformatic analyses described the Cys-rich domain as a 
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Zn-chelating unit, containing 9 conserved cysteines and 1 histidine (Figure 13). 
Interestingly, the Cys-rich domain of Tet proteins is located at a similar position with the 
N-terminal part of AlkB (Yu et al., 2006). However, no evidence existed so far, how the 
presence of this domain influences Tet proteins. Further discussion about the Cys-rich 
domain is continued in chapter 3.2.2. 
The catalytic domain of Tet family members share a double strand β-helix (DSBH) 
structure that binds to Fe (II) and 2OG, in which case the structure couples the two-
electron oxidation of substrate to the oxidative decarboxylation of 2OG and gives 
succinate and CO2 (Figure 6, see chapter 1.3). The DSBH contains a characteristic His-
Xxx-Asp/Glu...His triad motif (Loenarz and Schofield, 2008; Loenarz and Schofield, 
2011). Based on the resolved crystal structure of orthologue AlkB (Yu et al., 2006), 
secondary structure prediction of Tet proteins is summarized (Figure 13), and an extra 
insert loop in DSBH domain is thus identified (Figure 6, see chapter 1.3). This low 
complexity insert loop varies greatly in size and sequence among Tet1/2/3. It was 
speculated to be located on the exterior surface on one side of the catalytic domain, but 
to date, no experimental evidence for this hypothesis is available (Iyer et al., 2009). Thus 
it raises the question about the biological contribution of this insert loop in Tet proteins. 
Potentially, this domain might be involved in protein-protein interactions or might be target 
of post-translational modifications. In my Ph.D study, we found that the insert part of Tet2 
is involved in interacting with Ogt, but the functional relevance of this interaction is 
unclear (chapter 2.3). 
To better understand the biological functions and peculiarities of the Tet proteins was one 
of the initial aims of this thesis. Therefore we defined the fragments of isolated domains 
according to the previously reported bioinformatic analysis (Iyer et al., 2009) and 
secondary structure prediction by online server Jpred (Cole et al., 2008; Figure 13). We 
then cloned the isolated domains of Tet1/2/3 and their corresponding deletion mutants 
into mammalian expression vectors, in order to investigate them with different in vitro and 
in vivo methodologies. 
In an earlier study, we could show that Tet1 comprising a CXXC domain, which has a 
DNA binding with a preference to unmethylated and methylated cytosine (Frauer et al., 
2011, see chapter 2.1; Liu et al., 2013, see chapter 2.2). Thus interesting questions arise: 
whether the DNA binding properties observed for the Tet1 CXXC fragment are 
attributable to the whole protein? And how the Cys-rich region and DSBH dioxygenase 





Figure 13: Multiple sequence alignment and secondary structure prediction of catalytic domain in human and mouse Tet 
proteins. Tet proteins belong to the nucleic-acid-modifying 2-oxoglutarate and Fe (II)-dependent dioxygenase superfamily. 
Conserved cysteine-rich regions extend from N-terminal domains to dioxygenase cores. Characteristic double stranded β-
helix (DSBH) structures, containing unstructured insert loops, occupy the carboxyl-terminus of Tet proteins. Multiple protein 
sequences are aligned by online server ClustalW version 2 (Larkin et al., 2007). Second structure prediction is made by 
online server Jpred (Cole et al., 2008). 
A direct DNA competition binding assay demonstrated In vitro that wide-type mouse 
Tet1/2/3 shows obvious and similar binding preference in respect of the modification state 
of DNA substrates (Figure 9, see chapter 2.4). For individual domains, only the N-
terminus of Tet1 encoding CXXC6 binds to DNA; in contrast, all three catalytic domains of 
Tet1/2/3 show DNA affinity. The preference of these constructs is analogous: nucleotides 
containing unmodified and symmetrically methylated CpG sites represent higher affinity 
with Tet proteins. And interestingly, substrates with the centered hydroxymethylated CpG 
site drastically reduce DNA binding activity of the constructs. This result is consistent with 
our earlier study (Liu et al., 2013, see chapter 2.2). It indicates that Tet1 applies dual 
DNA affinity regions and Tet1/2/3 chiefly use the catalytic box to bind DNA. In line, it was 
reported that a Tet1 fragment, lacking the complete N-terminal domain, can still catalyze 
the oxidative reaction (Tahiliani et al., 2009), consistent with the independent DNA 
association of C-terminus. Hence, the N-terminus seems to be negligible for catalytic 
activity or to chiefly discriminate DNA binding and gene targeting. 
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3.2.2 Cysteine-rich region: an evolutionary conserved domain in Tet family 
Dnmt proteins, which transfer methyl moieties onto cytosine, play a contradictory 
biological role to Tet proteins, which removes methyl moieties by oxidation. Fellinger et al. 
demonstrated that the N-terminal domain of Dnmt1 can form a stable dimer by 
hydrophobic interactions, and this aggregation might play an important role in the process 
of Dnmt1 targeting discrimination of hemi-methylated DNA substrate from other 
modification states (Fellinger et al., 2009). In addition, Tahiliani et al. presented very 
interesting data supporting the hypothesis that multimerization also exists in Tet proteins. 
Using recombinant proteins, immunoblotting showed that the entire catalytic domain of 
human TET1 (TET1-CD) forms multimers when exposed to oxidizing native condition, but 
not in denaturing SDS condition (Tahiliani et al., 2009). The tendency of TET1-CD to 
multimerize appears to at least partly involve the disulfide bond formation by the Cys-rich 
region, because the DSBH domain alone cannot form the dimerization bond. Whether a 
potential multimerization also exists in vivo and whether this might influence the function 
of Tet1 are still elusive. Therefore it attracts my interest to investigate whether 
multimerization of Tet1 occurs in cells. 
Therefore, I decided to apply in vivo F3H assay to investigate this question (Dambacher 
et al., 2012). A combination between fluorescently labeled full-length Tet1 and truncated 
Tet proteins was used to fine map potential dimerization interphases. I expected to see 
the co-localization of green and red fluorescence if a multimerization among Tet 
molecules exists.  
In contrast to the publication from Tahiliani, the F3H assay does not support the 
hypothesis of Tet1 multimerization in a cellular environment, at least not in the 
engineered BHK fibroblast cell line. With isolated Cys-rich region, extended to N-terminus 
or C-terminus, or full-length Tet1, co-localization was not detected (Figure 10, see 
chapter 2.4). In conclusion, protein multimerization was not observed for Tet1 in the F3H 
assay. This discrepancy might be due to experimental differences between the in vivo 
F3H and in vitro protein interaction detections. Under in vitro conditions, intermolecular 
disulfide bonds can be formed during extraction, which are resistant to reducing agent 
(Tahiliani et al., 2009). In contrast, F3H enables the study of in vivo molecular interaction.  
As described in chapter 3.2.1, the Cys-rich domain is specifically conserved through 
metazoan Tet proteins, and shows little sequence homology with other members of the 
2OG-Fe (II) dioxygenase family. Hence, the functional relevance of the Cys-rich region is 
still an interesting question. Tet2 mRNA expression is relatively high in hematopoietic 
progenitors, and deletions or mutations of Tet2 were found in a wide range of myeloid 
malignancies, indicating the diverse biological functions of Tet2 in hematopoietic cell 
lineage (Ko et al., 2010; Langemeijer et al., 2009; Delhommeau et al., 2009; Konstandin 
et al., 2011). Among the numerous mutations of human TET2 reported in acute myeloid 
leukemia (AML), myeloproliferative neoplasms (MPN) and chronic myelomonocytic 
leukemia (CMML), two point mutations were described to locate in the Cys-rich region 
(Abdel-Wahab et al., 2009). They are C1135Y in AML and C1194F in MPN patients, both 
of which belong to the nine characteristic and conserved cysteines (Figure 13). This 
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inspired me to find out the implication of Cys-rich domain using the mouse Tet2 
constructs with the corresponding residues mutated, namely C1050Y and C1108F. In the 
outlook, it might be interesting to correlate functional properties of these leukemia-related 
mutations, such as cellular localization, DNA-binding activity and the influence of these 
two mutations on generating genomic 5hmC, with the onset and progression of the 
diseases. In conclusion, the domain architecture might encode many clues for Tet1/2/3 
evolution, distinct biological functions and diseases. 
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3.3 Cellular functions of Tet proteins: methodology development 
and comparison 
3.3.1 5-Hydroxymethylcytosine detection: a key step forward to a detailed 
understanding of DNA demethylation process 
DNA methylation was considered as a relatively stable, repressive epigenetic mark. With 
the discovery of Tet proteins, it was shown that 5mC can be further modified to 5hmC, 
5fC and 5caC, reflecting a so far undescribed DNA demethylation pathway (chapter 1.2). 
Speculation that Tet proteins and the hydroxylation product 5hmC play a central role in 
the DNA demethylation process is supporting by more and more recent investigations 
(Tahiliani et al., 2009; Ito et al., 2010; Nable and Kohli, 2011; Iqbal et al. 2011; Wossidlo 
et al., 2011). To dissect the individual steps of the demethylation process in quality, 
quantity and time, the detection and quantification of 5hmC abundance becomes an 
important task. For better understanding the mechanistic basis of regulation and functions 
of Tet proteins, we developed our own β-glucosyltransferase (Bgt)-dependent 5hmC 
detection assay. Hereon I discussed the advantage and disadvantage of these 
approaches, in comparison with the method established in our lab. Using our isotope-
labeled method, we examined the genomic 5hmC levels in different tissues and 
investigated the regulatory mechanism of Tet proteins, including the dioxygenase activity 
of Tet1 and its CXXC-deletion, as well as the activity of different Tet3 isoforms, in order to 
elucidate the dioxygenation activity of Tet proteins under different regulatory 
mechanisms. 
Before the discovery of 5hmC and other oxidative products of 5mC in genome, only two 
major states of the cytosine base were described in mammalian genome: either 
methylated or unmodified (Jaenisch and Bird, 2003). At that time, methods and assays 
were designed based on the previous knowledge. Most techniques, including bisulfite 
conversion and methylation-sensitive DNA restriction endonuclease assay, were set up to 
distinguish only these two states (Fraga and Esteller, 2002).   
To date, a simple and fast method in detecting 5mC has been widely accepted and 
applied, based on methylation-sensitive DNA restriction endonucleases, for example 
HpaII and its isoschizomer MspI (Walder et al., 1983). HpaII cleaves only unmodified 
cytosine in a 5’-CCGG-3’ context. In contrast, MspI cleaves the fragments regardless of 
the modification. But now, it is found the occurrence of either methylation or 
hydroxymethylation blocks the cleavage. Even though several methylation-sensitive 
methods exist, the set of endonuclease enzymatic methods cannot discriminate 5hmC 
from 5mC (Nestor et al., 2010; Ichiyanagi 2012). Hence, this method becomes invalid in 
representing the cytosine modification status if 5hmC is present. 
Before 5hmC, 5fC and 5caC were discovered, bisulfite sequencing (BS) conversion was 
another traditional and often-used method for detecting DNA methylation states. Bisulfite 
treatment converts unmethylated cytosine to uracil, and subsequent PCR amplification of 
the converted DNA results in thymine. In contrast, this reaction leaves 5mC unaffected 
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(Fraga and Esteller, 2002). The comparative analysis between original and converted 
sequences will represent the methylation status of DNA. Recently, it was found that 
bisulfite conversion on 5hmC will yield cytosine 5-methylenesulfonate (CMS), and 
therefore 5hmC is indistinguishable from 5mC since the C-to-T transmission does not 
occur, meaning that BS-based methods are not applicable for detecting the intermediates 
of a potential demethylation process either (Huang et al., 2010; Nestor et al., 2010). 
Consequently, the discovery of 5hmC in mammalian genome requires review of DNA 
modification. Many publications showed that 5mC and 5hmC are not only structural 
similar, but are also experimentally indistinguishable from each other by using traditional 
5mC mapping methods (Nestor et al., 2010; Huang et al., 2010). Thus, previous DNA 
methylation data might require re-evaluation in the context of 5hmC. Meanwhile, it is also 
necessary to develop methods to specifically detect 5hmC. An overlook of recently 
reported methods for 5hmC is summarized in table 1, with comparison with the Bgt-
dependent 5hmC measurement method in our group (Szwagierczak et al., 2010). 
Mass spectrometry based methods (Le et al., 2011; Song et al., 2013) and high-pressure 
liquid chromatography (HPLC) with UV detection (Kriaucionis and Heintz, 2009; 
Liutkeviciute et al., 2009) were used to quantify oxidative intermediates of 5mC. These 
assays are well-established and sensitive. Digested genomic DNA containing around 
0.1% 5hmC can be precisely measured (Kriaucionis and Heintz, 2009; Le et al., 2011). 
However, none of these procedures is easily applicable in a mid- or high-throughput 
manner.  
A comparative method is based on selective oxidation by potassium perruthenate 
(KRuO4) of 5hmC to 5fC. Bisulfite treatment can deaminate 5fC to uracil. The comparison 
of sequence data with or without chemical treatment can facilitate a single-base 
resolution mapping of 5hmC. However, considering the low abundance of 5hmC in 
genome, a very high read coverage is required for understanding genome-wide 5mC 
hydroxylation. The high cost of this method restricts its application to most researches 
(Booth et al., 2012). 
The most straight-forward method to analyze global or local 5hmC level is based on 
5hmC immunoprecipitation. There, a specific antibody is used to enrich and analyze 
5hmC-containing sequences. A method named hydroxymethylated-DNA 
immunoprecipitation-sequencing (hMeDIP-seq) was established to analyze the global 
distribution of 5hmC in genome (Williams et al., 2011; Ficz et al., 2011; Wu et al., 2011a). 
Nevertheless, there are also disadvantages being reported, that hMeDIP-seq does not 
work for scattered 5hmC sites, and the precipitation efficiency is dependent of 5hmC 
density (Ko et al., 2010). As shown in reference, a comparative analysis even 
demonstrated that 5hmC-specific antibody basing methods show predominant 
enrichment of precipitating with poly-CA repeats, rising doubts in existing hMeDIP-seq 
data (Matarese et al., 2011). 
Instead of directly immunizing against 5hmC, the bisulfite-treatment intermediate CMS is 
found to be highly immunogenic, resulting in highly specific poly-or monoclonal 
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antibodies. With these tools, it is possible to immunoprecipitate DNA with CMS, and thus 
this method could be applied to indirectly map genome-wide 5hmC level by the detection 
of CMS (Pastor et al., 2011; Huang et al., 2012). However, this method is also designed 
for bulky and high-intensity CMS, but does not work well in genomic regions with sparse 
5hmC either.  
A distinctive property of 5hmC is the glucose affinity and a series of methods are 
developed using β-glucosyltransferase (Bgt) for identification of 5hmC. 
Glucosyltransferases of T-even bacteriophages can transfer glucose from UDP-glucose 
to hydroxyl group of 5hmC in DNA (Szwagierczak et al., 2010; Kornberg et al., 1961; 
Georgopoulos and Revel, 1971), and thus the abundance of 5hmC could be determined 
by the covalently attached glucose. The engineered UDP-glucose alternates and is read 
out by different techniques. 
Song et al. reported a single-base resolution method in 2012. An azide-substituted 
glucose is added to 5hmC by Bgt, then a biotin tag is attached by click chemistry 
reaction, and finally the read-out is done using real-time sequencing (Song et al., 2012a). 
Another laboratory combined many enzymatic and chemical steps to biotinylate 5hmC. 
This method also begins with a glucose transferring and is named as glucosylation, 
periodate oxidation, biotinylation (GLIB), describing the series of reactions. GLIB enables 
precipitation of DNA fragments containing very low density of 5hmC, but produces 
obviously higher unspecific background precipitation of DNA (Pastor et al., 2011; Pastor 
et al., 2012). 
Our research group was among the first, which applied Bgt-catalyzing UDP-glucose 
transferring reaction on 5hmC detection (Szwagierczak et al., 2010; Song et al., 2011a). 
This method uses tritium-labeled UDP-glucose as adduct to 5hmC, and has been shown 
to be highly sensitive and accurate for many reasons. The Bgt is shown to modify all 
tested 5hmC-containing DNA strands and does not exhibit sequential or structural bias. 
The one-step covalent affinity is of high efficiency, strong and highly specific, so we 
reasoned that the incorporated UDP-[3H] glucose could reflect the actual abundance of 
5hmC. Thus this technology promises high robustness as compared to potential immune-
based methods. Tritium-labeling is a widely-used and advantageous tag in many 
biological applications, due to the ease that compounds can be synthesized with a high 
specific activity. With a similar size of ordinary hydrogen atom, a tritium atom is not likely 
to structural interfere with the molecular surrounding of the target 5hmC, preventing the 
physical interruption between labels and DNA, and thus increases the sensitivity of 
detection. Experimental data confirmed that the attachment of [3H] glucose to 5hmC 
dramatically enhances the sensitivity and simplicity of the 5hmC detection and 
quantification in bulky biological samples (Szwagierczak et al., 2010; Liu et al., 2013, see 
chapter 2.2). 
Technologically, there were some technological improvements after the initial publishing 
of the assay (Szwagierczak et al., 2010): we later used abundant UDP-[3H] glucose, 
instead of a mixture of “hot” and “cold” UDP-glucose in order to enhance the signal and 
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improve sensitivity. For better DNA retrieval after purification, we have tested DNA 
precipitation by trichloroacetic acid (TCA) and silica membrane binding, and the optimized 
protocol applies the silica column chromatography and vacuum. For quantification, we 
assume that all DNA samples, including controls, get clearly free from non-reactive UDP-
[3H] glucose and get retrieved with the same ratio. A few essential steps need to be 
considered and controlled to ensure accurate measurements, such as the 
homogenization of genomic DNA into fragment of a size ranging from 200-1000bp by 
sonification. Calibration curves should be made using a mixture of 5hmC-containing and 
unmodified reference fragments, with percentage gradient of 5hmC. The high linear 
relationship between [3H]-glucose incorporation and percentage of 5hmC indicates the 
robustness of the method (Figure 14). 
 
Figure 14: (a) Scheme of the 5hmC glucosylation reaction catalyzed by β-glucosyltransferase (Bgt), UDP-glucose with 
tritium-labeled as cofactor. Glucose is transferred to hydroxyl moiety of 5hmC in DNA. The 5hmC is radioactive and can be 
detected by liquid scintillation (Szwagierczak et al., 2010). (b) Calibration curve using mixtures of 5hmC-containing and 
unmodified reference fragment, with percentage gradient of 5hmC. Note the high linearity between [
3
H]-glucose 
incorporation and percentage of 5hmC. 
In conclusion, along with the development in the research field of DNA demethylation, it is 
found that the Tet protein-catalyzing oxidative modifications on the cytosine base leads to 
a demethylation pathway. New challenges arise, re-evaluation of established DNA 
methylation data is necessary, and most importantly new methodology of efficient 5hmC-
detection is required. Up to date, a few of methods for 5hmC quantification, enrichment 
and mapping exist (Table 1). The advantages of our tritium-labeling glucose transferring 
method are that it is specific, accurate, high-throughput, available for genomic-wide 
detection, allowing parallel processing of large sample number, and is easy to operate 
(Szwagierczak et al., 2010; Song et al., 2011a; Liu et al., 2013, see chapter 2.2). And we 
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Tritium-labeling glucose 
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2011;  
Antibody against 5hmC 
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Allowing processing of 
large number of DNA 
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Pastor et al., 
2011; Pastor 
et al., 2012 
Glucose is transferred to 
5hmC by Bgt, oxidized 
with sodium periodate to 
yield aldehydes, and 
reacted with the aldehyde 
reactive probe (ARP), 
yielding two biotins at the 
site of every 5hmC. 
Pull down 5hmC-
containing DNA 
fragments by streptavidin 
beads, followed by 
sequencing. 
high specificity and 
sensitivity 
higher background 
precipitation of DNA 
CMS-based DNA 
sequencing 
Pastor et al., 
2011; Huang 
et al., 2012; 
Ko et al., 2010 
5hmC is converted to 5-
methylenesulfonate 
(CMS) with sodium 
bisulfite. Special antisera 
against cytosine CMS pull 
down the DNA, and 
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More sensitive than anti-
5hmC in DNA dot blot 
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High density dependence of 
CpG 
Click-chemistry Song et al., 
2011a 
An azide-containing 
glucose is transferred 
onto 5hmC by Bgt. The 
azide group is chemically 
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3.3.2 Monoclonal antibodies against Tet proteins: a useful tool to 
understand in vivo properties 
As described in previous chapters 1.2.3, Tet1/2/3 proteins are expressed differentially 
during development and play different roles in cellular processes, despite their similar 
domain structure among the Tet proteins. Important questions arise, including what are 
the cellular features of Tets and how are they differentially regulated. To better 
understand Tet proteins in vivo, specific tools to analyze Tet proteins in different 
biological assays should be applied. To date, no specific antibody against Tet proteins 
exists. Hence, we generated antigens of mouse Tet1/2/3 by expressing them in E. coli 
and followed by purification process. The insert loops in C-terminus of low evolutionary 
conservation were selected as targeting sequence for the antibodies, in order to minimize 
the cross-talk among Tet1/2/3 proteins (Figure 7, see chapter 2.4). For antibody 
production, these antigens were individually used to immunize rats (Rottach et al., 2008), 
which were further applied in many biochemical methods (chapter 2.4). Using these 
antibodies, we pull-down the endogenous Tet proteins, identified their interaction partners 
and characterized their glycosylation modification (chapter 2.3). In addition, I analyzed 
the localization pattern of endogenous Tet1 and Tet2 in ES cells in the early, middle and 
late S phase (chapter 2.4).  
Study of the human ES cell cycle showed that the pluripotent ES cells maintain the four 
canonical cell cycle stages G1, S, G2, and M. However, stem cells represent unique cell 
cycle characteristics, such as an absent G0 phase, short doubling time due to 
abbreviated G1 phase, and differentially regulated cell cycle checkpoint (Becker et al., 
2006; Barta et al., 2013). Therefore we adopted PCNA as the marker to distinguish non-
replication and DNA synthesis stage. Our immunofluorescence result demonstrated that 
Tet1 and Tet2 are expressed in ES cells (Figure 8, see chapter 2.4), which is consistent 
with published mRNA expression data (Szwagierczak et al., 2010) and the high 
abundance of 5hmC in ES cells (Szwagierczak et al., 2010, Ficz et al., 2011). The 
subcellular localization of Tet1 and 2 shows enrichment through the whole synthesis and 
also in non-replication stage. Dnmt1 is known to be recruited to replication forks by 
interaction with PCNA (Chuang et al., 1997; Leonhardt et al., 1992). In contrast, the 
enriched spots of Tet proteins do not co-localize with DNA replication foci, indicating the 
onset of hydroxylation of target genes is separated from the replication and methylation 
apparatus. The mechanism of how Tet proteins specifically discriminate and target genes 
remains largely unknown.  
In addition, another question is interesting: whether expression levels of Tet1 and Tet2 
fluctuate according to the cell cycle stages? Live-cell imaging system is a very useful tool 
for tracing fluorescent-labeled protein expression profiles in vivo. Biochemical analysis in 
vitro usually applies synchronization cells, meaning arresting cells at certain cell cycle 
stage and releasing them synchronically from the same phases. Therefore, my future 
plan is to analyze the expression fluctuation of endogenous Tet proteins during the cell 
cycle by our antibodies. 
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3.4 Interaction of Tet proteins with Ogt and Oga 
As introduced in chapter 1.2 and 1.3, Tet proteins play a pivotal role in DNA 
demethylation and developmental reprogramming. Although the expression of Tet 
proteins and the abundance of their oxidative products are explosively studied 
(Szwagierczak et al., 2010; Tahiliani et al., 2009; Ito et al., 2011; Pastor et al., 2011; 
Williams et al., 2011), little is known about the regulation, interaction network and post-
translational modification of Tet proteins. In our research, we investigated the interaction 
partner and modification of Tet proteins via series of in vivo and in vitro technologies 
(chapter 2.3). 
We initially generated monoclonal antibodies against Tet proteins for cellular and 
biochemical applications. Using these tools, we immunoprecipitated (IP) Tet1/2 and 
analyzed by LC-MS/MS. Thus, a set of interaction proteins of Tet1 and 2 were identified. 
A dominant interaction partner, O-GlcNAc transferase (Ogt), was demonstrated. Through 
co-IP and F3H assay, we provided novel evidence for Ogt interaction with all three mouse 
Tet proteins (chapter 2.3). This is in contrast with previous researches finding that Ogt 
interacts with only one or two members of Tet family (Shi et al., 2013; Chen et al., 2012; 
Vella et al., 2013).  
Functionally, Ogt is responsible for catalyzing the addition of O-linked N-
acetylglucosamine (O-GlcNAc) to serine or threonine residues of proteins, and another 
enzyme O-GlcNAcase (Oga) catalyzes the selectively removal of O-GlcNAc from target 
substrates (Hanover et al., 2012; Butkinaree et al., 2010). In addition to Ogt, we also 
confirmed the interaction between Oga and Tets, which indicates that the O-GlcNAc 
cycling of Tet proteins is possible to occur. 
In addition, for further understanding the details of the interaction between Tet proteins 
and Ogt/Oga, we fine mapped the interaction domains of Tet2 by in vivo F3H assay. 
Here, we identified that the catalytic domain of Tet2 is the main platform for interaction, 
which might indicates a correlation between the dioxygenase activity and O-
GlcNAcylation for Tet proteins, in accordance with a previous research indicating that the 
DSBH domain of Tet2 interacts with Ogt (Chen et al., 2012). 
O-GlcNAcylation is a widespread post-translational modification (PTM), which was 
reported to have a multitude of biological functions in cells, including responding to 
nutrient/stress availability (Love et al., 2010; Love and Hanover 2005), regulating the 
epigenome and high-order chromatin structure (Sakabe et al., 2010) and interplaying with 
other PTM for metabolic controlling of signaling transduction, gene transcription and 
cytoskeletal functions (Kamemura and Hart, 2003; Zeidan and Hart, 2010; Hart et al., 
2011). PTM system, describing the chemical modification of a protein after its translation, 
largely increases the diversity of the proteome and is also involved in protein functions. 
Therefore the understanding of PTM regulation on proteins is a topic of interest and 
attracts a great deal of research effort. 
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In our study, O-GlcNAcylation modification of Tet proteins is confirmed by 
immunofluorescence in vivo and biochemical approaches in vitro (chapter 2.3). The 
interactors Ogt/Oga are shown to regulate the glycosylation status of Tet proteins. 
Consistent with Chen’s result (Chen et al., 2012), we did not detect the impact of Ogt/Oga 
over-expression on genomic 5hmC abundance (data not shown). In a previous 
manuscript, O-GlcNAcylation was reported to be essential for Tet1 localization and 5hmC 
enrichment on Tet1-target genes (Shi et al., 2013). However, the biological function and 
mechanism of O-GlcNAcylation regulation on Tet proteins are still largely unclear. Hence, 
we will expand our experimental repertoire and test other hypothesis, such as the cross-
talk among different PTMs. 
Interplays between different PTMs drastically encode large amount of information. Cross-
talk exists among acetylation, ubiquitination and O-GlcNAcylation, mostly controlling 
degradation of misfolding, damaged and unwanted proteins, and that is essential for 
cellular homeostasis (Ruan et al., 2013). For example, research in human demonstrated 
that DNMT1 can be acetylated by a protein lysine acetyltransferase 5 (KAT5) and this 
reaction triggers ubiquitination of DNMT1, which promotes proteasomal degradation of 
DNMT1. In contrast, DNMT1 is deacetylated by histone deacetylase 1 (HDAC1) and 
deubiquitinated by USP7, by which it protects and stabilizes DNMT1. These antagonistic 
regulation pathways link acetylation and ubiquitination on the same protein (Du et al., 
2011). Conclusively, different PTMs might interplay each other in promoting or inhibiting 
manners, and carry out cooperative functions. 
Our future plan includes the investigation of regulation link between ubiquitination, 
acetylation and O-GlcNAcylation for Tet proteins. Furthermore, both a research about the 
Tet1 and our own data from mass spectrometry, F3H assay and co-immunoprecipitation 
represented a significant protein interaction between histone deacetylase Hdac1/2 with 
Tet1/2/3 (William et al., 2011; unpublished data), which indicates involvement of 
acetylation on Tet proteins. Although the multifaceted post-translational modification is 
implied from our data, whether and how these PTMs serve for the Tet functions, stability 
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2OGFeDO: 2-oxoglutarate and iron (II) dependent dioxygenase superfamily  
5caC: 5-carboxylcytosine 
5fC: 5-formylcytosine 
5hmC: 5-hydroxymethylcytosine  
5mC: 5-methylcytosine  
AA: amino acid 
AID: activation-induced cytidine deaminase 
AlkB: Alpha-ketoglutarate-dependent dioxygenase 
AML: acute myeloid leukemia 
APOBEC1: apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 
BAH: bromo adjacent homology domain  
BER: base excision repair  
BGT: β-glucosyltransferase 
CpG: cytosine-phosphatidyl-guanine  
CMML: chronic myelomonocytic leukemia 
C-MYC: Myc proto-oncogene protein 
DNA: deoxyribonucleic acid  
DNMT: DNA methyltransferase  
E3-ligase: ubiquitin ligase  
ELP: elongator complex protein  
ES cells: embryonic stem cells  
GADD45: growth arrest and DNA damage inducible protein 45 
GFP: green fluorescent protein  
H3K9me: H3 lysine 9 methyltransferase  
HDAC: histone deacetylase  
HMTs: histone methyltransferases  
HP1: heterochromatin protein 1  
KAT5: lysine acetyltransferase 5 
MBD: methyl-CpG binding domain protein  
MLL: mixed lineage leukemia 
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MPN: myeloproliferative neoplasms 
MTase: 5mC methyltransferase  
NER: Nucleotide excision repair 
NP95: nuclear protein with 95 kilodalton  
OCT4: octamer binding transcription factor 4  
OGA: O-GlcNAcase 
O-GlcNAc: O-linked N-acetylglucosamine 
OGT: O-GlcNAc transferase 
PBD: PCNA binding domain 
PC center: prolylcysteinyl dipeptide center 
PCNA: proliferating cell nuclear antigen  
PDB: protein data bank  
PHD: plant homeodomain 
PGCs: primordial germ cells 
Ring: really interesting new gene 
PRC: polycomb repressive complex  
PTM: post-translational modification 
PWWP: proline-tryptophan-proline motif  
SAH: S-adenosyl-L-homocysteine 
SAM: S-adenosyl-L-methionine 
S phase: synthesis phase  
SRA: SET and Ring-associated  
TDG: thymidine glycosylase  
TET: ten-eleven translocation 
TS: targeting sequence  
UDP: Uridine diphosphate 
UHRF1: ubiquitin-like, containing PHD and RING finger domains, 1 
USP7: ubiquitin specific peptidase 7 
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